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ABSTRACT 
Two streptococcal species, Streptococcus pneumoniae and Streptococcus agalactiae, are 
among the leading causes of pneumonia, sepsis, and meningitis in young children. S. 
pneumoniae infections are estimated to be responsible for over a million child deaths 
each year, while S. agalactiae is a noteworthy cause of invasive neonatal diseases, 
preterm labor, and stillbirth. Both species have developed sophisticated mechanisms 
either to persist in their host as long-term colonizers or to overcome the barriers set 
by the human immune system and cause serious infections. Both pathogens also 
show high genetic variability and are rapidly evolving to escape current treatment 
and prevention methods.  
To be able to fight against these pathogens, the host and the bacterial factors 
contributing to the outcome of the infection need to be thoroughly elucidated, and 
for this purpose, a proper animal model is an essential experimental tool. Although 
the traditionally used mammalian models have been informative in the study of the 
pathogenesis of S. pneumoniae and S. agalactiae, ethical issues and high costs limit their 
use in large-scale experiments. Therefore, I examined the potential of using another 
vertebrate, the zebrafish (Danio rerio), in the study of the host-pathogen interactions 
in S. pneumoniae and S. agalactiae infections. Zebrafish are small, and they can be easily 
handled and kept in large numbers. Also, they provide versatile opportunities for 
genetic manipulation. Importantly, the zebrafish immune system, with both the 
innate and adaptive arms, is highly similar to the human immune system, which 
makes zebrafish an attractive model for the study of infectious diseases.  
In this thesis, both S. pneumoniae and S. agalactiae were shown to be able to cause 
an infection in zebrafish, with the pathology resembling human sepsis and 
meningitis. Additionally, the virulence of S. pneumoniae and S. agalactiae lacking 
common virulence factors was attenuated in zebrafish, emphasizing that these 
infections are promoted by the same pathogenic factors as in human infections. The 
zebrafish embryo model was also used for the closer analysis of the innate immune 
response to a S. pneumoniae infection in a whole-genome level transcriptome analysis 
and in a genetic screen. These studies revealed that, at the level of gene expression, 
the early host responses to S. pneumoniae in zebrafish are strikingly similar to human 
responses and include the activation of genes coding for pro-inflammatory 
  
cytokines, chemokines, acute phase proteins, and antimicrobial peptides. Especially 
the expression of complement-related genes was highly induced upon infection 
suggesting an important role for the complement system in the innate immune 
response to a S. pneumoniae infection also in our model. Finally, in the genetic screen, 
the lack of the acute phase protein CRP (C-reactive protein), which has been shown 
to promote the phagocytosis of S. pneumoniae in humans, was identified as a potential 
predisposing factor to a severe S. pneumoniae infection in zebrafish.  
Altogether, this thesis describes the conservation of the main host-pathogen 
interactions in S. pneumoniae and S. agalactiae infections in zebrafish. Due to the 
notable similarities with human infections, this model is suitable for the identification 
of novel virulence factors promoting streptococcal pathogenesis as well as for the 
evaluation of the host factors affecting the susceptibility to the infection. The 
unraveling of these factors may in the future provide us with important insights into 
the treatment and prevention of the devastating diseases caused by these pathogens. 
 
 
 
 
 
 
 
 
 
 
  
TIIVISTELMÄ  
Streptococcus pneumoniae (pneumokokki) ja Streptococcus agalactiae ovat maailman 
yleisimpiä keuhkokuumeen, sepsiksen ja aivokalvontulehduksen aiheuttajia erityisesti 
pienillä lapsilla. S. pneumoniae-bakteerin on arvoitu olevan vastuussa jopa yli puolen 
miljoonan lapsen kuolemasta vuosittain, kun taas S. agalactiae on merkittävä 
taudinaiheuttaja vastasyntyneillä sekä altistava tekijä ennenaikaiselle synnytykselle ja 
raskauden keskeytymiselle. Molemmat patogeenit ovat kehittäneet monipuolisia 
mekanismeja pystyäkseen oleilemaan isännässään pitkäaikaisina, oireettomina 
kommensaaleina tai toisaalta taas karatakseen isännän immuunipuolustukselta ja 
aiheuttamaan vakavia infektioita. Nämä streptokokit ovat myös osoittaneet laajaa 
kantojenvälistä vaihtelua sekä nopeaa mikroevoluutiota ja siten haastavat nykyisiä 
hoito- ja ehkäisykeinoja.  
Jotta näitä merkittäviä patogeenejä vastaan voitaisiin kehittää tehokkaita 
hoitokeinoja, niiden taudinaiheuttamismekanismit pitäisi tuntea läpikotaisin. 
Tällaista tutkimusta varten tarvitaan oikeanlaisia eläinmalleja. Perinteisesti käytetyt 
nisäkäsmallit ovat auttaneet selvittämään streptokokkien sekä ihmisen välisiä 
vuorovaikutuksia, mutta ongelmat eettisyydessä sekä korkea hinta vaikeuttavat 
esimerkiksi hiirten käyttöä kokeissa, jossa tarvitaan suuria yksilömääriä. Sen vuoksi 
pyrin tässä väitöskirjassa tutkimaan toisen selkärankaisen, seeprakalan (Danio rerio), 
potentiaalia S. pneumoniae -ja S. agalactiae -bakteerien taudinaiheuttamismekanismien 
tutkimisessa. Seeprakalat ovat pieniä ja helposti käsiteltäviä, niiden ylläpitoon 
tarvitaan vain suhteellisen vähän tilaa ja ne omaavat monipuolisia geneettisen 
manipulaation mahdollisuuksia. Näiden ominaisuuksien lisäksi seeprakalan 
immuunipuolustus on pitkälle kehittynyt ja hyvin samankaltainen kuin ihmisellä, 
minkä vuoksi seeprakala onkin houkutteleva malli infektiotutkimuksiin.  
Tämä tutkimus osoitti, että S. pneumoniae ja S. agalactiae aiheuttavat seeprakalassa 
infektion, jossa on samoja piirteitä kuin ihmisen sepsiksessä ja 
aivokalvontulehduksessa. S. pneumoniae -ja S. agalactiae -mutantit, joilta puuttui 
tunnettuja virulenssitekijöitä, olivat seeprakalassa taudinaiheuttamiskyvyltään 
villityypin bakteeria heikompia, josta päättelimme, että nämä bakteerit käyttävät 
samoja infektiomekanismeja sekä seeprakaloissa että ihmisissä. Tämän lisäksi 
käytimme seeprakalan poikasia S. pneumoniae-infektion aikaisen synnynnäisen 
  
immuunivasteen tarkemmassa tutkimisessa. Tätä varten määritimme infektion aikana 
ilmentyviä geenejä sekä tutkimme S. pneumoniae -infektion alttiustekijöitä geneettisen 
seulonnan avulla. Nämä tutkimukset osoittivat, että seeprakalan synnynnäinen 
immuunivaste S. pneumoniae-infektiossa on hyvin samankaltainen kuin ihmisen vaste, 
koostuen mm. pro-inflammatoristen sytokiinien, kemokiinien, akuutin vaiheen 
proteiinien sekä antimikrobiaalisten peptidien tuotannosta. Analyysin mukaan S. 
pneumoniae aktivoi erityisesti komplementti-välitteiseen immuunivasteeseen liittyviä 
geenejä, mikä viittaa näiden mekanismien tärkeään rooliin infektion vastustamisessa. 
Geneettinen seulonta puolestaan paljasti, että kuten ihmisellä, C-reaktiivisen 
proteiinin (CRP) puutos saattaa altistaa seeprakalat vakavammalle S. pneumoniae-
infektiolle.  
Kaiken kaikkiaan, tämä väitöskirja osoittaa, että sekä patogeenien 
taudinaiheuttamismekanismit että isännän puolustusreaktiot S. pneumoniae -ja S. 
agalactiae -bakteereita vastaan ovat hyvin samankaltaisia seeprakalla ja ihmisellä. 
Tämän vuoksi seeprakalaa voidaan luotettavasti käyttää vaihtoehtoisena 
mallieläimenä tutkittaessa streptokokkien ja ihmisen välisiä vuorovaikutuksia. Mikä 
tärkeintä, seeprakalan avulla voidaan tulevaisuudessa saada tärkeää tietoa 
pneumokokin taudinaiheuttamismekanismeista sekä uusia lähtökohtia nykyistä 
tehokkaampien hoitokeinojen kehittämiseen.   
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1 INTRODUCTION 
The streptococcus genus forms an extremely versatile group of Gram-positive 
bacteria, which are adapted to several niches and hosts, and are capable of causing a 
wide spectrum of infectious diseases. In humans, streptococci are predominantly 
harmless commensals and a part of the human microbiota at the mucous membranes 
of the mouth, skin, intestine, genital tract, or the respiratory tract (Nobbs et al., 2015; 
Cole et al., 2008). However, streptococcal bacteria also form one of the most invasive 
groups of human pathogens that are capable of causing severe systemic infections 
such as bacteremic pneumonia, sepsis, and meningitis (Krzysciak et al., 2013). 
From the almost one hundred different streptococci known to us, two 
opportunistic and highly invasive species, Streptococcus pneumoniae (also known as 
pneumococcus) and Streptococcus agalactiae (or group B streptococcus), are responsible 
for significant morbidity and mortality among infants and young children. S. 
pneumoniae is a common colonizer of the human nasopharynx from where it may 
occasionally spread to deeper parts of the body and cause life-threatening invasive 
infections. According to the World Health Organization, WHO, about 1 million 
children die of a pneumococcal disease each year, making it one of the most common 
causes of death at a young age (WHO 2014). S. agalactiae, on the other hand, is a 
typical commensal in the human intestine and in the lower genital tract of pregnant 
women, from where it may be transmitted to the unborn baby before or during labor. 
In infants, the transmission of S. agalactiae may manifest into a severe invasive 
infection, either during the first days (early-onset disease) or the first months (late-
onset disease) of life. The typical clinical presentations of a S. agalactiae infection are 
pneumonia, sepsis, and meningitis, but in addition to the neonatal disease, S. agalactiae 
is also a notable cause of stillbirths and preterm labor. Altogether, S. agalactiae is 
estimated to cause over 150 000 infant deaths and stillbirths every year (WHO 2017).    
The first S. pneumoniae infections were described as early as in the late 18th 
century, but until to the discovery of penicillin in 1929 (Fleming 1929), the treatment 
of these infections was only minimally successful. The great effectiveness of 
penicillin, and also other antibiotics, has later been overshadowed by the appearance 
of antibiotic resistant S. pneumoniae isolates. Since the description of the first penicillin 
resistant S. pneumoniae isolate in 1965 (Kislak et al., 1965), the prevalence of strains 
 14 
 
resistant to antibiotics has rapidly increased and reached a proportion of as high as 
40 % by 2008 (Woodhead et al., 2011). To overcome the obvious limitations of 
antibiotic treatments, two S. pneumoniae vaccine formulations are currently in global 
use. While proven effective, these vaccines are based on the serotype specific 
polysaccharide antigens, which only give protection against a small proportion of S. 
pneumoniae serotypes. As a consequence, the overall incidence of S. pneumoniae 
infections, as well as the prevalence of antibiotic resistant isolates have remained 
nearly the same (Neves et al., 2018; Camilli et al., 2017; Lee et al., 2017). In the case 
of S. agalactiae, a maternal antibiotic treatment is the first choice for the prevention 
of a neonatal disease. However, due to the inefficient screening methods for 
maternal colonization and no protective effect of intrapartum antibiotics on a late-
onset S. agalactiae disease, novel treatments and preventive strategies are constantly 
being searched for. Currently, there is no S. agalactiae vaccine in clinical use. 
For both S. pneumoniae and S. agalactiae, the use of novel drugs acting on the 
immune response instead of targeting the pathogen itself, is a promising strategy for 
treatment. Similarly, novel protein-based vaccine antigens might overcome issues 
concerning the current serotype-specific vaccines. To be able to modulate the 
specific factors at the interphase of the host and the pathogen, these interactions 
need to be known in detail. To gain this knowledge, studies using animal models are 
necessary, and previously these studies have mainly been carried out in mammalian 
models. To overcome the ethical and practical issues concerning the mammalian 
models, this doctoral thesis introduces a novel vertebrate model organism, the 
zebrafish (Danio rerio), for the study of host-pathogen interactions in S. pneumoniae 
and S. agalactiae infections.          
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2 REVIEW OF THE LITERATURE 
2.1 The pathogenesis of streptococcal bacteria  
 
The genus streptococcus consists of over 100 gram-positive species capable of 
inhabiting a variety of ecological niches. The flexibility and adaptability of 
streptococcal bacteria is emphasized by the number of different host species (e.g. 
human, cattle, fish) and tissues (oral cavity, respiratory tract, genital tract, skin), 
where they typically live as harmless commensals (Nobbs et al., 2015; Cole et al., 
2008). On the other hand, streptococci also comprise one of the most infective 
group of pathogens causing diseases of varying severities in humans of all age groups 
(Krzysciak et al., 2013). Noteworthy, many streptococcal species can escape from 
the colonization site, invade deeper parts of the host’s body, and cause life-
threatening invasive infections (Krzysciak et al., 2013). When the bacteria succeed in 
invading the blood, lower respiratory tract, or brain, consequences can be highly 
dangerous or even fatal. By far the most important human pathogens within the 
streptococcus genus are S. pneumoniae, S. agalactiae, and S. pyogenes, all of which are 
frequently isolated from patients with invasive infections (Krzysciak et al., 2013). As 
they are the main focus areas of this thesis, the pathogenesis of S. pneumoniae and S. 
agalactiae are next described in more detail. 
 
2.2 The epidemiology and pathogenesis of Streptococcus 
pneumoniae 
 
S. pneumoniae was first identified in the 1880’s and since then it has been a major 
cause of disease burden all around the world (Watson et al., 1993). Like other 
streptococci, S. pneumoniae is mostly an asymptomatic commensal bacterium, residing 
in the human nasopharynx (Henriques-Normark and Normark 2010). As far as is 
known, humans are the only natural hosts for S. pneumoniae and as much as 60 % of 
the human population is estimated to carry one or several S. pneumoniae strains and 
serotypes (Henriques-Normark and Normark 2010). Local upper respiratory tract 
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infections such as sinusitis and otitis media are the most common clinical 
manifestations of a S. pneumoniae infection. As many as 80 % of all children have at 
least one episode of otitis media during the first three years of their lives and in many 
cases children suffer from repeated infections at a young age (Laursen et al., 2017). 
Therefore, in addition to causing significant morbidity in young children, otitis media 
associated with S. pneumoniae is a major cause of economic burden and antibiotic 
consumption (Laursen et al., 2017; Weycker et al., 2010). 
The harmless commensalism in the upper respiratory tract may occasionally turn 
into a more severe invasive S. pneumoniae disease. The prerequisite of the onset of an 
invasive disease is the escape of S. pneumoniae from the host’s mucosal immune 
system and its spread into deeper parts of the body, including the lungs, the blood, 
or the cerebrospinal fluid, where it causes pneumococcal pneumonia, bacteremia or 
meningitis, respectively (Feldman and Anderson 2014; Ludwig et al., 2012; Lynch 
and Zhanel 2010). Half a million children of under 5 years are estimated to die 
annually of pneumococcal pneumonia alone (Becker-Dreps et al., 2017), while the 
other two clinical presentations are also associated with high mortality rates (on 
average 12 % for all the invasive S. pneumoniae infections) (Backhaus et al., 2016; 
Ludwig et al., 2012; Weycker et al., 2010). The incidence and the severity of S. 
pneumoniae infections are the highest at the extremes of age: in children of under 2 
years and in the elderly of over 65 years (Ludwig et al., 2012; Lynch and Zhanel 
2010). Another important group at risk includes individuals with an 
immunocompromised condition, as is exemplified by AIDS (acquired 
immunodeficiency syndrome) patients, among which the mortality rate of an 
invasive S. pneumoniae infection can be even 100 times higher than in other risk 
groups (Zhang et al., 2015). Since S. pneumoniae is transmitted by becoming directly 
in contact with respiratory secretions, crowded settings, like day care centers, 
schools, and hospitals, are the main sites for the spread of S. pneumoniae colonization 
(Lynch and Zhanel 2010). 
2.2.1 Host-pathogen interactions in a S. pneumoniae infection 
 
An infection is an outcome of the interplay between the host’s immune system and 
the pathogen’s virulence factors. The first interactions of S. pneumoniae with a human 
occur at the colonization site, the nasopharynx, where the progression of the 
infection is typically halted by the innate and adaptive mucosal immune responses, 
which prevent the uncontrolled replication and spread of the bacteria (Calbo and 
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Garau 2010). However, S. pneumoniae expresses a plethora of soluble and membrane 
bound molecules, which either hide the bacteria from the host, allowing longer 
colonization or blood stream survival, or promote the progression of an invasive 
disease. Together, these factors contribute to the success of each of the three stages 
of the infection, 1) the colonization and the attachment to the respiratory 
endothelium, 2) the transendothelial migration to reach the circulation, and 3) the 
invasive state of the disease (Henriques-Normark and Normark 2010; Kadioglu et 
al., 2008). Importantly, the expression of virulence factors is tightly controlled during 
the infection by the bacteria’s regulatory systems to meet the requirements set by the 
environment and the state of the disease (Gómez-Mejia et al., 2017). Many of the S. 
pneumoniae virulence factors are also recognized by the immune system conferring 
protection against the pathogen. A brief introduction to some of the most important 
host and S. pneumoniae responses participating in the battle between the two, are given 
next. 
2.2.1.1. The key components of the immune response to S. pneumoniae 
 
The innate immunity forms the front line of defense against invading pathogens in 
every multicellular organism. The innate immune response comprises of the 
mechanical barriers and soluble components and immune cells providing unspecific 
and fast protection during the first minutes and hours of the invasion (Calbo and 
Garau 2010). Innate immune mechanisms are also responsible for activating the type 
specific adaptive immune response capable of maintaining an immunological 
memory for a previously encountered pathogen (Paterson and Mitchell 2006). In a 
natural infection, S. pneumoniae enters the body through the nasal and oral cavity and, 
therefore, the first physical barriers are set by the epithelial cells lining the upper 
respiratory tract. These cells produce a viscous mucus that acts by trapping the 
bacteria leaving them unable to move downwards in the respiratory tract (Stannard 
and O'Callaghan 2006). The mucus together with the entrapped S. pneumoniae are 
then removed from the respiratory tract by coughing and by the movement of cilia, 
the hair-like structures on the surface of epithelial cells (Stannard and O'Callaghan 
2006). Human respiratory mucosa also produces the enzyme lysozyme, which 
actively degrades the peptidoglycan in the cell wall of S. pneumoniae (Henriques-
Normark and Normark 2010).  
Pattern recognition receptors (PRRs) are a diverse set of host molecules 
responsible for the early recognition of invaders and the initiation of the 
inflammatory response (Suresh and Mosser 2013). The group of PRRs include for 
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example Toll-like receptors (TLRs), NOD-like receptors (NLRs), C-type lectins, 
Scavenger receptors and various cytosolic DNA censors (Suresh and Mosser 2013). 
Of those recognizing S. pneumoniae, a few examples are given below. During an 
infection, these receptors recognize conserved molecules (microbe associated 
molecular patterns, PAMPs) on the surface of or released by the invading pathogens 
(Suresh and Mosser 2013). Upon activation, these receptors may trigger signaling 
cascades which lead to the production of soluble inflammatory mediators or activate 
the intake of bacteria by the cell. Three classes of TLRs have so far been shown to 
play a role in the recognition of S. pneumoniae: TLR2, TLR4, and TLR9 (Albiger et 
al., 2007; Malley et al., 2003; Yoshimura et al., 1999). TLR2 and TLR4 are expressed 
on the surface of numerous host cells, including the innate immune cells, epithelial 
cells, and a subtype of T cells, and they have been shown to recognize constituents 
of the pneumococcal cell wall, (e.g. lipoteichoic acid and peptidoglycan) and soluble 
pneumolysin, respectively (Malley et al., 2003; Schroder et al., 2003; Yoshimura et 
al., 1999). Unlike TLR2 and TLR4, TLR9 is an endosomal receptor and is known to 
recognize the DNA of phagocytosed S. pneumoniae (Albiger et al., 2007). In many 
cases, these three TLRs bind to an intracellular adapter protein MyD88 (Myeloid 
differentiation primary response 88) which, through a signaling cascade, activates the 
transcription factor NF-ĸB (nuclear factor kappa-light-chain-enhancer of activated 
B cells) (Koppe et al., 2012; Albiger et al., 2005). NF-ĸB controls the expression of 
many host genes, including genes encoding the proinflammatory cytokines and 
chemokines, such as IL1B, IL6, IL8, and TNF, resulting in the recruitment of the 
innate and adaptive immune cells and the activation of a general inflammatory 
response to S. pneumoniae (Anderson and Feldman 2011).  
Besides TLRs, other types of innate PRRs have been found to respond to S. 
pneumoniae related molecules. NOD2 is a cytosolic NLR, which can recognize S. 
pneumoniae proteoglycans and activate the NF-ĸB dependent expression of pro-
inflammatory genes (Davis et al., 2011; Opitz et al., 2004). Another NLR, NLRP3, 
binds to pneumolysin and contributes to the inflammasome mediated proteolytic 
activation of IL1B and IL18 (Witzenrath et al., 2011; McNeela et al., 2010). The 
cytosolic DNA sensor AIM2 also acts through the inflammasome after recognizing 
endosomal S. pneumoniae DNA (Fang et al., 2011). As an example of the C-type 
lectins, mouse SIGN-R1 is known to respond to S. pneumoniae, namely, to its 
polysaccharide capsule and to activate the intake and killing of the bacteria by 
macrophages (Lanoue et al., 2004). Similarly, a scavenger receptor MARCO 
(macrophage receptor with collagenous structure) on the surface of macrophages is 
shown to recognize and promote the intake of S. pneumoniae, via a yet unknown 
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ligand, and lead to the enhanced TLR2 and NOD2 -mediated signaling (Dorrington 
et al., 2013; Arredouani et al., 2004). A schematic presentation of the selected host 
receptors involved in S. pneumoniae recognition, is shown in Figure 1. 
 
 
Figure 1. The host’s pattern recognition receptors participating in the recognition of S. 
pneumoniae. The image is a simplified schematic representation of the selected host-S. 
pneumoniae interactions described in the text. Various bacterial factors (orange), are bound by 
the surface (TLR2, TLR4), endosomal (TLR9) or cytosolic (NOD2) receptors of host’s 
antigen presenting cells. The recognition of S. pneumoniae cell wall components (LTA, 
peptidoglycans), pneumolysin, and endosomal DNA and proteoglycans leads to the 
activation of the transcription factor NF-κB which triggers the expression of pro-
inflammatory genes. In addition, the pneumolysin of S. pneumoniae activates the 
inflammasome cascade leading to the proteolytic activation of Il1B and Il18. The image is 
out of scale. TLR=toll-like receptor, LTA=lipoteichoic acid, Ply=pneumolysin.  
Macrophages are the resident innate immune cells in several tissues, including 
those of the lungs, and have therefore an important role in the clearance of S. 
pneumoniae during the early stages of an infection (Dockrell et al., 2003). 
Macrophage’s main roles are to engulf and kill S. pneumoniae and, also to trigger an 
inflammatory response to recruit other immune cells (Calbo and Garau 2010). 
Another type of leukocytes, neutrophils, are soon recruited to the site of infection 
where they adopt the role of the primary cell type in the clearance of S. pneumoniae 
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(Dockrell et al., 2012; Calbo and Garau 2010; Kolling et al., 2001). Although 
phagocytosis and the following intracellular killing of the bacteria through the action 
of hydrolytic enzymes and reactive oxygen species are the main clearance 
mechanisms of neutrophils, these cells are also found to contribute to the 
entrapment of S. pneumoniae, through the formation of neutralizing NETs, the 
neutrophil extracellular traps (Papayannopoulos 2018; Beiter et al., 2006).  
The phagocytic activity of neutrophils and macrophages is greatly enhanced by 
the action of the complement system, a complex network of over 30 proteins 
which can induce an efficient inflammatory and cytolytic reaction as a response to 
invading pathogens (Dunkelberger and Song 2010). In a S. pneumoniae infection, the 
effector functions of the complement system are initiated by the antibody, CRP (C-
reactive protein) -or SAP (Serum amyloid P) -dependent classical pathway, 
through spontaneous activation by the alternative pathway, or the lectin pathway 
(Ali et al., 2012; Yuste et al., 2007; Brown et al., 2002). The activation of complement 
by either one of these mechanisms ultimately leads to the proteolytic cleavage of the 
component 3 (C3) into the proinflammatory mediator C3a and the opsonin C3b 
(Dunkelberger and Song 2010). As its main function during the infection, the 
complement system greatly enhances the phagocytotic activity of neutrophils by 
marking the S. pneumoniae surface with C3b (Dunkelberger and Song 2010). In 
addition, through the function of C3a, and many other anaphylatoxins, several 
immune cell types are recruited to the site of infection (Dunkelberger and Song 
2010). However, due to the protective role of the thick polysaccharide capsule, 
complement does not seem to have a membrane attack complex -mediated cytolytic 
activity towards S. pneumoniae (Andre et al., 2017). 
To completely eradicate a S. pneumoniae infection, the innate immune mechanisms 
represented above need to act in a synergy with the adaptive immune mechanisms. 
The adaptive immunity comprises of the cellular and humoral parts, characterized 
by the function of T and B lymphocytes, respectively (Murphy 2012). In general, 
two main classes of T cells exist, the cytotoxic CD8+ T cells which destroy the host’s 
own harmful cells by inducing apoptosis and the helper CD4+ cells, which stimulate 
B cells and other leukocytes and regulate the immune response (Murphy 2012). B 
cells, on the other hand, secrete specific antibodies and are mainly responsible for 
the immunological memory (Murphy 2012). Traditionally, the adaptive immune 
response to S. pneumoniae has been thought to be mainly mediated by the B cells and 
the secreted antibodies (immunoglobulins, Ig) against the protein and the 
polysaccharide antigens of S. pneumoniae (Malley 2010; Lee et al., 2003). As explained 
above, the host’s phagocytosing cells are an important part of the innate immune 
 21 
 
response to S. pneumoniae, since they are able to engulf and destroy the attacking 
bacteria. However, these cells, mainly the macrophages and the dendritic cells, also 
act by linking the innate and adaptive responses by presenting specific peptide 
antigens derived from the engulfed S. pneumoniae on their surface (Murphy 2012). 
These antigens are bound to the major histocompatibility complexes (MHC) and 
interact with the T cell receptors on the surface of helper T cells. T cells, then, can 
activate the antibody production in B cells by straight interaction and by secreting 
stimulating cytokines. Since, the MHCs are only able to present the peptide antigens, 
another mechanism exists for the activation of the B cells by the polysaccharide 
antigens. This mechanism is T cell independent and occurs when the 
polysaccharides on the surface of S. pneumoniae bind directly to the antibodies on the 
B cells (Lee et al., 2003). More recently, another adaptive response to S. pneumoniae 
has been reported, an antibody-independent T cell response (Zhang et al., 2009; 
Lu et al., 2008). In this mechanism, the IL17A secreting CD4+ helper T cells are the 
important mediators, which recognize S. pneumoniae protein antigens and confer 
protection against the colonization through enhanced phagocytosis by neutrophils 
and macrophages (Zhang et al., 2009; Lu et al., 2008).  
2.2.1.2 Examples of the S. pneumoniae virulence factors  
 
During the long time that it has coexisted with its host, S. pneumoniae has developed 
sophisticated methods to escape from the above-mentioned traps set by the immune 
system. Some examples of these factors are given next. First, being more a 
characteristic than a virulence factor, multiple S. pneumoniae may form large 
communities, biofilms, which isolate the bacteria from the environment and confer 
longer persistence at the colonization site (Chao et al., 2015). More specifically, 
biofilms for example, hamper the binding of antibodies and other opsonins, but can 
also prevent the penetration of antibiotics to the bacterial surface (Chao et al., 2015; 
Steel et al., 2013). As another isolating factor, the S. pneumoniae cell wall is surrounded 
by the layer of polysaccharide chains which form a so-called capsule. The capsule 
has important roles in several steps of the infection and is therefore considered the 
most important virulence factor of S. pneumoniae (Geno et al., 2015). Moreover, the 
variation in the composition of capsule polysaccharides is the basis for the high 
variability among S. pneumoniae, dividing the species into more than 90 serotypes 
(Geno et al., 2015). During colonization, the capsule prevents the entrapment and 
clearance of the bacterial cell by the mucus and subsequently promotes the early 
steps of the infection (Nelson et al., 2007). During colonization, the capsule observes 
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a thinner, “transparent” form, which has been proposed to expose components of 
the cell wall that promote the binding of the bacteria to the endothelium (Weiser 
1998; Weiser et al., 1994). The thin capsule also appears beneficial during the 
migration through the epithelial cell layer into the circulation (Steel et al., 2013). 
Along with promoting colonization, the main role of the capsule in the pathogenesis 
of S. pneumoniae is to prevent bacterial phagocytosis by the host’s macrophages and 
neutrophils. Therefore, to achieve the best antiphagocytic activity during the invasive 
state, the capsule returns to its thick, or “opaque” form (Serrano et al., 2006; Kim et 
al., 1999; Weiser et al., 1994). By hampering the binding of immunoglobulin, 
complement, and CRP to the bacterial cell wall, the capsule prevents bacterial 
clearance by opsonophagocytosis (Hyams et al., 2010a; Mitchell and Mitchell 2010). 
On the host side, the capsular polysaccharides are bound by antibodies which 
promote the activation of complement and the phagocytosis of S. pneumoniae 
(Anderson and Feldman 2011). The antibodies recognizing the capsular structures 
are also the basis for the serotype specific protection and the development of an 
immunological memory against S. pneumoniae (Malley 2010). The great importance of 
the capsule in the pathogenesis of S. pneumoniae has been demonstrated in animal 
models where the unencapsulated bacteria have been shown to be avirulent (Morona 
et al., 2004; Briles et al., 1992). 
S. pneumoniae produces a variety of surface exposed proteins may be divided into 
the classes of LPXTG-anchored proteins, lipoproteins, choline-binding 
proteins and non-classical proteins based on the motifs anchoring them on the 
bacterial surface (Mitchell and Mitchell 2010). These proteins serve diverse functions 
in the virulence of S. pneumoniae and in the modulation of host’s responses. Some of 
them, mostly choline-binding proteins and non-classical proteins, are surface 
adhesins promoting the attachment of the bacteria to the epithelial cells, an action 
that determines the success of the infection (Hammerschmidt 2006). For example, 
two choline-binding proteins with particular relevance in vaccine development, are 
the pneumococcal surface protein A (PspA) and the pneumococcal surface 
protein C (PspC), which bind various glycoconjugates on host cells as well as 
lactoferrin and the epithelial polymeric immunoglobulin receptor, respectively ( 
Zhang et al., 2000; Hammerschmidt et al., 1999; Hammerschmidt et al., 1997). 
Besides promoting adherence, PspA and PspC also have important 
immunomodulatory functions in S. pneumoniae virulence, namely, the disturbance of 
the activation of complement and subsequent opsonophagocytosis (Yuste et al., 
2010; Dave et al., 2004; Jedrzejas et al., 2000; Janulczyk et al., 2000). As examples of 
the non-classical surface adhesins, with no recognized anchor motifs, 
 23 
 
pneumococcal adherence and virulence factors A (PavA) and B (PavB) bind 
to the host’s extracellular matrix, and this way, promote adherence and 
transendothelial migration (Bumbaca et al., 2004; Holmes et al., 2001). In addition 
to several cell surface adhesion proteins, some strains of S. pneumoniae also possess 
extended polymer structures, or pili, which contribute to the attachment of the 
bacterium to the respiratory epithelium, but also stimulate the intake of bacteria by 
macrophages (Orrskog et al., 2012; Barocchi et al., 2006).  
Pneumolysin (ply) and autolysin LytA are other virulence proteins important in 
S. pneumoniae pathogenesis, during both the colonization and the invasive disease. 
Pneumolysin is a well-studied protein of S. pneumoniae with a wide array of different 
roles during the infection, both in promoting the virulence of S. pneumoniae and in 
inducing the host’s immune response (Marriott et al., 2008). Pneumolysin is a toxin 
that in high concentrations can cause the lysis of host cells by forming pores on the 
cell surface (Marriott et al., 2008). Through its cytotoxic effect on the respiratory 
epithelium, for example, pneumolysin promotes the transendothelial migration of 
bacteria into the circulation (Anderson and Feldman 2011; Feldman et al., 1990). 
Pneumolysin also supports the infection by activating the complement system, in 
attempt to guide the complement to act further away from the infection, consume 
the complement components or exhaust the host with an excessive inflammatory 
response (Marriott et al., 2008; Alcantara et al., 2001; Paton et al., 1984). On the 
other hand, pneumolysin is a soluble and exposed protein and therefore frequently 
recognized by the host’s immune system. By binding to macrophages through the 
TLR4, pneumolysin promotes the production of proinflammatory cytokines and the 
chemotaxis of neutrophils and CD4+ T cells to the site of infection (Koppe et al., 
2012; Malley et al., 2003). Pneumolysin has also been found to interact with a type 
of NLR, the NLRP3 in macrophages, with the same consequence (Witzenrath et al., 
2011; McNeela et al., 2010). Autolysin LytA, on the other hand, is another choline-
binding protein and one of the many hydrolytic enzymes (LytA, LytB, LytC, CbpE) 
of S. pneumoniae (Mitchell and Mitchell 2010). LytA cleaves the peptidoglycan in the 
S. pneumoniae cell wall, and this way, takes care of the cell wall turnover and enables 
cell growth (Mellroth et al., 2012; Berry et al., 1989a). More importantly, the activity 
of LytA is responsible for the lysis of the bacterial cells, autolysis, and the release of 
inflammatory components and toxins, including pneumolysin, into the surroundings 
(Steel et al., 2013; Kadioglu et al., 2008). 
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2.3 The epidemiology and pathogenesis of Streptococcus 
agalactiae 
 
S. agalactiae is a highly invasive streptococcus, which is not restricted to only humans 
but is also an important pathogen in goats, cows, fish, and seals (Delannoy et al., 
2013; Brochet et al., 2006). Originally, in the late 1880’s, S. agalactiae (or group B 
streptococcus, GBS) was discovered as an infectious agent in cattle and almost 50 
years later it was isolated from human vaginal swaps (Le Doare and Heath 2013; 
Lancefield and Hare 1935). Nowadays, this pathogen is best known as the dominant 
pathogen in neonates. The vaginal tract of a pregnant woman is the main reservoir 
of S. agalactiae and, occasionally, it may cause an infection of the upper genital tract 
and placenta, or more rarely, bacteremia and pneumonia (Hall et al., 2017; Deutscher 
et al., 2011). An S. agalactiae colonization and infection in pregnant women is also 
associated with a higher risk of premature birth and stillbirth (Bianchi-Jassir et al., 
2017). An average of 20 % of pregnant women worldwide are carriers of S. agalactiae, 
and the vertical transmission prior or during birth is estimated to occur in 50 % of 
cases, 1-2 % of which develop into a neonatal disease (Russell et al., 2017a; Russell 
et al., 2017b; Seale et al., 2017; Le Doare and Heath 2013). The clinical outcomes of 
a S. agalactiae infection in neonates can be classified into two groups, an early-onset 
and a late-onset disease, both being associated with high (9-15 %) mortality rates and 
a risk for long-term dysfunction (Seale et al., 2017; Le Doare and Heath 2013). The 
S. agalactiae infection presented during the first six days of life is termed as early-onset 
and the most common outcomes during this period are sepsis and pneumonia 
(Russell et al., 2017b; Le Doare and Heath 2013). A late-onset S. agalactiae infection 
in turn, occurs within the first three months after birth and in most cases, develops 
into meningitis (Le Doare and Heath 2013). Besides vertical transmission, a late-
onset S. agalactiae infection may also be acquired from the hospital or community 
sources (Le Doare and Heath 2013). Altogether, S. agalactiae is the leading cause of 
sepsis and meningitis in neonates and accounts for almost 150 000 stillbirths and 
infant deaths annually (Seale et al., 2017). Moreover, meningitis caused by S. agalactiae 
causes moderate or severe neurological impairments in 20 % of the survivors (Kohli-
Lynch et al., 2017). 
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2.3.1 Host-pathogen interactions in a S. agalactiae infection 
2.3.1.1. The key components of the immune response to S. agalactiae 
 
Due to the close relatedness and the structural similarities between S. pneumoniae and 
S. agalactiae, these two bacteria also share basic mechanisms of pathogenesis. 
Moreover, the host immune response employs the same components of the innate 
and adaptive immune system in the clearance of a S. agalactiae infection, as it does in 
a S. pneumoniae infection. These host-pathogen interactions are only briefly described 
in this review. S. agalactiae has been found to colonize multiple mucosal sites, 
including the intestine, genital tract, and respiratory tract where the mucosal 
immune response plays an important role in preventing the progression of the 
disease. These responses include the mucus entrapment, phagocytosis and 
intracellular killing by resident macrophages, and the specific production of IgA 
(Kolter and Henneke 2017; Vornhagen et al., 2017). When it is able to proceed into 
the circulation, S. agalactiae encounters effectors, such as phagocytosing neutrophils, 
the complement system, and Ig secreting B cells, which act in co-operation to 
prevent fulminant sepsis and the onset of meningitis (Kolter and Henneke 2017; 
Doran et al., 2016). Importantly, while S. agalactiae is mostly a harmless colonizer in 
humans, the early developmental stage of these responses, particularly the 
immaturity of phagocytes and the adaptive immune response during the first months 
of life, may explain the high prevalence and severe consequences of an invasive S. 
agalactiae disease in neonates (Basha et al., 2014).  
Like in a S. pneumoniae infection, the innate immune response to S. agalactiae is 
triggered by the activation of PRRs on the surface of dendritic cells and 
macrophages. These PRRs include, for example, TLR2 and TLR7 that recognize S. 
agalactiae lipoproteins and RNA, respectively (Mancuso et al., 2009; Henneke et al., 
2008). The activation of TLRs by S. agalactiae typically leads to the induction of 
proinflammatory mediators, such as IL1B, IL6, IL8, and TNF, in a Myd88-
dependent manner, as well as the production of type I interferons (IFN) (Landwehr-
Kenzel and Henneke 2014; Mancuso et al., 2009; Henneke et al., 2008). The 
production of IFN is also induced by the interaction of the cytosolic censors STING 
and cGAS with S. agalactiae DNA (Andrade et al., 2016; Charrel-Dennis et al., 2008). 
The inflammasome mediated activation of IL1B and IL18, on the other hand, is 
triggered by the recognition of the S. agalactiae RNA and β-hemolysin by NLRP3 
(Gupta et al., 2014; Costa et al., 2012). A schematic presentation of the selected host 
receptors involved in S. agalactiae recognition, is shown in Figure 2. 
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Figure 2. The host’s pattern recognition receptors participating in the recognition of S. 
agalactiae. The image is a a simplified chematic representation of the selected host-S. agalactiae 
interactions described in the text. Various bacterial factors (yellow), are bound by the surface 
(TLR2), endosomal (TLR7) or cytosolic (SIGN/cGAS) receptors of host’s antigen 
presenting cells. The recognition of S. agalactiae lipoproteins and endosomal nucleic acids 
leads to the activation of the transcription factor NF-κB which triggers the production of 
various cytokines, chemokines, and interferons. In addition, endosomal S. agalactiae β-
hemolysin activates the inflammasome cascade leading to the proteolytic activation of Il1B 
and Il18. The S. agalactiae β-hemolysin also activates the histamine and cytokine production 
by mast cells. Ultimately the recognition results in the immune cell recruitment and an 
inflammatory response. The image is out of scale. TLR=toll-like receptor. IRF=interferon 
regulatory factor. 
Upon recognition through various PRRs, macrophages recruit other immune 
cells to the site of infection. As with S. pneumoniae, neutrophils play a crucial role in 
the phagocytic clearance of S. agalactiae and the entrapment of bacteria by 
extracellular traps (NETs) (Vornhagen et al., 2017). Like in a S. pneumoniae infection, 
specific IgA and IgG antibodies against the polysaccharides of the S. agalactiae 
capsule are key components in the adaptive immune response to S. agalactiae. 
Additionally, various other surface structures, including the pilus and the surface 
proteins Ripb and alpha C, may trigger the production of specific antibodies and an 
immunological memory (Lachenauer and Madoff 1996; Stålhammar-Carlemalm et 
al., 1993). Yet another cell type, mast cells, have relatively recently been associated 
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with the initiation of the immune response against S. agalactiae in the lower genital 
tract. Although best known for their role in allergies, mast cells also act in the first 
steps of the immune response by recruiting neutrophils to the S. agalactiae 
colonization site (Gendrin et al., 2015). The mechanism of recruitment includes the 
degranulation of mast cells by the S. agalactiae β-hemolysin and the subsequent release 
of histamine and proinflammatory cytokines (Gendrin et al., 2015).  
2.3.1.2 Examples of the S. agalactiae virulence factors 
 
The development of an invasive S. agalactiae infection requires successful 
colonization, translocation, survival in the bloodstream and, in the case of 
meningitis, crossing of the blood-brain barrier (BBB), a layer of specialized 
endothelial cells separating the central nervous system from the blood (Doran et al., 
2016; Landwehr-Kenzel and Henneke 2014). To overcome these challenges, S. 
agalactiae produces a diverse array of virulence determinants, which interfere with the 
host’s clearance mechanisms and account for the specific interactions leading to the 
penetration of the barriers. In general, the adhesion and tissue penetration at distinct 
colonization sites, as well as at the BBB are mostly mediated by the same host-
pathogen interactions (Vornhagen et al., 2017; Doran et al., 2016; Landwehr-Kenzel 
and Henneke 2014). First, the formation of a biofilm has been shown to be 
important also during S. agalactiae colonization, as the biofilm protects the bacterial 
community from the environment, and also facilitates the attachment of bacteria to 
epithelial cells (Rosini and Margarit 2015). Among the protein virulence factors of S. 
agalactiae (e.g. LPXTG-anchored proteins and lipoproteins), numerous adhesion 
molecules mediate the binding of S. agalactiae to the mucosal epithelium and the 
BBB, and some of them also promote passage through these barriers (Doran et al., 
2016; Lindahl et al., 2005). For example, fibronectin-binding protein A (FbsA) and 
laminin-binding protein (Lmb) attach S. agalactiae to the extracellular matrix while 
another fibronectin-binding protein, FbsB contributes to the invasion into tissues 
(Schubert et al., 2004; Gutekunst et al., 2004; Schubert et al., 2002; Spellerberg et al., 
1999). In addition, S. agalactiae’s Alpha C proteins and serine rich proteins (Srr) also 
participate in attaching the bacteria to the extracellular matrix and the surface of 
epithelial cells (Seo et al., 2012; Seo et al., 2013; Samen et al., 2007; Bolduc and 
Madoff 2007; Bolduc et al., 2002). Like S. pneumoniae, S. agalactiae possess pilus 
structures which facilitate the binding of the bacteria to the epithelium, and also to 
the BBB (Doran et al., 2016; Konto-Ghiorghi et al., 2009; Dramsi et al., 2006). 
Importantly, another factor mediating adherence to the epithelial cells and the BBB 
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is the hypervirulent GBS adhesin (HvgA) (Tazi et al., 2010). Intriguingly, this 
surface exposed adhesion molecule is only expressed in S. agalactiae serotype III, the 
sequence type 17 (ST-17) clone, which is the most common isolate in meningitis 
associated with the late-onset neonatal disease (Tazi et al., 2010). 
Like in S. pneumoniae, the cell wall of S. agalactiae is covered by a thick 
polysaccharide capsule (Vornhagen et al., 2017; Landwehr-Kenzel and Henneke 
2014). This structure also shares the mechanisms with the S. pneumoniae capsule in 
promoting immune evasion during the invasive disease and in providing antigens for 
antibody-mediated recognition (Doran et al., 2016; Landwehr-Kenzel and Henneke 
2014; Campbell et al., 1991). Based on the varying capsule composition and 
immunogenicity, S. agalactiae are divided into 10 serotypes (Doran et al., 2016). For 
these reasons and due to the avirulent nature of the capsule-deficient S. agalactiae, the 
capsule is thought to be the most important virulence factor of S. agalactiae (Rubens 
et al., 1987). Another virulence factor, β-hemolysin plays a role in many steps of the 
S. agalactiae infection. First, β-hemolysin is capable of modulating epithelial and 
endothelial cells at the intestinal, amniotic, and blood-brain barriers, and cause the 
translocation of bacteria through these barriers (Whidbey et al., 2013; Doran et al., 
2003; Doran et al., 2002). Second, in order to cause severe tissue damage, β-
hemolysin can also use its cytolytic activity against several types of host cells, 
including brain endothelial cells and primary neurons (Doran et al., 2016; Reiß et al., 
2011). Moreover, β-hemolysin uses several strategies to resist or modulate the host’s 
immune response, including the inhibition of complement, protection form 
intracellular killing in neutrophils, and induction of the expression of the anti-
inflammatory IL10 (Doran et al., 2016; Landwehr-Kenzel and Henneke 2014; Sagar 
et al., 2013; Bebien et al., 2012; Liu et al., 2004).  
Finally, the expression of the above-mentioned virulence factors in addition to 
many more bacterial components is highly regulated in the course of an infection to 
either maintain colonization or enable invasion (Landwehr-Kenzel and Henneke 
2014). S. agalactiae’s two-component control system CovS/CovR (control of 
virulence sensor/regulator) is one of the many systems responsible for such a 
regulatory mechanism (Jiang et al., 2005). This system consists of two domains: 
CovS, which responds to changes in environmental conditions and 
activates/inactivates CovR, the regulatory part of the system (Lamy et al., 2004). 
When activated, CovR regulates the expression of the other virulence factors of S. 
agalactiae, including the pilus and β-hemolysin (Lamy et al., 2004). In addition to 
disease progression, the regulated expression of S. agalactiae genes under different 
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environmental conditions most probably contribute to the high adaptability of this 
streptococci to multiple ecological niches (Rajagopal 2009).  
2.4 The remaining challenges in the eradication of S. 
pneumoniae and S. agalactiae 
 
The current treatment methods for S. pneumoniae and for S. agalactiae rely on 
antibiotics (Braye et al., 2017; Woodhead et al., 2011). In the case of suspected or 
diagnosed maternal S. agalactiae colonization, intrapartum antibiotic prophylaxis is 
recommended (Braye et al., 2017). In fact, systematic screens to detect maternal 
colonization are conducted in many countries using either of the two recommended 
strategies, the risk-factor based screening or the universal screening (Braye et al., 
2017; Heath 2016). However, the efficiency of the screen may vary among countries, 
and also, both strategies may lead to false positive and false negative results and, 
consequently, to unnecessary or insufficient antibiotic treatments (Braye et al., 2017). 
Despite the downsides of the screening, the intrapartum antibiotic prophylaxis 
regime has been proved efficient in preventing the vertical transmission of S. 
agalactiae and the early-onset infection in neonates, but it has no effect on the late-
onset disease (Toyofuku et al., 2017). In the case of S. pneumoniae, the discovery of 
penicillin in 1929 revolutionized the treatment and the prognosis of S. pneumoniae 
infections turning hopeless cases into treatable conditions (Chain et al., 1940; 
Fleming 1929). However, the great success of antibiotic treatments has later been 
overshadowed by an increase in the incidence of antibiotic resistant strains of S. 
pneumoniae (Kim et al., 2016; Liñares et al., 2010; File 2006). In 2008, the proportion 
of clinical isolates resistant to β-lactams, macrolides or tetracyclines, and importantly, 
also multidrug resistant strains, had reached a worryingly high incidence rate of as 
much as 40 %, and since that, the rate has remained nearly the same Neves et al., 
2018; Camilli et al., 2017; Lee et al., 2017; Woodhead et al., 2011).    
Due to the challenges in treating S. pneumoniae and S. agalactiae with antibiotics, 
preventive vaccination strategies hold more promise in the battle against these two 
streptococci. Currently, there is no vaccine for S. agalactiae in clinical use. The 
inefficient screening methods, concerns about the excessive use of antibiotics, and 
the limited methods for preventing the late-onset neonatal disease have, however, 
driven the development of vaccines to a point where several potential alternatives 
have made it into clinical trials (Heath 2016). These vaccine candidates are based on 
the capsular polysaccharides from the most relevant serotypes, which are conjugated 
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to a carrier protein (Heath 2016). In the case of S. pneumoniae, two vaccine 
formulations, also based on the immunogenicity of capsule polysaccharides, are 
currently in global use, the pneumococcal polysaccharide vaccine (PPV23) and the 
conjugate vaccine (PCV) (Falkenhorst et al., 2017; Feldman and Anderson 2014; 
Lynch and Zhanel 2010). The polysaccharide vaccine consists of plain 
polysaccharide antigens and, thus, its efficiency is poor in children under 2-years of 
age, due to their immature T cell independent immune response (Lee et al., 2003). 
The polysaccharides in the conjugate vaccine, on the other hand, are linked to an 
immunogenic carrier protein, which can also elicit a strong T cell dependent immune 
response and, therefore, provide better protection compared to PPV (Feldman and 
Anderson 2014; Lee et al., 2003). Consequently, since 2000, the licensing year for the 
conjugate vaccine PCV7, this vaccine type has been the first choice for vaccination 
and, together with the updated version of PCV13, has shown to decrease the 
incidence of S. pneumoniae infections remarkably (Becker-Dreps et al., 2017; Corcoran 
et al., 2017; Waight et al., 2015; Moore et al., 2015; Isaacman et al., 2010; Huang et 
al., 2009). For instance, in the United States, the incidence of invasive S. pneumoniae 
diseases dropped to almost zero after the introduction of PCV7, while the incidence 
of pneumonia decreased by 39 % in children (Pilishvili et al., 2010; Grijalva et al., 
2007).  
Despite the clear positive effect of S. pneumoniae vaccines, the high capsular 
variability among the species together with the serotype specific nature of protective 
antibodies has raised concerns about the global efficacy of the polysaccharide based 
vaccines (Geno et al., 2015). As mentioned previously, there are over 90 capsular 
variants (or serotypes) of S. pneumoniae, which differ in their ability to colonize and 
invade, and in their geographical distribution (Geno et al., 2015; Grabenstein and 
Musey 2014; Rodrigo and Lim 2014). Out of the over 90 serotypes, PCV7 provided 
protections against seven of the clinically most relevant serotypes and resulted in a 
clear decline in the prevalence of these serotypes (Huang et al., 2009). However, as 
the carriage of vaccine serotypes decreased, the emergence of the uncovered 
serotypes became evident and the new serotypes soon started to take the role of the 
most common infectious agents (Huang et al., 2009). To respond to the burden of 
newly emerged serotypes, the PCV13 vaccine, covering 13 serotypes, was introduced 
in 2009 (Geno et al., 2015). Although the positive impact of PCV13 has been evident, 
serotype replacement remains a major challenge in the prevention of S. pneumoniae 
infections and forces vaccine developers into a continuous race with the evolving S. 
pneumoniae. 
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As discussed, S. pneumoniae shows strong adaptability to the changing 
environment and can readily respond to the pressures introduced by antibiotics and 
vaccines to ensure better survival. Other selective pressures include competition for 
nutrients and interactions with host’s immune system (Henriques-Normark et al., 
2008). The wide spectrum of hosts and the original transition to humans, on the 
other hand, emphasize the similar adaptability of S. agalactiae (Flores et al., 2015). 
Although in a much larger scale for S. pneumoniae, both streptococci show notable 
genetic variation within the species, but also within serotypes (Flores et al., 2015; 
Henriques-Normark et al., 2008). This genetic variation explains the intraspecies 
differences for example in the pathogenicity, invasiveness, and target hosts and is 
caused by the evolution of the genomes of both streptococci (Nobbs et al., 2015; 
Straume et al., 2015). The mechanisms driving genome evolution include point 
mutations and larger rearrangement within the genome, but also the transfer of 
genetic material between bacteria form the same or different species (Straume et al., 
2015; Nobbs et al., 2015). Since both the streptococci described in this thesis are 
efficient colonizers and share their niche with many other bacteria, the prolonged 
habitation of these sites provides favorable circumstances for the horizontal transfer 
of genes (Nobbs et al., 2015). With the horizontal transfer of genetic material, a 
bacterium may gain, for example, antibiotic resistance or change its serotype to one 
not covered by the current vaccines (Straume et al., 2015). Antibiotic resistance may 
also be acquired through the accumulation of point mutations in the genes encoding 
the target molecules of antibiotics, such as S. pneumoniae penicillin-binding proteins 
(Straume et al., 2015). With the same mechanism, bacteria may also gain useful 
changes in the structure and function of virulence factors and regulatory systems, 
which may help them escape the immune system or leads to improved invasiveness 
(Flores et al., 2015; Mitchell and Mitchell 2010).  
To circumvent the detrimental effects of genome evolution to the treatment and 
prevention of S. pneumoniae and S. agalactiae, novel approaches are needed. In the case 
of S. pneumoniae, treatment strategies modulating the host’s immune response, rather 
than targeting the bacteria directly, are being investigated (Zumla et al., 2016; 
Feldman and Anderson 2014). In addition, vaccines based on non-capsular antigens 
are constantly being developed to gain broader protection against S. pneumoniae and 
S. agalactiae serotypes (Heath 2016; Alderson 2016). So far, several proteins of both 
pathogens have proved to be potential vaccine antigens either alone or in 
combination, including the S. pneumoniae’s pneumolysin, PspA and PspC and the S. 
agalactiae’s Alpha C and Rib proteins, and the pilus (Kamtchoua et al., 2013; Margarit 
et al., 2009; Ogunniyi et al., 2007; Cao et al., 2007; Larsson et al., 1999). 
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2.5 An overview of the zebrafish as a model organism 
 
Animal models have been for long utilized in biomedical research to gain a better 
understanding of human physiology or embryogenesis, but also to mimic biological 
responses to normal and pathological conditions. Through these studies, animal 
models have improved our knowledge about many diseases, and also contributed to 
the development of new drugs and vaccines. Regarding the complex nature of the 
human immune system, the comprehensive modeling of infectious diseases would 
not be possible without a proper animal model. The use of invertebrate models has 
provided important discoveries about the human immune system, exemplified by 
the Toll-like receptors originally found in the fruit fly Drosophila melanogaster (Lemaitre 
et al., 1996). In addition, invertebrate models have also been extensively used in the 
study of host-pathogen interactions during an infection (O'Callaghan and Vergunst 
2010). However, due to similarities with human anatomy and physiology and, 
therefore, better translation of the results to humans, mammalian models, like mice, 
rats, rabbits, and non-human primates, have gained more popularity in the fields of 
immunology and infectious diseases than invertebrates (Andersen and Winter 2017). 
However, another vertebrate, the zebrafish (Danio rerio), has more recently shown its 
value by providing a practical and ethical alternative for mammals in the study of 
complex interactions between microbes and the host’s immune system (Goldsmith 
and Jobin 2012; Meeker and Trede 2008).  
Zebrafish are small teleost fish which are native to the Himalayan region where 
they commonly inhabit slowly-moving streams, ponds, and rice fields (Spence et al., 
2008). Due to the small size of the adult fish (<6 cm), zebrafish can be maintained 
in laboratory conditions with a high population density and are thus more cost-
effective compared to mammals (Bowman and Zon 2010; Meeker and Trede 2008). 
In addition, the embryonic development of zebrafish is fast (most of the internal 
organs are fully developed at 5 days post fertilization) and they reach the adulthood 
in a relatively short time (in 2-3 months). Because of the short generation time (2-3 
months) and high fecundity, zebrafish are especially well-suited for studies requiring 
a large number of animals, like genetic or chemical screens (Bowman and Zon 2010; 
Meeker and Trede 2008). Importantly, the transparency of the embryos provides a 
unique opportunity for live imaging during embryogenesis, and the visualization of 
cellular and molecular functions in different conditions and genetic backgrounds 
(Tobin et al., 2012). Yet another beneficial characteristic of the zebrafish as a model 
organism is its relatively easy genetic manipulation and the availability of several 
genetic tools (discussed later).  
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While the ethical concerns, high costs, and small number of progeny are 
noteworthy disadvantages of most mammalian models, zebrafish also has its own 
limitations as a model organism. First, the clear anatomical differences in fish 
compared to humans, including gills instead of lungs, no limbs or lymph nodes, 
different sites of hematopoiesis, and a very different reproductive system limit the 
modeling of certain types of diseases (Tobin et al., 2012; Menke et al., 2011). Second, 
the zebrafish is a relatively new model organism, which affects the availability of 
some reagents and tools, including antibodies specific to surface markers, zebrafish 
cell lines, and a lack of a feasible homologous recombination mediated knock-in 
method (Tobin et al., 2012; Meeker and Trede 2008). Third, the teleost-specific 
genome duplication event during evolution together with the still limited gene 
annotation might pose challenges to comparative genomics and gene manipulation 
(Howe et al., 2014; Goldsmith and Jobin 2012). The sequencing of the zebrafish 
genome revealed that approximately 70 % of all human genes have an ortholog in 
fish. However, due to the duplication event, 50 % of these human genes correspond 
to several copies in the zebrafish (Howe et al., 2014). Finally, the environmental 
conditions of zebrafish are different from humans, as is exemplified by temperature. 
While zebrafish are raised at 28 °C, human specific pathogens have adapted to 37 
°C, which might limit or change the nature of the pathogenicity of certain microbes 
in this model (Allen and Neely 2010). Despite the above-mentioned limitations, 
zebrafish do have great potential in disease modelling, drug discovery, and vaccine 
development. Importantly, a major characteristic driving the development of 
zebrafish disease models is the similarity of the immune systems of fish and humans. 
Therefore, the zebrafish immune system and its relation to the human immune 
system is reviewed next. 
2.5.1 The zebrafish immune system and its relation to the human 
immune system 
 
As vertebrates, zebrafish possess a highly evolved innate immune system. Due to the 
ancient genome duplication event and the following diversification, components of 
the zebrafish innate immunity show great diversity, providing perhaps a broader 
protection to invading pathogens compared to mammals (van der Vaart et al., 2012; 
Stein et al., 2007). Then again, the zebrafish adaptive immune response comprises 
of all the main components found in humans (Kanther and Rawls 2010). Therefore, 
this organism provides a suitable model for the study of the adaptive immune 
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response as well. As a unique characteristic, the development of the zebrafish 
immune system is graduated, the fully functional adaptive responses appearing as 
late as 4 weeks post fertilization (wpf) (Lam et al., 2004). This provides an attractive 
possibility to study the vertebrate innate immune system in zebrafish embryos and 
larvae without the influence of the adaptive immunity. However, when using the 
zebrafish embryo model to study host-pathogen interactions, the hematopoietic 
context into which the microbe is introduced should be carefully considered, since 
it might affect the outcome of the microbial challenge (Lohi et al., 2013; Kanther 
and Rawls 2010; Paik and Zon 2010).  
In the developing embryo, the primitive wave of hematopoiesis begins already at 
12 hours post fertilization (hpf) giving rice to the primitive phagocytosing cells: 
macrophages around 20 hpf and neutrophils around 30 hpf (Le Guyader et al., 
2008; Herbomel et al., 1999). The primitive macrophages are able to phagocytose 
invading pathogens already at 30 hpf and are the dominant cells clearing bacteria in 
zebrafish during the first 2 days of development (Torraca et al., 2014; Colucci-Guyon 
et al., 2011; Herbomel et al., 1999). The phagocytosing activity of primitive 
neutrophils starts around 50 hpf, but at a seemingly lower level (Colucci-Guyon et 
al., 2011; Le Guyader et al., 2008). Neutrophils, however, are the main cell type 
responsible for bacterial clearance in larvae and adult zebrafish (Harvie and 
Huttenlocher 2015; Le Guyader et al., 2008). The second wave of hematopoiesis, the 
definitive wave, starts around 30 hpf and gives rise to multipotent myeloid and 
lymphoid progenitors, which around 4 days post fertilization (dpf) start to colonize 
the definitive hematopoietic tissues in adult fish, the kidney marrow and the thymus 
(bone marrow and thymus in humans) (Paik and Zon 2010; Jin et al., 2007; 
Murayama et al., 2006). In general, the definitive hematopoiesis in zebrafish 
produces all of the innate immune cell types observed in humans, except for 
basophilic granulocytes. Out of the three human granulocyte lineages, zebrafish have 
neutrophils and eosinophils (Balla et al., 2010; Le Guyader et al., 2008). Moreover, 
zebrafish monocytes, macrophages, dendritic cells, mast cells, and Natural killer 
(NK) -like cells have also been described (Lugo-Villarino et al., 2010; Dobson et 
al., 2008; Yoder et al., 2004; Yoder et al., 2001; Herbomel et al., 1999). Although the 
lymphopoiesis and the Rag-dependent rearrangements of lymphocyte receptors 
occur already at 4 dpf, the adaptive immune system with a protective antibody 
response is fully active only after 4 wpf (Lam et al., 2004).  
Like humans, zebrafish possess an array of pattern recognition receptors (PRRs), 
which are bound by the conserved molecular structures derived from pathogens. 
The TLRs, NLRs, lectins, and the common adaptor proteins are conserved between 
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human and zebrafish at varying levels, while the group of mammalian cytosolic DNA 
censors seems to be absent (Li et al., 2017; van der Vaart et al., 2012). In general, 
zebrafish cytokines and chemokines are highly diverged in zebrafish compared to 
humans, although the counterparts for the most important proinflammatory 
cytokines, IL1B, IL6, and TNF, and the anti-inflammatory cytokine IL10, do exist 
with similar functionalities (Varela et al., 2012; van der Vaart et al., 2012; 
Stockhammer et al., 2009; Pressley et al., 2005). In contrast, the group of interferons 
mainly responsible for antiviral responses, seems to be more distinct in zebrafish 
than in humans (Yoon et al., 2016; Stein et al., 2007). While humans have three types 
of interferons, type I (IFNα, IFNβ), type II IFN (IFNγ), and type III IFN (IFNλ), 
zebrafish possess only type II IFNs with two members, IFNγ (or IFNγ2) and IFNγ-
rel (or IFNγ1) (Yoon et al., 2016).  
Zebrafish has homologous genes for the 10 human TLRs, except for TLR6 and 
TLR10 (Meijer et al., 2004). Due to the genome duplication, human TLR4, TLR5, 
and TLR8 have two counterparts in the zebrafish genome (Meijer et al., 2004). In 
addition, the zebrafish genome encodes for fish specific TLRs and TLRs found 
exclusively in fish, amphibians and birds (Li et al., 2017). The ligand specificity for 
some of the zebrafish TLRs is still only partly known, but recent studies have shown 
clear functional conservation with some of the TLRs, including TLR2, TLR5 and 
TLR9 (S. Yang et al., 2015; Yeh et al., 2013). Interestingly, this genomic conservation 
does not necessarily implicate functional similarity (e.g. TLR4), however, nor does 
the absence of a clear homolog in zebrafish genome always signify the loss of a 
homologous function in the species. The knowledge of the ligand specificity of the 
TLRs from other fish species suggests that, for example, the zebrafish TLR14 might 
be a functional counterpart for human TLR6 and TLR10, compensating for the 
absence of these human homologs in zebrafish (Hwang et al., 2011). As described 
for the TLRs, the common adaptor proteins (such as MyD88, Tirap, Ticam1 and 
Sarm) and the components of the TLR downstream signaling cascades leading to the 
activation of the NF-ĸB mediated proinflammatory response, as well as the 
components of interferon signaling, are also well conserved (Stein et al., 2007). 
While the receptors of the TLR family in zebrafish show clear conservation with 
the mammalian TLR family supplemented with a few fish specific members, the 
family of NLRs in zebrafish seems to be highly expanded with more than 400 
members compared to 23 NLRs in human (Li et al., 2017; Howe et al., 2014). Among 
this huge gene family, the homologs for Nod1, Nod2, and Nod3, to name a few, have 
been identified and also represent similar functionalities in the innate immune 
response as their human counterparts (Li et al., 2017; Howe et al., 2014). In contrast, 
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the functions of the hundreds of fish specific NLRs and their possible roles in 
pathogen recognition remain unknown (Li et al., 2017; Howe et al., 2014). Some C-
type lectins, including the complement activating mannose-binding lectin (MBL) 
as well as scavenger receptors have been identified in zebrafish (Yang et al., 2014; 
Benard et al., 2014; Jackson et al., 2007).  
As an important part of the innate immune response to pathogens, the 
complement system is also highly conserved in zebrafish and includes all three 
activation pathways (Boshra et al., 2006; Boshra et al., 2004). A genomic comparison 
between fish and humans revealed the existence of zebrafish genes for all of the 
more than 30 complement proteins in humans (Zhang and Cui 2014; Boshra et al., 
2006). Although the structural similarity between the human and zebrafish 
complement system postulates also functional conservation, the roles of most 
zebrafish complement proteins have not yet been characterized. Importantly, as 
described for other components of the innate immunity, the zebrafish genes for the 
complement system show isotypic diversity, as is exemplified by the existence of 
eight copies of genes for the C3 in the zebrafish genome (Forn-Cuní et al., 2014; 
Gongora et al., 1998).  
As described above, the zebrafish innate immune response shows a higher level 
of diversity and complexity compared to mammals. The zebrafish adaptive 
immunity, on the other hand, contains all the main components of the human 
adaptive immune response, but does not provide the same diversity for specific 
antigen recognition. To bridge the innate and adaptive immune responses, the 
antigen presenting cells (APCs) take in, process, and present the pathogen-derived 
molecules to the naïve T cells (Murphy 2012). The professional APCs in mammals 
include dendritic cells, macrophages and B cells, which all present the pathogen 
derived antigen through a type II MHC and the co-receptors. Similarly, the role of 
the APCs in zebrafish is carried out by the same cell types with the characteristic 
MHC II expression (Lewis et al., 2014; Renshaw and Trede 2012; Lugo-Villarino et 
al., 2010). Zebrafish dendritic cells are found in great numbers in the spleen and gut, 
and these organs are thought to serve as secondary lymphoid organs, the sites of 
antigen presentation (the spleen, lymph nodes and gut in mammals) (Renshaw and 
Trede 2012; Lugo-Villarino et al., 2010). Upon stimulation, the naïve CD4+ T cells 
specialize into distinct subsets, such as Th1, Th2 and Th17 with characteristic 
cytokine repertoires and specialized functions, also found in zebrafish (Dee et al., 
2016; Mitra et al., 2010). In addition to CD4+ T cells, the adaptive cellular immune 
response in zebrafish is substituted by other T cell types, cytotoxic CD8+ cells and 
CD4+/CD25+ T regulatory cells (Kasheta et al., 2017; Renshaw and Trede 2012). 
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The CD4+ helper T cells stimulate B cell maturation and proliferation leading to the 
production of antibodies. A notable difference between the zebrafish and 
mammalian adaptive immune response lies in the antibody classes and the diversity. 
In general, based on the B cell numbers, the zebrafish adaptive immune response is 
estimated to be 5 orders of magnitude simpler than in humans (Weinstein et al., 
2009). In addition, although zebrafish undergo Rag-dependent VDJ 
recombination, the somatic hypermutation creating variability in the antigen 
recognition is less efficient than in mammals (Marianes and Zimmerman 2011; 
Weinstein et al., 2009). Importantly, in contrast to five antibody classes in humans 
(IgM, IgG, IgD, IgE, and IgA), zebrafish only expresses two mammalian classes 
(IgM, IgD) in addition to a fish specific IgZ class and do not undergo class 
switching (Hu et al., 2010; Danilova et al., 2005; Wakae et al., 2005). However, 
despite these differences and limitations, zebrafish have been shown to mount a 
protective antibody response upon immunization and have successfully been used 
in vaccination studies (Myllymäki et al., 2017; Oksanen et al., 2016; Oksanen et al., 
2013; Cui et al., 2010; Lam et al., 2004).  
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Table 1. Comparison of the selected components of the immune systems of zebrafish and 
human 
  HUMAN ZEBRAFISH 
innate cell types  
macrophages yes yes 
granulocytes eosinophils, neutrophils, 
basophils 
eosinophils, neutrophils 
dendritic cells yes yes 
mast cells yes yes 
Natural Killer cells yes yes 
pattern recognition receptors 
Toll-like receptors 10 different (TLR1-
TLR10) 
homologs for the human 
genes encoding TLR1-
TLR5 and TLR7-TLR9. 
Two copies of TLR4, 
TLR 5 and TLR8. Several 
zebrafish specific genes.   
NOD-like receptors 23 members over 400 members 
complement system 
pathways classical, alternative and 
lectin pathway 
classical, alternative and 
lectin pathway 
protein components over 30 protein 
components 
homologs for all the 
complement genes in 
humans. Several copies 
of each component. 
adaptive immune cells 
antigen presenting cells macrophages, dendritic 
cells, B cells 
macrophages, dendritic 
cells, B cells 
T cells helper, cytotoxic and 
regulatory T cells, Th1, 
Th2 and Th17 responses 
helper, cytotoxic and 
regulatory T cells, Th1, 
Th2 and Th17 responses 
B cells yes yes 
antibody response 
Ig classes IgA, IgD, IgG, IgE, IgM  IgD, IgM, IgZ  
VDJ recombination yes yes 
class switching yes no 
somatic hypermutation yes yes 
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2.5.2. Zebrafish toolbox 
 
Both zebrafish embryos and adult zebrafish have been utilized in the study of 
infectious diseases due to the similarities with human immune system, as described 
above. Moreover, both models also provide unique possibilities for studies due to a 
toolbox full of practical methods for imaging, genetic manipulation, and 
experimental infections. An experimental bacterial infection in zebrafish larvae, for 
example, can be conducted through various routes to achieve either a systemic 
infection (e.g. the blood circulation valley or the caudal vein) or a local infection (e.g. 
the hindbrain, the otic vesicle, or the pericardial cavity) (Saralahti and Rämet 2015; 
Harvie et al., 2013; Prajsnar et al., 2008; van der Sar et al., 2003; Davis et al., 2002). 
Alternatively, a more natural infection can be accomplished by static immersion or 
through the alimentary tract (Harriff et al., 2007; Pressley et al., 2005). The yolk sac 
injection at 0-1 dpf represents a high-throughput and even automated method for 
an experimental infection, and can be conducted with slowly replicating bacteria, 
which then disseminate from the injection site into various tissues (Spaink et al., 
2013). In adult zebrafish, two routes of infection are mostly used, the intraperitoneal 
route to cause a systemic infection, and the intramuscular route to follow the 
dissemination of bacteria from the local infection site (Miller and Neely 2004).  
The transparency of the zebrafish embryos provides an additional benefit for the 
in vivo imaging of the infection dynamics and immune cell functions. Zebrafish are 
naturally non-pigmented until 2 dpf, after which the amount of pigmentation in the 
skin can be restricted either chemically or genetically to extend the imaging period 
(Antinucci and Hindges 2016; Karlsson et al., 2001). Through the genetic 
manipulation of the pigmentation genes, the advantages of imaging can also be 
extended to adult zebrafish (casper and crystal lines) (Antinucci and Hindges 2016; 
White et al., 2008). The in vivo imaging of zebrafish is even more enhanced by the 
availability of transgenic zebrafish lines, in which distinct cell lines or signaling 
molecules are marked by a fluorescent reporter. Nowadays, a fluorescent reporter 
lines for a myeloid cell population (Ward et al., 2003), macrophages (Ellett et al., 
2011), neutrophils (Renshaw et al., 2006), T cells (Langenau et al., 2004), MyD88 
(Hall et al., 2009), NF-ĸB (Kanther et al., 2011), and many others are available. When 
combined with fluorescent particles or labelled microbes, these lines have helped to 
reveal new aspects of phagocytosis, cell migration, cell-cell interactions, and 
chemotaxis, for example (Meijer and Spaink 2011). In addition, in the absence of 
zebrafish specific antibodies, the fluorescent reporter lines have proved practical in 
fluorescent-activated cell sorting (FACS). Finally, to utilize the vast imaging 
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properties of zebrafish larvae even more, bioassays with labelled sensors and probes 
to detect the production and the role of hydrogen peroxide, reactive oxygen species, 
and nitric oxide as part of the host’s antimicrobial defense have been developed 
(Meijer et al., 2014).  
Due to the unavailability of zebrafish embryonic stem cells and the inefficient 
homologous recombination methods, the zebrafish lacks a proper method for 
creating engineered mutations or knock-in models. On the other hand, the zebrafish 
provides a versatile toolbox for reverse and forward genetics, including methods 
based on morpholino oligonucleotides, targeted nucleases, or transposable elements 
and retroviruses (Huang et al., 2012). The use of antisense morpholino 
oligonucleotides (MO) to disrupt target mRNAs has gained popularity among 
zebrafish researchers due to its simplicity in design and applicability to almost any 
gene (Nasevicius and Ekker 2000). However, concerns regarding possible off-target 
effects in addition to the only partial and transient nature of the knockdown, have 
increased the interest in conventional knock-out methods. The current methods for 
creating targeted mutations into the zebrafish genome rely on nucleases that cause a 
double-strand break in the specific site of the DNA and subsequently mutate the site 
(Varshney and Burgess 2014; Hisano et al., 2014). Of the three methods available, 
the zinc finger nuclease method, the TALEN method, and the CRISPR/Cas9 
method, CRISPR/Cas9 has proved to be superior compared to the other two due 
to its easiness of design, cost-effectiveness, larger number of possible target 
sequences, and the unique possibility to conduct multiplex gene targeting (Varshney 
and Burgess 2014). However, although the CRISPR/Cas9 method holds promise 
for the introduction of engineered mutations and knock-ins via homologous 
recombination, such an application has so far proved to be very inefficient in 
zebrafish (Albadri et al., 2017). 
Possibilities for forward genetics in zebrafish are also numerous and several 
methods have been successfully used in large-scale screens to reveal novel genes 
associated with embryonic development (Golling et al., 2002; Haffter et al., 1996) 
genetic disorders (Haffter et al., 1996), infection susceptibility (Tobin et al., 2010), 
and immune cell development (Iwanami et al., 2016; Seiler et al., 2015), for example. 
Traditionally, chemical mutagenesis with ethylnitrosourea (ENU) has been used to 
introduce germline mutations in such screens (Driever et al., 1996; Haffter et al., 
1996), however, the laborious identification of the mutated genes has tempted the 
use of retrovirus or transposon based insertional mutagenesis (Song and Cui 2013; 
Amsterdam et al., 2011; Sivasubbu et al., 2007). As an example of the insertional 
mutagenesis methods, the tol2 transposon from medaka can introduce relatively 
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large DNA transgenes in an unbiased manner and, therefore, has become particularly 
popular in mutagenesis and transgenesis in zebrafish (Kawakami 2007). One of the 
most sophisticated versions of the tol2 transposon is the introduction of a protein 
trap and a fluorescent reporter to the insertion site simultaneously silencing the gene 
and allowing the visualization of the expression of the disrupted gene (Clark et al., 
2011). In addition, a Gal4/UAS -based method for the temporal and tissue specific 
expression of transgenes has been applied to zebrafish (Halpern et al., 2008). 
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3 AIMS OF THE STUDY 
Despite the notable achievements in the eradication of S. agalactiae and S. pneumoniae 
infections through optimized antibiotic treatments and, in the case of S. pneumoniae, 
also effective vaccination programs, these streptococci remain a global health burden 
for humans. The serotypic diversity as well as the rapid microevolution of both 
streptococci present challenges for the treatment and prevention of S. agalactiae and 
S. pneumoniae infections when using conventional methods. However, in order to find 
novel drug targets and vaccine candidates for the fight against a bacterial infection, 
the pathogenic mechanisms associated with the infection need to be known in detail. 
In the search for host and bacterial factors affecting the outcome of the infection, a 
proper animal model, which is capable of reproducing the human pathology and can 
mimic the host-pathogen interactions seen in human infections, is essential. 
Although, mammalian models have been informative in the study of the pathogenic 
mechanisms of S. pneumoniae and S. agalactiae, these models are limited in their 
ethicality and practicality and are not, thus, suited for large-scale studies. Lower 
vertebrates, on the other hand, have the potential of serving as alternative models in 
the study of immune responses and infectious diseases. Therefore, the specific aims 
of this thesis were: 
 
1) To test, whether the zebrafish (Danio rerio) can be used to model the host-
pathogen interactions in human S. pneumoniae and S. agalactiae infections. 
 
2) To study the role of innate and adaptive immune responses in a S. 
pneumoniae infection in zebrafish and to evaluate the suitability of this 
model for the search of novel vaccine candidates against S. pneumoniae. 
 
3) To identify, through a genetic screen, host factors that affect the 
susceptibility to S. pneumoniae infections. 
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4 MATERIALS AND METHODS 
4.1 Zebrafish and the ethical statements (I-IV) 
 
The AB or TL (Tupfel long fin, leot1 -/-, lofdt2 -/-) zebrafish were used as wild type 
reference lines in the study (obtained from ZIRC, Zebrafish international resource 
center, University of Oregon, Oregon, USA). Other zebrafish lines were the 
transgenic myeloid cell reporter line Tg(Spi:EGFP) (ZIRC), the Rag1 mutant 
zebrafish line (Rag1hu1999) (ZIRC), and the MyD88hu3568 mutant zebrafish line (van 
der Vaart et al., 2013) (a generous gift from Professor Annemarie Meijer, Leiden 
University). All the zebrafish lines were maintained according to the standard 
protocols (Nusslein-Volhard and Dahm 2002) and the guidelines set by the Ethical 
board in Finland. Briefly, the zebrafish embryos were grown at 28 °C on a Petri dish 
containing E3-medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM 
MgSO4, 10-5 % Methylene Blue) until 6 dpf after which they were transferred to a 
filtered flow-through water system (28 °C) with a 14/10-hour light/dark cycle. The 
fish were fed once (adults) or twice (larvae) a day with fresh (Artemia) and dry food 
(SDS-400 or GEMMA micro). The well-being of the fish was monitored daily and 
the unwell fish were removed from the system and euthanized with an overdose of 
an anesthetic tricaine (0.08 % 3-aminobenzoic acid ethyl ester, pH 7.0) (Sigma-
Aldrich, St. Louis, Missouri, USA). Infected embryos and adult fish were kept in 
isolation in corresponding conditions. In all the experiments, the adult fish and the 
embryos were anesthetized in 0.02 % tricaine and euthanized in 0.08 % tricaine. 
Humane-endpoint criteria was followed throughout the study, and the maintenance 
and the experiments conducted with the adult zebrafish were approved by the 
Animal Experiment Board in Finland with the following licenses: 
ESLH/2008/07610/Ym-23, STH761A, ESAVI/2010/08379/Ym-23, STH603A, 
ESAVI/2106/04.10.03/2011, ESAVI/6403/04.10.03/2012, ESAVI/6407-
/04.10.03/2012, ESAVI/733/04.10.07/2013,  ESAVI/8108/04.10.07/2015, 
ESAVI/10366/04.10.07/2016, ESAVI/10366/04.10.07/2016, ESAVI/2464-
/04.10.07/2017, LSLH-2007-7254/ym-23, ESAVI/10079/04.10.06/2015. 
 
 44 
 
4.2 Bacterial strains and culture (I-IV) 
 
As pathogens capable of infecting humans, S. pneumoniae and S. agalactiae are classified 
as biosafety level 2 bacteria and are, therefore, handled with special safety, including 
the appropriate protective equipment and the inactivation of the contaminated water 
and equipment with an appropriate disinfectant. The wild type S. pneumoniae used 
throughout the studies was the wild type TIGR4 (T4) of serotype 4, ST205, originally 
isolated from a patient suffering from an invasive S. pneumoniae disease (Aaberge et 
al., 1995). Two wild type lines for S. agalactiae were used, the NEM316 (serotype II, 
ST-23) and the FIM314 (serotype II, ST-17) isolated from a septic neonatal patient. 
Other bacterial strains included the isogenic T4 and NEM316 mutants deficient in 
selected virulence determinants (Table 2). 
Unless otherwise stated, all the bacterial strains were grown overnight on 5 % 
lamb blood agar plates (Tammer-Tutkan maljat Oy, Tampere, Finland) in 37 °C and 
5 % CO2. Bacterial cells were suspended in 5 ml Todd Hewitt broth (Becton, 
Dickinson and Company, New Jersey, USA) supplemented with 0.5 % Todd Hewitt 
Yeast extract (Becton, Dickinson and Company), and grown in 37 °C until they 
reached the mid-log phase of growth (OD620 0.4) corresponding to 108 colony 
forming units (cfu) / 1 ml. The cells were harvested by centrifugation (10 min in 
4000 rpm for S. pneumoniae and 7000 rpm for S. agalactiae) and resuspended in 0.2 M 
KCl to obtain the desired concentrations. The final bacterial concentrations were 
confirmed by quantitative plating; serial dilutions of the bacterial solution were 
plated on the lamb blood agar plates and grown overnight at 37 °C and 5 % CO2.  
 
Table 2. The bacterial strains used in the study.   
Strain Species Serotype Sequence type Phenotype 
T4 S. pneumoniae 4 205 Wild type 
T4R S. pneumoniae 4 205 Capsule deficient 
T4Δlyt S. pneumoniae 4 205 Autolysin A deficient 
T4Δply S. pneumoniae 4 205 Pneumolysin deficient 
T4ΔrlrA S. pneumoniae 4 205 Pilus deficient 
FIM314 S. agalactiae II 17 Wild type 
NEM316 S. agalactiae II 23 Wild type 
ΔcylE S. agalactiae II 23 β-hemolysin deficient 
ΔcpsD S. agalactiae II 23 Capsule deficient 
ΔcovSR S. agalactiae II 23 CovS/CovR deficient 
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4.3 Experimental infection in zebrafish embryos (I, IV) 
4.3.1 Microinjection of zebrafish embryos 
 
2 dpf zebrafish embryos were infected through an intravenous microinjection with 
a desired concentration of S. pneumoniae. Prior to the injection, zebrafish embryos 
were manually dechorionated, anesthetized, and laid on agar plates with wedged-
shaped troughs. The microinjection needles were prepared from 1.0 mm x 0.78 mm 
borosilicate glass capillaries (Harvard Apparatus, Holliston, Massachusetts, USA) 
using the Sutter P-97 capillary needle puller (Sutter instruments, Novato, California, 
USA). The needle was filled with a desired injection solution labelled with 1 % of 70 
kDa Rhodamine Dextran (RD) (Invitrogen, Carlsbad, California, USA) and 
calibrated to release a dose of 2 nl. Injections directed to the blood circulation valley 
were carried out using the micromanipulator (Narishige international, London, UK) 
and the PV830 Pneumatic PicoPump microinjector (World precision instrument, 
Sarasota, Florida, USA). The success of the injection was monitored by visually 
inspecting the dispersion of the labelled injection solution and by the temporal 
cardiac arrest of the injected embryos. 
4.3.2 Survival assays in zebrafish embryos     
 
In the S. pneumoniae survival assays, 2 dpf zebrafish embryos were intravenously 
infected with a desired concentration of wild type T4 or the isogenic T4 mutants as 
described above. The final bacterial count per injection was confirmed by 
quantitative plating before and after injecting each group. As a mock-infected control 
group, 2 dpf embryos were injected with 0.2 M KCl labelled with RD. The infected 
and control embryos were kept on 24-well plates, a single embryo in a separate well, 
and the mortality of the embryos was monitored once a day for 4 days. The lack of 
movement and heartbeat were considered as the signs of death. At the end of the 
experiment (6 dpf), the surviving embryos were euthanized and the Kaplan-Meier 
survival graphs were drawn to obtain the survival rates. 
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4.3.3 Determination of bacterial load in zebrafish embryos 
 
To obtain the bacterial load in infected embryos at selected time points, 5 embryos 
per group were randomly selected and euthanized. Embryos were washed in 1x 
phosphate buffered saline (PBS) solution and manually homogenized in 200 μl 1x 
PBS with 1 % Triton-X (Sigma-Aldrich) by pipetting up and down. Each sample was 
homogenized evenly to achieve comparable bacterial counts. When properly 
dispersed, 10-fold serial dilutions were prepared in 1x PBS. The bacterial counts in 
the dilutions were determined by quantitative plating on the lamb blood agar plates 
containing 1 μg/ml erythromycin (Tammer-Tutkan maljat Oy).  
4.4 Experimental infection in adult zebrafish (II, III) 
4.4.1 Intraperitoneal infection 
 
5-8 months old adult zebrafish were infected intraperitoneally with S. pneumoniae or 
S. agalactiae (Neely et al., 2002). Briefly, prior to injection, zebrafish were anesthetized 
and laid on a moist foam bed ventral side up. An omnican 30 G insulin syringe and 
needle (Braun, Melsungen, Germany) was used to administer 5 μl of the injection 
solution labelled with 0.3 mg/ml filtered phenol red (Sigma Aldrich) into the 
zebrafish abdomen. Special care was taken to avoid causing any harm for the fish 
through the handling or through the injection. Successfully injected fish were 
transferred to a tank containing fresh water and the recovery of the fish was followed 
before returning them into the water system. Any fish observed to be bleeding or 
otherwise suffering was immediately removed from the system and euthanized.  
4.4.2 Intramuscular injection 
 
5-8 months old adult zebrafish were used for intramuscular injection. For the 
injection, anesthetized fish were laid on a moist foam bed dorsal side up. The 
intramuscular injection was carried out using the microinjection instruments 
described in section 4.3.1 “Microinjection of zebrafish embryos” and the needle for 
the injection was prepared from 1.0 mm x 0.5 mm aluminosilicate glass capillaries 
(Harvard Apparatus) as described above. To carry out the injection, a needle was 
filled with 5 μl of the injection solution labelled with 0.3 mg/ml filtered phenol red, 
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after which the needle was positioned anterior to the dorsal fin at 45˚ angle in relation 
to the spine. The injection solution was administered to the dorsal muscle and the 
successfully injected and recovered fish were moved to the water system as explained 
for intraperitoneal injection. 
4.4.3 Survival assays in adult zebrafish 
 
In the survival assays of the adult zebrafish, groups of 15-20 zebrafish were randomly 
selected to be intraperitoneally or intramuscularly infected with desired 
concentrations of S. pneumoniae or S. agalactiae. The final bacterial count per injection 
was confirmed by quantitative plating before and after injecting each group. As a 
mock-infected control group, 15-20 adult fish were injected with 0.2 M KCl labelled 
with phenol red. The infected and control fish were kept in a stand-alone flow-
through system, and their survival was checked twice a day for a 7-day period. Fish 
showing any signs of infection, including aberrant swimming behavior, increased rate 
of respiration, visible lesions, or cerebral edema were immediately euthanized and 
recorded as deceased. At the end of the experiment, surviving fish were euthanized 
and the Kaplan-Meier survival graphs were drawn to obtain the survival rates. 
4.4.4 Determination of bacterial load from zebrafish blood 
 
Following intraperitoneal infection, the bacterial counts were determined from adult 
zebrafish blood at certain time points during the 7-day follow up. Five randomly 
chosen zebrafish were sacrificed for the collection of blood samples. First, the fish 
were euthanized and the skin was dried and sterilized with 70 % EtOH to avoid the 
contamination of the sample. Thereafter, a sterile scalpel blade was used to cut the 
fish neckline and 5 μl of blood was collected from the wound by pipetting. The blood 
sample was quickly transferred to a tube containing 45 μl of 0.2 M KCl and mixed 
thoroughly to prevent coagulation. The bacterial counts in each sample were 
determined by quantitative plating of 10-fold serial dilutions in 0.2 M KCl on 
selective blood agar plates. 
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4.4.5 Determination of bacterial load from zebrafish brain 
 
The brain from 5 intraperitoneally infected adult fish were dissected for the 
determination of bacterial counts at selected time points. For the dissection, fish 
were euthanized and tacked on a dissecting board dorsal side up and the fish skin 
was cleaned as described above. Using sterile scalpel blade and forceps, the skull 
plate was removed and the exposed brain collected. The collected tissue was 
transferred to a tube containing 200 μl of 1x PBS and homogenized using a sterile 
pestle. For the quantitation, 10-fold serial dilutions were prepared in 1x PBS and 
plated on selective blood agar plates.    
4.5 Characterization of the zebrafish immune response to S. 
agalactiae and S. pneumoniae infection (I-IV) 
4.5.1 Morpholino oligonucleotide gene knockdown (I) 
 
The antisense morpholino oligonucleotides (MO) were used to silence the 
expression of wasa (previously wasp2, Wiskott-Aldrich syndrome (eczema-thrombocytopenia) 
a), wasb (previously wasp1, Wiskott-Aldrich syndrome (eczema-thrombocytopenia) b) and spi1b 
(previously pu.1, Spi-1 proto-oncogene b). The translation blocking (TB) and splice 
blocking (SB) MOs were obtained from the Gene Tools (Philomath, USA). The 
genes wasa and wasb were silenced in a single embryo by using two translation 
blocking (TB) MOs. One TB and one SB MO were used as a combination to silence 
the spi1b expression (Table 3). To prepare the MO injection solutions, the 1 mM 
MO stocks were heated at 65 °C for 5 minutes to reduce secondary structures and 
to dissolve the precipitated MO. The MO injection solutions were prepared in 0.2 
M KCl with the following concentrations: for Wasp 100 μM + 100 μM (wasa + wasb) 
and for spi1b 130 μM + 130 μM (TB + SB). To visualize the success of the injection, 
1 % RD was added to the solution. A total of 1 nl MO solution was microinjected 
into the yolk sac of 1-cell stage zebrafish eggs. As a control, a group of eggs were 
injected with random control MO (Gene Tools). After the injection, eggs were kept 
in E3-medium (28 °C) and the success of the injection was verified 24 hours post 
injection (hpi) by visualizing the embryos under the fluorescent microscope (Lumar 
VI.1; Carl Zeiss Microimaging GMbH, Cardiff, UK).    
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Table 3. The antisense morpholino oligonucleotide sequences. MO=morpholino oligonucleotide, 
TB=translation blocking, SB=splicing blocking. (The spi1b MO sequences were obtained from 
Clay et al., 2007) 
Target gene MO MO sequence 5'→3'  
wasb (ZDB-GENE-030131-7098) TB CCCTTTGCTTTTGCCTTTGCTCATC 
wasa (ZDB-GENE-081104-419) TB CCTCATGGCCTCATACGCCGTCTAA 
spi1b (ZDB-GENE-980526-164) TB CCTCCATTCTGTACGGATGCAGCAT 
spi1b (ZDB-GENE-980526-164) SB GGTCCTTCTCCTTACCATGCTCTCC 
4.5.2 Live imaging of phagocytosis in zebrafish embryos (I) 
 
For live imaging of phagocytosis of S. pneumoniae in zebrafish embryos, transgenic 
Tg(spi:EGFP) embryos were injected with T4 labelled with BaclightTM Red bacterial 
stain (Invitrogen, Thermo Fisher Scientific). The bacteria were cultured as previously 
described and the labelling was carried out according to the manufacturer’s 
instructions. The S. pneumoniae infections in zebrafish larvae were conducted as 
described earlier at 2 dpf. At 1-day post injection (dpi), randomly selected embryos 
were anesthetized and mounted onto 1 % low-melting-point agarose (Sigma-
Aldrich) for imaging. The fluorescence imaging was carried out at 1-3 hpi using the 
Olympus BX51WI microscope (Olympus Corporation, Tokyo, Japan) with 40x or 
100x water immersion objectives (Olympus Corporation). Image J (National 
institutes of Health, Maryland, USA) was used to assemble the stacks of obtained 
images and the final editing was done with Photoshop C2S (Adobe systems Inc., 
California, USA).    
4.5.3 Quantitative analysis of the gene expression levels (I, II, IV) 
4.5.3.1 Total RNA extraction 
 
In original communication I, groups of 10-15 infected or control embryos were 
euthanized and pooled for RNA extraction 18 hpi. In original communication II, the 
adult zebrafish brain was isolated, as described above, for the RNA extraction at 
various time points. Total RNA from pooled embryos or the adult zebrafish brain 
were homogenized in TRI Reagent (MRC, Ohio, USA) using a pestle and the 
following RNA extraction was conducted according to the manufacturer’s 
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instructions. After the extraction, the RNA concentrations were measured with the 
NanoDrop spectrophotometer (Thermo Fisher Scientific Inc, Waltham, 
Massachusetts, USA). In original communication IV, the RNA extraction from the 
pool of 5 embryos was conducted using the Qiagen RNeasy Mini Kit (Qiagen, 
Hilden, Germany) according to the manufacturer’s instructions.  
4.5.3.2 Quantitative RT-PCR 
 
The expression levels of tnfa, il1b, and il6 were measured from the RNA extracted 
from the pooled embryos or the brain tissue. The qRT-PCR was performed using 
the iScriptTM One-Step RT-PCR Kit with SYBR® Green (Bio-Rad Laboratories, 
Hercules, California, USA), according to the manufacturer’s instructions. The 
expression levels were normalized to the expression of actb1. The primers for tnfa, 
il1b, and actb1 are listed in the Table 4. The thermal cycling was performed using the 
Bio-Rad CFX 96 instrument (Bio-Rad Laboratories) and the following program with 
melt curve analysis: 1. 50 °C for 10 minutes, 2. 95 °C for 5 minutes, 3. 95 °C for 10 
seconds, 4. 60 °C for 30 seconds (steps 3-4 40 times). CFX Software version 1.6 
(Bio-Rad Laboratories) were used to analyze the results and the double delta Ct 
method (ΔΔCt) was used to calculate the relative gene expression. 
 
Table 4. The primer sequences. (il1b and actb1 primer sequences were obtained from 
Pressley et al., 2005) 
Gene Forward primer 5'→3' Reverse primer 5'→3' 
tnfa GGGCAATCAACAAGATGGAAG GCAGCTGATGTGCAAAGACAC 
il1b TGGACTTCGCAGCACAAAATG GTTCACTTCACGCTCTTGGATG 
actb1 ATGGATGAGGAAATCGCTG ATGCCAACCATCACTCCCTG 
4.5.3.3 mRNA sequencing 
 
The RNA for sequencing was extracted from pooled (5x) KCl injected wild type, T4 
injected wild type and T4 injected mutant94 embryos at 18 hpi. The RNA extraction 
is described in the section 4.5.2.1 “Total RNA extraction”. The genomic DNA was 
removed from the samples using the RapidOut DNA removal Kit (Thermo 
Scientific, Thermo Fisher Scientific) according to the manufacturers’ instruction, 
after which the concentration and the purity of the samples were measured using the 
NanoDrop spectrophotometer and the QubitTM RNA BR Assay Kit (InvitrogenTM, 
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Thermo Fisher Scientific). In addition, the integrity of the RNA sample was verified 
with the Fragment Analyzer (Advanced Analytical Technologies, Iowa, USA) using 
the Standard Sensitivity RNA Analysis Kit (Advanced Analytical Technologies) and 
the PROSize® 2.0 Data Analysis Software (Advanced Analytical Technologies). 
The cDNA library preparation and the RNA sequencing was done by Novogene, 
Hong Kong. Briefly, the 250-300 bp cDNA library was sequenced with the 150 bp 
paired-end sequencing on the Illumina platform and with a sequencing depth of >20 
million reads/sample. The obtained reads were aligned against the GRCz10 
zebrafish reference genome using the STAR software and the read counts 
normalized using the DEseq2. The differential gene expression was determined by 
DEseq2. The 3-fold induction and 3-fold reduction in gene expression were set as 
limits for the differentially expressed genes. 
4.5.4 A forward genetic screen for host genes affecting S. pneumoniae 
infection (IV) 
4.5.4.1 Generating mutant fish lines for the forward genetic screen 
 
The pGBT RP2-1 (addgene #31828) and the pt3TS-Tol2 (addgene #31831) 
plasmids for the gene-breaking tol2 transposon -based mutagenesis were obtained 
from Professor Stephen Ekker’s Laboratory, Maya Clinic, USA (Clark et al., 2011). 
To produce the Tol2 transposase mRNA for the mutagenesis, the pt3TS-Tol2 
plasmid was linearized with Fast Digest restriction enzyme BamHI (Thermo 
Scientific, Thermo Fisher Scientific) and in vitro transcribed with mMESSAGE 
mMACHINE SP6 transcription Kit (InvitrogenTM, Thermo Fisher Scientific) 
according to the manufacturers’ instructions. The mRNA was purified with lithium 
chloride precipitation and dissolved in RNase free water. For the mutagenesis, 1 nl 
of the injection mixture containing 12,5 ng/μl of the pGBT RP2-1 and 12,5 ng/μl 
Tol2 transposase mRNA was microinjected into the cell of early 1-cell stage AB 
zebrafish eggs. The injected embryos were screened for the successful injection by 
the mosaic expression of GFP (green fluorescent protein) under the Zeiss Lumar 
V12 or the Nikon AZ100 (Nikon Corporation, Tokyo, Japan) fluorescence 
microscope. The GFP positive embryos were selected to be grown into adulthood 
and for subsequent crosses as F0 generation.  
The mosaic F0 fish were crossed to TL fish to obtain the heterozygous F1 fish 
carrying multiple inserts. A single F1 fish served as a founder for a specific mutant 
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line named according to the running number given for the F1 fish (for example 
mutant94). Each F1 fish was individually crossed with TL fish to obtain the 
heterozygous F2 offspring. The F2 fish of a certain mutant line were in-crossed to 
gain homozygous F3 fish for the experiments. In every step of the crosses (Figure 
3), the germline transmission of the inserts was verified by observing the embryos 
under the Zeiss Lumar V12 or the Nikon AZ100 fluorescent microscope. Only 
positive embryos were selected for the crosses and the phenotypic analyses. The 
phenotype of each mutant line was analyzed by survival assays (described in the 
section 4.3.2 “Survival assays in zebrafish embryos”) and if a phenotype was 
observed, also by determining bacterial burden (described in the section 4.3.3 
“Determination of the bacterial load in zebrafish embryos”).  
 
 
Figure 3. Breeding zebrafish for mutagenesis screen. WT=wild type, +/- = heterozygous, 
+/+ = homozygous. 
4.5.5 Immunization assay (III) 
 
To determine the induction of immunological memory of adult zebrafish against S. 
pneumoniae, groups of 20-30 fish were immunized with heat-killed T4 (1x104 colony 
forming units, cfu), sublethal dose of live T4 (5x104 cfu), or live T4R (1.5x106 cfu). 
To prepare the heat-killed bacteria, T4 was cultured and the cells harvested as 
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described above. The bacterial cells were resuspended in 500 μl of 0.2 M KCl and 
then autoclaved to inactivate the bacteria. The fish were immunized intramuscularly 
and infected with 2.5x106 cfu of T4 through the same route 2 or 3 weeks after 
immunization. The infection dose was verified as above. The two control groups 
received KCl immunization or no immunization. The mortality of the infected fish 
was followed for 14 days and the deaths recorded, after which the surviving fish were 
euthanized.  
4.6 Statistical analyses 
 
GraphPad Prism software (version 5.02) was used to carry out the statistical analyses 
for the survival assay, relative cytokine expression, and the comparison of bacterial 
counts. The survival rates were analyzed with the Mantel-Cox Log Rank test. The 
data for bacterial counts and relative cytokine expression was analyzed either using 
the one-way ANOVA/Kruskal-Wallis test with Dunn’s multiple comparison post-
test (multiple samples) or the two-tailed Student’s t-test (two samples). A p-value of 
<0.05 was considered statistically significant.  
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5 SUMMARY OF THE RESULTS 
5.1 S. pneumoniae causes a fulminant, dose-dependent 
infection in zebrafish (I, III) 
 
Since to my knowledge, the zebrafish model had not been described in the context 
of a S. pneumoniae infection, we first tested the ability of this human-specific pathogen 
to cause an infection in zebrafish. Since the differences in the natural environmental 
temperatures of S. pneumoniae (37 °C) and the zebrafish (28 °C) were evident, we also 
tested the ability of the S. pneumoniae strain T4 and its isogenic mutants to grow at 28 
°C in vitro. This experiment showed no differences in the growth rates of the S. 
pneumoniae strains incubated at 28 °C and 37 °C. 
In original communication I, the infectivity of the wild type S. pneumoniae strain 
T4 was tested in 2 days old zebrafish embryos by survival assays with various doses 
(100 cfu, 1000 cfu and 10000 cfu) of the bacterium. After an intravenous injection 
of T4 into the zebrafish embryos, the infection progressed rapidly, the highest 
mortality occurring by 48 hpi (Figure 4A, Figure 1A in I). Importantly, the outcome 
of the infection was dose-dependent with an LD50 dose of ~100 cfu (combined 
mean survival 49 %). In original communication III, the corresponding dose-
dependent disease progression was observed in adult zebrafish after intraperitoneal 
and intramuscular infections (Figure 4B, Figures 1A-B in III). The infection of adult 
zebrafish with a moderate dose of T4 (2.5x106 cfu) resulted in increased survival rates 
after the intramuscular infection (66 %) compared to the intraperitoneal infection 
(44 %) (Figures 1A-B in III). The highest mortality rate was also reached at a later 
time point for the intramuscular (48-72 hpi) than for the intraperitoneal infection 
(24-48 hpi) indicating an overall delayed disease progression in the local infection 
route compared to systemic administration. With both infection routes, the fish 
showed common signs of a severe infection; edema at the infection site, aberrant 
swimming behavior and increased respiration. Moreover, in a local intramuscular 
injection, fish developed hypopigmented lesions and severe tissue necrosis at the 
dorsal muscle, previously also observed in other streptococcal infections (Neely et 
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al., 2002). Intriguingly, some of the challenged fish also had visible cerebral edema, 
a sign of meningitis (Figure 4 in III). 
 
Figure 4. S. pneumoniae causes a fulminant systemic infection in zebrafish. A) The survival 
of 2 dpf zebrafish embryos from a S. pneumoniae infection is dose-dependent. B) The survival 
of adult zebrafish after an intraperitoneal injection of S. pneumoniae is dose-dependent. The 
graphs represent the collated results from three individual experiments (n=24 in A, n=15 in 
B) and the asterisks depict the statistically significant difference of *p<0.01 and ***p<0.0001. 
cfu=colony forming units. Figure A modified from original communication I, and B from original 
communication III.  
Since the survival assays showed that zebrafish could tolerate the small and 
moderate doses of S. pneumoniae, we further examined the ability of the embryos and 
adult fish to clear the bacteria after the challenge. For this, we followed the change 
in the bacterial burden in both models during the infection. When the bacterial 
counts in dead and live embryos were determined at various time points after the 
infection (original communication I), the rapid replication of S. pneumoniae in the 
dying embryos was observed during the 48-hour follow-up (Figure 5A, Figure 2A 
in I). Importantly, the bacterial counts in surviving embryos started to decrease at 24 
hpi and approached 0 cfu by 48 hpi. Similarly, the bacterial counts in the blood of 
adult zebrafish, after an intraperitoneal infection (original communication III), 
reached their maximum at 6 hpi and decreased to 0 cfu by 48 hpi in live fish (Figure 
5B, Figure 1C in III).  
S. pneumoniae is one of the leading causes of bacterial meningitis in humans (Doran 
et al., 2016). As mentioned above, we observed visible signs of meningitis in adult 
zebrafish during the survival assay and, therefore, we wanted to test whether S. 
pneumoniae can infiltrate from the blood to the brain in zebrafish. For this, we 
extracted the whole brain from intraperitoneally infected (2.5x106 cfu) fish and 
determined the bacterial loads at several time points. As a result, we noticed the 
presence of bacteria in the brain already at 2 hpi, after which the bacterial loads 
increased until 12-24 hpi (Figure 5B, Figure 5 in III). Noteworthy, the bacterial 
burden in the brain correlated with the bacterial burden in the blood. From these 
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experiments concerning the infectivity of S. pneumoniae in zebrafish, we concluded 
that this human pathogen is able to cause a dose-dependent infection in both 
zebrafish embryos and adult fish. The infection is characterized by fulminant 
bacteremia and the dissemination of bacteria into the brain. Importantly, zebrafish 
are also capable of restricting the replication of S. pneumoniae by some surveillance 
mechanisms, leading to the clearance of bacteria from the bloodstream and the 
survival of the fish.   
 
Figure 5. The bacterial burden in zebrafish embryos and adult zebrafish after a S. pneumoniae 
infection. A) The surviving embryos are able to clear S. pneumoniae by 48 h post an 
intravenous injection of 100 cfu. A dot represents the bacterial load in single live (black dot) 
or dead (grey circle) embryos. The asterisks depict the statistically significant difference 
between the live and dead fish. B) The bacterial burden in the brain of adult zebrafish 
correlates with the bacterial burden in the blood after an intraperitoneal injection of 2.5x106 
cfu of T4. The figure represents the mean (+standard deviation) bacterial burden at each 
time point. Both graphs represent the collated results from at least three individual 
experiments (n=5 in A, n=10 in B). cfu=colony forming units. Figure A modified from original 
communication I, and B from original communication III.  
5.2 The pathogenesis of S. pneumoniae in zebrafish is 
mediated by known virulence factors (I, III) 
 
The first steps in the progression of an infectious disease are determined by the 
interplay between the host’s innate immune response and the pathogen’s virulence 
factors. Several S. pneumoniae virulence determinants have been shown to mediate 
specific interactions with the host and contribute to the progression of the infection 
(Kadioglu et al., 2008). To examine whether the same interactions play a role in the 
progression of a S. pneumoniae infection in zebrafish, we first compared the virulence 
capacity of the wild type (WT) S. pneumoniae (T4) and the T4 mutants lacking the 
capsule (T4R), pneumolysin (T4Δply), autolysin A (T4Δlyt), or the pilus (T4ΔrlrA) in 
zebrafish embryos (original communication I) and adult zebrafish (original 
communication III). The polysaccharide capsule of S. pneumoniae appears essential 
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during the infection due to its antiphagocytic activity, and therefore, the 
unencapsulated strains of S. pneumoniae have been shown to be avirulent in several 
animal models (Hyams et al., 2010a; Morona et al., 2004; Briles et al., 1992). Similarly, 
the capsule deficiency led to an almost complete loss of virulence in both of our 
models, with the survival percentages of 97 % for T4R and 41 % for T4 in embryos 
(Figure 6A, Figure 3 in I) and 73 % for T4R and 38 % for T4 in adults (Figure 2 in 
III). In addition, in contrast to the wild type T4, the unencapsulated mutants of S. 
pneumoniae failed to induce TNF-α mediated inflammation in zebrafish embryos 
(Figure 6B, Figure 4B in I). 
 
Figure 6. S. pneumoniae pathogenesis is mediated by conserved host-pathogen interactions. 
A) S. pneumoniae mutants lacking the capsule (T4R), the pneumolysin (T4Δply), and the 
autolysin LytA (T4ΔlytA) are attenuated in zebrafish embryos compared to the wild type S. 
pneumoniae (T4). The pilus mutant (T4ΔrlrA) shows virulence levels comparable to wild type. 
In the survival assay, 2 dpf zebrafish embryos were infected with 100 cfu of wild type T4 or 
the mutants. B) The expression of tnfa is induced 18 h post a T4 but not a T4R challenge. 
The tnfa expression was measured with qRT-PCR from a pool of 10 zebrafish embryos 
infected 2 dpf with 100 cfu. The tnfa expression was normalized to the expression of actb1 
and the figure represents the mean (+ standard deviation) fold change in the expression 
compared to KCl injected embryos. The graphs represent the collated results from three 
individual experiments (n=24 in A and n=3 in B) and the asterisks depict the statistically 
significant differences of ***p<0.0001 and **p<0.001. Figures modified from original 
communication I. 
Similar to the unencapsulated S. pneumoniae mutants, the virulence of the mutants 
deficient in pneumolysin (T4Δply) and autolysin A (T4Δlyt) was attenuated in 
zebrafish. The observed mean survival percentages were 62 % for T4Δply and 73 % 
for T4Δlyt compared to 41 % for T4 in embryos, (Figure 6A, Figure 3 in I) and 46 
% for T4Δply and 73 % for T4Δlyt compared to 38 % for T4 in adult fish (Figure 2 
in III). Another virulence factor of S. pneumoniae, the pilus, has been shown to 
mediate the adhesion of the bacteria to the epithelium during colonization (Barocchi 
et al., 2006), but to also stimulate bacterial intake by macrophages during the invasive 
disease (Orrskog et al., 2012). In our models of a systemic S. pneumoniae infection, 
the pilus seems to have a minor or dispensable role, since the injection of the pilus 
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deficient mutant or the wild type T4 resulted in equivalent survival rates in zebrafish 
embryos (T4 41 % versus T4ΔrlrA 50 %) and adult fish (T4 38 % versus T4ΔrlrA 
42 %). Overall, however, these results indicate that a S. pneumoniae infection follows 
a conserved pathogenic mechanism in zebrafish. 
5.3 The innate immune response to a S. pneumoniae infection 
in zebrafish embryos is well conserved (I, IV) 
5.3.1 The clearance of S. pneumoniae in zebrafish embryos is 
dependent on myeloid cells and phagocytosis (I) 
 
The observed conserved mechanisms of S. pneumoniae pathogenesis in fish and 
mammals tempted us to test whether a similar conservation could also be seen in the 
host response. Therefore, we started to examine the innate immune response to S. 
pneumoniae in zebrafish embryos. In humans, macrophages and neutrophils are the 
first immune cells to encounter invading pathogens during the infection and are the 
main cells responsible for the phagocytosis and intracellular killing of S. pneumoniae 
(Dockrell et al., 2012). To characterize the role of these cells in zebrafish during a S. 
pneumoniae infection, we manipulated the myeloid cell number and function in 
zebrafish embryos with the antisense morpholino oligonucleotide (MO) gene 
knockdown method. The MO knockdown of spi1b (previous name pu.1), previously 
shown to deplete myeloid cells (Rhodes et al., 2005), predisposed the zebrafish 
embryos to a significantly more severe S. pneumoniae infection with a faster disease 
progression (most deaths occurring by 24 hpi, compared to 48 hpi for WT embryos) 
and higher mortality (final survival percent 15 % compared to 51 % for WT) (Figure 
7A, Figure 5 in I). A similar survival pattern (most deaths by 24 hpi, final survival 
percent 30 %) was observed in zebrafish embryos where wasa and wasb (previous 
names wasp2 and wasp1, respectively) were knocked down, which has previously been 
shown to hamper the migration of immune cells and phagocytosis, due to a defect 
in the function of the actin cytoskeleton (Cvejic et al., 2008). 
Since the MO studies gave us a clear indication of the importance of 
phagocytosing cells in the clearance of S. pneumoniae in zebrafish, we next visualized 
the function of myeloid cells during a S. pneumoniae infection in vivo. For this, we 
employed the transgenic zebrafish reporter line Tg(Spi1:EGFP), which expresses 
GFP under the promoter for the myeloid transcription factor gene Spi1b (Ward et 
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al., 2003). By using fluorescently labelled S. pneumoniae, we were able to visualize the 
interaction between the myeloid cells and bacteria in vivo in real-time. At 1-3 hours 
post an intravenous infection, S. pneumoniae were seen to co-localize with myeloid 
cells in the circulation (Figure 7B-C, Figure 4C-D in I). More importantly, myeloid 
cells with cell wall protrusions were observed to reach out for the bacteria while 
some bacteria were found ingested by the myeloid cells. Together, these studies 
provided proof for the existence of a specific interaction between S. pneumoniae and 
zebrafish myeloid cells and emphasized the conservation of the important role of 
phagocytosis in the clearance of S. pneumoniae during a septic infection.      
 
Figure 7. The survival of zebrafish embryos from a S. pneumoniae infection is dependent on 
myeloid cells and phagocytosis. A) The survival of zebrafish embryos is decreased upon the 
morpholino knockdown (MO) of spi1b or wasa/b compared to wild type embryos. MOs were 
injected into 1-cell stage zebrafish eggs, after which the morphant and the wild type embryos 
were intravenously infected at 2 dpf with 50 cfu of T4. The graph represents the collated 
results from three individual experiments (n=24 in each) and the asterisks depict the 
statistically significant differences of *p<0.01 and **p<0.001. B-C) Myeloid cells (green) are 
seen to reach (B) for the S. pneumoniae (red) and engulf (C) the bacteria 1-3 hpi. A live 
fluorescence image was taken of Tg(spi1:EGFP) transgenic zebrafish embryos infected with 
100 cfu of BaclightTM Red stained T4. The experiment was repeated at least three times. 
Figures A and C modified from original communication I. Figure B from original 
communication I (Rounioja et al., 2011).  
5.3.2 A transcriptome analysis reveals well-conserved innate immune 
response to S. pneumoniae in zebrafish embryos (IV) 
 
To characterize the zebrafish innate immune response to S. pneumoniae in more detail, 
we carried out a whole genome transcriptome analysis (RNA sequencing) for wild 
type zebrafish embryos infected with 100 cfu of T4. Altogether, among the 129 
differentially expressed genes at 18 hours post a S. pneumoniae infection, 57 protein 
coding genes were upregulated and 33 protein coding genes were downregulated at 
least 3-fold in wild type embryos compared to a KCl injection (Table 1, Table S1, 
and Table S3 in IV). Importantly, a notable proportion (26/57 genes) of the 
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upregulated protein coding genes were associated with the innate immune response, 
falling into the categories of the complement system (9/26 genes), acute phase 
response (3/26 genes), antimicrobial peptides (4/26 genes), immune signaling and 
regulation (4/26), cell migration and chemotaxis (3/26 genes), and macrophage 
function (3/26 genes) (Figure 1 and Table 1 in IV). On a smaller scale, the expression 
of genes associated with metabolic processes (13/57 genes), other functions (6/57 
genes), or unknown function (12/57 genes) were also induced upon the infection. 
Of the downregulated protein coding genes, 7/33 genes have previously been 
associated with development and reproduction, 1/33 with metabolic processes, and 
5/33 with other processes. For 20/33 downregulated protein coding genes, on the 
other hand, no functional prediction was found. 
In particular, the expression of genes associated with the complement system was 
induced at the chosen time point suggesting their important role in the innate 
immune response to S. pneumoniae also in this organism. The induced complement-
related genes coded for four C3 variants (c3a.1, c3a.2, c3a.3, c3a.6), a putative 
counterpart for human C2 (si:ch1073-280e3.1), C1r (c1r), Complement factor B (cfb), 
and two negative regulators, Factor H like 5 (cfhl5) and the C1 inhibitor (serping1) 
(Figure 8, Figure 2 in IV). The other induced genes associated with the activation 
of complement were the crp and crp3, the two zebrafish variants for the human CRP 
gene.  
Figure 8. Complement -related genes induced at 18 hours post a S. pneumoniae infection in 
zebrafish embryos. A+B) The figures represent the normalized read counts in T4 or KCl 
injected wild type (WT) embryos for the selected genes. The bars represent the mean read 
counts from 3 replicates (+ standard deviation) obtained by mRNA sequencing. The 3-fold 
increase in the expression was set as a threshold for induction. c3a.1=complement component 3, 
variant 1; c3a.2=complement component 3, variant 2; c3a.3=complement component 3, variant 3; 
c3a.6=complement component 3, variant 6; si:ch1073-280e3.1=a putative homolog for human complement 
component 2; C1r= complement component 1, r subcomponent; cfb=complement factor B; cfhl5=complement 
factor H like 5; and serping1= serpin peptidase inhibitor, clade G (C1 inhibitor), member 1. Figures 
modified from original communication IV. 
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5.3.3 The lack of CRP is a potential predisposing factor for a severe S. 
pneumoniae infection in zebrafish embryos (IV) 
 
To identify zebrafish genes important in the defense against S. pneumoniae in an 
unbiased manner, we carried out a forward genetic screen (original communication 
IV). In the screen, a gene-breaking Tol2 transposon -based mutagenesis (Clark et al., 
2011) was used to create 126 fish lines carrying random mutations, after which these 
lines were screened for their altered susceptibility to a S. pneumoniae infection by 
survival assays. In the assays, 100 cfu of T4 was intravenously injected into mutant 
and WT zebrafish embryos at 2 dpf and the mutant lines showing significantly 
decreased survival compared to WT were selected for further study.In this study, we 
chose 3 mutant lines with decreased survival to be analyzed more thoroughly. The 
survival results for the mutant lines with decreased survival (mutant94, mutant14, 
mutant460) and a line with the survival rate equivalent to WT (mutant286) are shown 
in Figure 9A. One of the lines, mutant94, had a particularly strong phenotype with 
a 28 % survival compared to the WT survival of 83 % upon infection with T4. The 
survival rates for the other mutant lines were 45 % for mutant14, 39 % for 
mutant460, and 80 % for mutant286. To test whether the hampered survival of the 
hypersusceptible mutant lines was due to the defects in the clearance mechanisms or 
to the overall weakness, we measured the bacterial burden in these lines during the 
infection. The results showed that the mutant94 embryos had significantly elevated 
bacterial counts at 18 hpi compared to the WT, while the bacterial burdens in the 
mutant14 and the mutant460 embryos were equivalent to those of the WT (Figure 
9B). Therefore, we concluded that, in contrast to the mutant14 and mutant460 which 
likely had decreased tolerance to infection, the mutant94 embryos had hampered 
defense mechanisms against T4 and thus developed a more severe S. pneumoniae 
infection. 
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Figure 9. S. pneumoniae causes a more severe infection in mutant94 embryos compared to 
wild type. A) The survival of mutant94 embryos is impaired in a S. pneumoniae infection. In 
the assay, 2 dpf embryos were intravenously injected with 100 cfu of T4. The survival of 
mutant 94 was compared to the wild type (WT) and to other mutant lines (mutant460, 
mutant14, and mutant286). B) The mutant94 embryos have an increased bacterial burden at 
18 hpi compared to wild type embryos. The zebrafish embryos were intravenously infected 
with 100 cfu of T4 and the bacterial counts were determined at 18 hpi. A dot represents the 
bacterial count in a single embryo and the line depicts the median. In both figures, the graphs 
represent the collated results from two or three individual experiments (n=24-48 in A and 
n=5 in B) and the asterisks depict the statistically significant difference of ***p<0.001. 
cfu=colony forming units. Figures modified from original communication IV. 
To identify the factors predisposing mutant94 to a more severe infection, we used 
total RNA sequencing to identify the differentially expressed genes in mutant94 
embryos upon a S. pneumoniae infection. Overall, of the 57 protein coding genes 
upregulated in S. pneumoniae infection, 9 genes were downregulated at 18 hours post 
a T4 infection in the mutant94 embryos compared to the infected WT embryos 
(Table S5 in IV). As the most striking difference, the expression of crp showed an 
83-fold reduction in mutant94 compared to the WT. The other two of the most 
downregulated genes were the zebrafish specific genes BX548011.1 and si:dkey-
9c18.3 with 43-fold and 29-fold reduction in expression, respectively. In contrast, the 
rest of the downregulated genes showed more subtle changes in expression (from 
3.5- to 7-fold). Of these differences, the defect in the production of Crp, shown to 
predispose mice to a more severe S. pneumoniae infection (Simons et al., 2014), 
appeared as the most probable explanation for the decreased resistance of mutant94 
embryos. 
In humans, the expression of CRP by the hepatocytes is induced by the pro-
inflammatory cytokines IL6, IL1B, and TNF (Slaats et al., 2016; Gruys et al., 2005; 
Zhang et al., 1995). Therefore, to further test our hypothesis, we checked the 
expression levels of il6, il1b, and tnfa from our transcriptome data. We noticed that 
all the genes were induced in T4 infection in WT embryos and that their expression 
levels were even more elevated in mutant94 embryos compared to the WT (2-fold 
increase in il6; 3-fold increase in il1b; 4-fold increase in tnfa compared to WT) 
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(Figure 10, Figure 4 in IV). These observations indicate that the lack of crp 
production in the mutant94 embryos was not due to the defect in the general 
inflammatory response and that the slight increase in the expression of these 
mediators may be due to a compensatory response to the hampered crp expression.  
 
Figure 10. Mutant94 embryos have defects in crp expression. The figure represents the 
normalized read counts for crp, il1b, il6, and tnfa in T4 or KCl injected wild type (WT) 
embryos or T4 infected mutant94 embryos. The bars represent the mean read counts from 
3 replicates (+ standard deviation) obtained by mRNA sequencing. The figure is modified 
from original communication IV. 
 
In conclusion, to study the innate immune response to S. pneumoniae in zebrafish 
we utilized forward and reverse genetics, in vivo imaging of immune cells, and a whole 
genome transcriptome analysis. Overall, our findings indicate a well conserved host 
response to S. pneumoniae in zebrafish embryos and validates the use of this model in 
the closer study of the defense mechanisms against the pathogen. To sum up, the 
methods used for the characterization of the innate immune response to S. 
pneumoniae in zebrafish embryos and the obtained results are collected into Figure 
11. 
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Figure 11. Characterization of the innate immune response to a S. pneumoniae infection in 
zebrafish embryos. A summary of the methods and results. 
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5.4 The adaptive immune response does not seem to play a 
role in the defense against S. pneumoniae in zebrafish (III) 
 
A major benefit of adult zebrafish as an infection model comes from the highly 
developed adaptive immune system with functional lymphocytes and the ability to 
mount an immunological memory. Moreover, zebrafish has been proven to serve as 
a suitable model for the evaluation of vaccine candidates (e.g. Oksanen et al., 2013; 
Lam et al., 2004). Therefore, the protective role of the adaptive immune response 
against S. pneumoniae in adult zebrafish was investigated by infecting Rag1-/- mutant 
zebrafish, which lack active T and B lymphocytes. Due to the defective adaptive 
immune response, the Rag1 deficiency in humans has been shown to be linked to a 
higher susceptibility to infections and similar results have been obtained from the 
studies using Rag-/- mice (e.g. Ribes et al., 2016; Geier et al., 2015; Blair et al., 2005). 
However, when the survival of the Rag1-/- fish was compared to the WT fish after 
an intraperitoneal injection of S. pneumoniae, we saw no differences in the survival of 
these two lines (final survival of 56 % for Rag1-/- and 59 % for WT) (Figure 12A, 
Figure 7A in III). Moreover, the immunization of adult zebrafish with heat killed T4, 
live T4, or live T4R three weeks prior to the infection failed to confer any significant 
protection (Figure 12B, Figure 7B in III). From these studies, we then concluded 
that, unlike in mammals, the defense against a S. pneumoniae infection in zebrafish is 
mainly dependent on the innate arm of immunity, while the adaptive arm plays a 
minor or no role in our model of a S. pneumoniae infection. 
 
Figure 12. The adaptive immune system has a limited role in the host response against S. 
pneumoniae in zebrafish. A) The zebrafish Rag1-/- mutants which are deficient in VDJ 
recombination and thus lack an adaptive immune response survived comparably to wild type 
(WT) fish. In the survival assay, wild type adult zebrafish or the Rag1-/- mutant fish were 
intraperitoneally infected with 2.5x106 cfu of T4. B) The immunization of adult zebrafish 
does not confer protection against a S. pneumoniae infection. The fish were immunized by 
intramuscular immunization with heat-killed T4 (1x104 cfu), a sublethal dose of live T4 
(5x104 cfu), or the unencapsulated mutant T4R (1.5x106 cfu), and infected intraperitoneally 
3 weeks post immunization with 2.5x106 cfu of T4. Control fish received KCl immunization 
or no immunization prior to infection. The graphs represent the collated results from three 
individual experiments (n=20 in each). Figures modified from original communication III. 
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5.5 A S. agalactiae infection in adult zebrafish is characterized 
by fulminant bacteremia and the dissemination of bacteria into 
the brain (II) 
 
Meningitis is a typical clinical manifestation of a neonatal S. agalactiae infection and 
is usually preceded by an overwhelming sepsis. To investigate the pathology of a S. 
agalactiae infection in zebrafish, the wild type FIM314 strain of S. agalactiae was 
administered into adult zebrafish with either an intraperitoneal or an intramuscular 
injection. Both routes of infection caused a rapidly progressing disease, which 
ultimately led to death in a dose-dependent manner. The infection kinetics were 
similar to S. pneumoniae, most of the deaths occurring by 48 h post an intraperitoneal 
infection and by 72 h post an intramuscular infection (Figure 13A, Figure 1A-B in 
II). The FIM314 strain appeared extremely virulent in zebrafish with a LD50 dose 
of ~100 cfu (56 % survival) for an intraperitoneal infection and ~10000 cfu (53 % 
survival) for an intramuscular infection. After an intraperitoneal injection of 100 cfu 
of FIM314, the high mortality was accompanied by an increasing level of bacteremia 
until 48 hpi (Figure 1C in II). The visible signs of the infection included damage at 
the injection site, common signs of illness, as well as swollen brain cavities and 
cerebral edema indicating high bacterial loads in the brain (Figure 2 in II).  
To examine the ability of S. agalactiae to invade the brain in zebrafish, we measured 
the bacterial loads in the blood and brain over time. After an intraperitoneal injection 
of 1x105 cfu of FIM314, bacteria were found in the blood immediately after the 
injection, while significant numbers of bacteria were detected in the brain at 6 hpi 
(Figure 13B, Figure 3A in II). In general, the level of bacteremia correlated with the 
bacterial counts in the brain, with a rapid increase in both from 6 hpi onwards. 
Bacterial meningitis is usually associated with an overwhelming inflammatory 
response in the brain also responsible for the severe tissue damage and sequelae 
(Barichello et al., 2013). Similarly, we observed an induction in the expression of il1b 
(15-fold increase) at 48 hpi and il6 (9-fold increase) at 24 hpi in the zebrafish brain 
upon a FIM314 infection compared to KCl injected fish (Figure 3B-C in II). The 
gradual increase in the il1b expression during the 48h follow-up is shown in Figure 
13C. With these results, we concluded that the pathology of a S. agalactiae infection 
in adult zebrafish resembles the neonatal S. agalactiae infection leading to a fulminant 
bacteremia and acute bacterial meningitis associated with high bacterial loads in the 
brain and the characteristic meningeal inflammation.  
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Figure 13. S. agalactiae causes fulminant bacteremia and meningitis in adult zebrafish. A)  
The survival of adult zebrafish from a S. agalactiae infection is dose-dependent. In this 
survival assay, adult zebrafish were intraperitonealy infected with various doses of the 
FIM314 strain of S. agalactiae. B) S. agalactiae is able to disseminate from the blood into the 
brain in adult zebrafish. Fish were intraperitoneally infected with 1x105 cfu of FIM314 after 
which the blood samples and the whole brain were collected. A dot represents the bacterial 
load in 5 μl of blood (black dots) or brain homogenate (grey circles) from single fish. The 
line depicts the median bacterial count. The graph shows the collated results from three 
individual experiments (n=5 in each). C) The expression of il1b is induced in the brain of 
adult zebrafish by 48 h post a S. agalactiae infection. The fish were intraperitoneally infected 
with 1x105 cfu of FIM314 and the expression levels were measured from dissected brains 
with qRT-PCR. The il1b expression levels were normalized to actb1 expression. The graph 
shows the mean fold change (+standard deviation) in expression compared to KCl injected 
fish from three individual experiments. All of the graphs represent the collated results from 
three individual experiments (n=15 in A, n=5 in B, and n=3) and the asterisks depict the 
statistically significant differences of *p<0.01 and ***p<0.0001. cfu=colony forming units. 
Figures modified from original communication II. 
5.6 S. agalactiae virulence factors contribute to the 
development of meningitis in zebrafish (II)   
 
The two determining factors in the onset of meningitis are the survival of the bacteria 
in the bloodstream and the ability to penetrate the blood-brain barrier, and several 
specific interactions between the host epithelial and immune cells and the bacteria 
have been found to contribute to these events (Barichello et al., 2013). Thus, we next 
asked whether the interactions known to promote the early steps in the onset of 
meningitis in rodents would also affect the outcome of the infection in zebrafish. 
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For this, we compared the virulence capacity of three S. agalactiae mutants, lacking 
either the antiphagocytic polysaccharide capsule (ΔcpsD), the cytolytic β-hemolysin 
(ΔcylE), or the CovS/CovR regulatory system (ΔcovSR) to the corresponding WT 
strain NEM316. After an intraperitoneal injection of 1x106 cfu of each strain, we 
noticed a significant increase in the survival of zebrafish infected with ΔcpsD (84 % 
survival), ΔcylE (82 % survival), and ΔcovSR (89 % survival) compared to the WT 
NEM316 (64 % survival) (Figure 14A, Figure 4 in II). Consistently, the bacterial 
amounts recovered from the blood and brain at 24 hpi were significantly lower in 
zebrafish infected with these mutants compared to the fish infected with WT S. 
agalactiae (Figure 14B, Figure 5A in II) indicating a hampered ability to survive in 
the blood and/or cross the BBB. Therefore, we concluded that the same interaction 
at the host-pathogen interphase in the blood and at the BBB promote the 
pathogenesis of S. agalctiae in zebrafish as has previously been detected in other 
animal models of S. agalactiae bacteremia and meningitis.  
 
 
Figure 14. Known virulence factors of S. agalactiae contribute to the severity of bacteremia 
and meningitis in zebrafish. A) S. agalactiae mutants lacking the β-hemolysin (ΔcylE), the 
capsule (ΔcpsD), or the CovS/CovR regulatory system (ΔcovSR) are attenuated in their 
virulence capacity in adult zebrafish compared to the corresponding wild type strain 
NEM316. In the survival assay, adult zebrafish were intraperitoneally infected with 1x106 cfu 
of wild type or the mutant bacteria. B) The S. agalactiae mutants cause lower levels of 
bacteremia and less dissemination of bacteria to the brain compared to the wild type S. 
agalactiae. Fish were intraperitoneally infected with 1x106 cfu of NEM316 or mutants and at 
24 hpi the blood samples and whole brains were collected. A dot represents the bacterial 
load in 5 μl of blood (back dots) or a brain homogenate (grey circles). The line depicts the 
median bacterial count. The graph shows the collated results from three individual 
experiments (n=15 in A, n=5 in B) and the asterisks depict the statistically significant 
differences of *p<0.01, **p<0.001, and ***p<0.0001). cfu=colony forming units. Figures 
modified from original communication II. 
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6 DISCUSSION 
6.1 Perspectives on the suitability of the zebrafish model for 
studying streptococcal infections  
 
Due to their high invasiveness and associated mortality, streptococcal bacteria are 
undoubtedly one of the most important groups of human pathogens. Despite the 
intensive study of the pathogenic mechanisms of streptococci in the past and 
present, much remains to be elucidated. The bacterial determinants contributing to 
the pathogenesis are strictly regulated and their expression restricted to certain 
tissues and stages of the infection. In addition, multiple host cells and soluble 
mediators participate in the host response in a coordinated way. Together, the host 
and the bacterial factors form a complex network of interactions which cannot be 
replicated in an in vitro experimental setting. In contrast, an appropriate animal model 
is needed to provide more natural conditions for the characterization of these 
factors, as well as for testing new drugs and vaccine antigens. 
For most streptococci, including S. agalactiae and S. pneumoniae, the most 
commonly used animal models are rodents, particularly the mouse. As mammals, 
mice exhibit a relatively high level of genetic homology, and share the basics of 
anatomy and physiology with humans, and therefore, are well suited for the study of 
most human diseases. The inbred mouse strains, with minimum individual variation 
and thus more uniform responses to experimental treatments, provide a practical 
research tool with reproducible results and high statistical power. In contrast, 
zebrafish cannot be inbred for several generations and provide a more heterogenous 
population, mimicking the natural variation in humans. In the case of S. pneumoniae 
and S. agalactiae infections, mice have been successfully used to reproduce the 
complete disease spectrum of these streptococcal bacteria, including otitis media, 
urinary tract infections, pneumonia, sepsis, and meningitis (Huang et al., 2016; 
Leclercq et al., 2016; Gendrin et al., 2015; Ulett et al., 2010; Chiavolini et al., 2008; 
Doran et al., 2003; Melhus and Ryan 2003; Saeland et al., 2000). In addition, factors 
promoting colonization in the nasopharynx (Krone et al., 2013; Balachandran et al., 
2002) and in the genital tract (Baker et al., 2017; Patras et al., 2015; Sheen et al., 2011) 
as well as the subsequent events leading to invasion have also been elucidated. Mice 
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have also been utilized in the analysis of post-infectious sequelae associated with 
meningitis, including brain damage and hearing loss (Grandgirard et al., 2007). 
However, depending on the bacterial strain used in the study, a high variation in the 
outcome of the infection has been observed in mice. Wild type mice seem to be 
relatively resistant to some S. pneumoniae strains and the infectivity of clinical isolates 
does not always recapitulate the virulence in humans (Sandgren et al., 2005; Briles et 
al., 1992). In general, however, mice models have provided invaluable information 
about the host and bacterial factors related to S. pneumoniae and S. agalactiae infections, 
and this knowledge has led to the development of current treatments or vaccines 
against both streptococci.  
Despite the obvious positive impact on human health, mammalian models also 
have issues concerning their cost and ethicality and are therefore not the best choice 
for experiments requiring large numbers of animals. It is also important to note that 
no animal model is perfect in mimicking the host-pathogen interactions in a human 
infection, and that it is the combination of different models that will provide us with 
the most comprehensive view of the pathogenesis. In this thesis, I have described a 
novel vertebrate model, the zebrafish, for the study of S. pneumoniae and S. agalactiae 
infections, that provides a more ethical but also practical, easy, and cost-effective 
alternative for the traditional rodent models. Among the most beneficial 
characteristics of this model are the unique methodologies for genetic manipulation 
and in vivo imaging as well as the suitability for large-scale experiments, such as 
chemical and genetic screens. These characteristics were also utilized in this thesis, 
especially in the form of a medium-scale genetic screen described in original 
communication IV. In addition, during this project, the choice between the zebrafish 
embryo and adult fish was weighted, since both models provide special benefits for 
the study of infectious diseases, namely the practicality and the versatile methodology 
of the embryos and the adaptive immune system of the adults.  
For the zoonotic S. agalactiae, which naturally infects both fish and humans, the 
zebrafish model is a rather logical choice for an animal model. In fact, other fish 
species, including other teleosts, have frequently been used in the elucidation of the 
host response to S. agalactiae (Zhu et al., 2017; Peng et al., 2017), as well as S. agalactiae 
virulence factors (Barato et al., 2016; Li et al., 2014), and vaccine candidates for 
aquaculture purposes (Cai et al., 2017; Zhang et al., 2017; Ma et al., 2017; Liu et al., 
2016). The adaptation of this pathogen to both fish and humans may also reflect the 
conserved host-pathogen interactions in zebrafish. In contrast, S. pneumoniae is 
currently known to be a human-specific pathogen in nature and may lack some 
species-specific interactions required for the pathogenesis in zebrafish, due to 
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different environmental conditions, for example. However, several previous 
examples of other human pathogens, such as S. pyogenes (Neely et al., 2002), 
Staphylococcus aureus (Prajsnar et al, 2008), and Salmonella typhimurium (van der Sar et 
al., 2003), as well as the study represented in this thesis highlight that the zebrafish 
infection models are not restricted to fish pathogens only. In the early studies of this 
project, both S. agalactiae and S. pneumoniae were shown to be able to cause an 
infection in zebrafish (original communications I, II, III). Importantly, the survival 
of the fish was dose-dependent indicating the presence of some sort of a defense 
mechanism that can recognize and clear the streptococci. This formed the basis for 
the further characterization of the zebrafish model for the study of the pathogenic 
mechanisms of these two streptococci.  
6.1.1 Studying the pathophysiology of S. agalactiae and S. pneumoniae 
infections in zebrafish    
 
The human mucosal sites at the respiratory tract, gut and the genital tract are the 
typical niches of S. agalactiae and S. pneumoniae and they also serve as the sites for 
bloodstream invasion. In the infection models presented in this thesis, the bacteria 
were mainly administered to the blood, by intravenous injections into embryos (I, 
IV) or an intraperitoneal infection (direct access to blood) in adult fish (II, III), 
bypassing the natural entry route at the mucosa. The benefit of the systemic 
administration of bacteria is the induction of comparable levels of bacteremia in 
every individual, giving a controlled experimental setting for the study of host and 
bacterial factors affecting bacterial clearance in the blood. Similarly, the 
dissemination of bacteria into the brain, and the interactions required for the 
penetration of the blood-brain barrier can be specifically investigated (II, III). To 
study the factors required for colonization and invasion, the crucial steps in the 
development of a natural streptococcal infection, other infection routes should be 
used. Since zebrafish lack the respiratory and the reproductive systems equivalent to 
humans, the mucosal surfaces at the gastrointestinal tract or the gills might provide 
streptococcal entry sites comparable to the human or mouse nasal, oral, or vaginal 
cavity. In general, the cellular architecture and the inflammatory response upon a 
bacterial or chemical stimulus in the zebrafish gills and gut have been shown to 
resemble those of humans (Progatzky et al., 2016; Brugman 2016; Shan et al., 2015; 
Rombout et al., 2014; Galindo-Villegas et al., 2012; Harriff et al., 2007) providing 
potential experimental colonization sites also for streptococci. In fact, S. pneumoniae 
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has been found to colonize the respiratory epithelium in the zebrafish gills leading 
to a lethal infection after bacterial immersion (Diez-Martinez et al., 2013), although 
the ability to invade the bloodstream from this site has not yet been evaluated.  
Streptococcal bacteria are found to cause an array of pathological conditions in 
humans, including for example, respiratory tract, skin, deep tissue, meningeal, and 
systemic infections (Cole et al., 2008). Although the anatomical differences between 
fish and mammals limit the modelling of certain infectious diseases, such as 
pneumonia, the pathology of the streptococcal infections in zebrafish described in 
this thesis and by others are strikingly similar to those in humans and mice (Saralahti 
and Rämet 2015; Phelps et al., 2009). A study by Neely et al. (2002) gave the first 
proof for successfully reproducing human streptococcal infections in zebrafish. The 
zoonotic pathogen S. iniae and the human-specific S. pyogenes were shown to cause 
an acute infection in adult zebrafish, with the clinical presentation resembling an 
invasive streptococcal infection in humans and local necrotizing fasciitis, respectively 
(Neely et al., 2002). In this thesis, I have shown the feasibility of using the zebrafish 
model in the study of the pathogenesis of S. pneumoniae and S. agalactiae. In zebrafish 
embryos, an intravenous injection of S. pneumoniae caused an acute systemic infection 
with dose-dependent lethality (I). The bacteria replicated fast during the first 24 hpi 
and induced a common inflammatory response (increased expression of il1b and tnfa) 
(I). Similarly, in adult zebrafish, the intraperitoneal administration of either S. 
pneumoniae (III) or S. agalactiae (II) caused a fulminant infection within the first 48 hpi. 
According to the significantly lower LD50 dose (~100 cfu), adult zebrafish appeared 
more susceptible to a S. agalactiae infection compared to S. pneumoniae (LD50 
~2.5x106 cfu). Nonetheless, both infections in adult fish were associated with the 
rapid replication of bacteria in the blood and the subsequent dissemination of 
bacteria into the brain accompanied with cerebral edema as a visible sign of 
meningeal inflammation (II, III). In mice and humans, the detrimental effects of 
meningitis are in part caused by an overwhelming inflammation and the infiltration 
of large numbers of leukocytes into the nervous system (Hoffman and Weber 2009). 
Consistently, the S. agalactiae infection was shown to induce an acute inflammatory 
response in the adult zebrafish brain as was exemplified by the increased expression 
of il1b and il6 (II). Later, supporting data by Jim et al. (2016) and Kim et al. (2015) 
demonstrated the ability of S. pneumoniae and S. agalactiae, respectively, to invade the 
brain of zebrafish embryos, and in the case of S. pneumoniae also the infiltration of 
neutrophils, were observed (Jim et al., 2016; Kim et al., 2015).  
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6.1.2 Studying the bacterial factors that promote a streptococcal infection 
in zebrafish 
 
One of the most challenging characteristics of streptococci is the variation and the 
poor predictability of the clinical outcome associated with certain strains and 
serotypes. It is well recognized that of the over 90 S. pneumoniae serotypes and the 10 
S. agalactiae serotypes, some are more often associated with colonization, while others 
predominate in invasive infections. The different virulence capacity of the S. 
pneumoniae serotypes is in part explained by the extensive sequence variation at the 
genomic locus containing the genes for capsule biosynthesis (Wen et al., 2016; 
Shainheit et al., 2014; Morona et al., 2004). However, another level of variation is 
created by the allelic diversity of the genes coding for other virulence factors, such 
as the adhesion proteins and toxins (Gámez et al., 2018; Cornick et al., 2017; Jefferies 
et al., 2007; Silva et al., 2006; Iannelli et al., 2002). In general, by analyzing the allelic 
variation at multiple loci as well as the protein expression profiles of different strains 
at different stages of the infection, the mechanisms promoting virulence are found 
to be multifactorial and complementary. Consequently, the molecular background 
for the virulence capacity of different strains remains largely unknown.  
Again, rodents have been frequently employed for the study of the pathogenic 
mechanisms of streptococci. By comparing the virulence of different serotypes, 
sequence types, as well as bacterial mutants lacking specific molecules, the 
importance of multiple membrane-bound and soluble virulence factors has been 
proved. One of the aims of this thesis was to find out whether the zebrafish model 
could be used in the search for novel virulence factors and their mechanisms of 
action in S. agalactiae and S. pneumoniae infections. The zebrafish model has been 
successfully used by others to verify the role of known virulence factors in the 
pathogenesis of streptococci, such as the capsule of S. iniae (Harvie et al., 2013; Lowe 
et al., 2007; Miller and Neely 2005; Neely et al., 2002), S. pyogenes (Kizy and Neely 
2009), and S. agalactiae (Kim et al., 2015). In addition to the classical virulence factors, 
others have also used the zebrafish model to unravel the role of novel streptococcal 
virulence determinants, including the M protein and the transcriptional regulator 
CpsY of S. iniae, the Iron uptake (Siu) transporter of S. pyogenes, and the regulatory 
protein CpsA of S. agalactiae (Hanson et al., 2012; Allen and Neely 2011; Locke et al., 
2008; Montanez et al., 2005). Moreover, as a great example of the practicality of the 
zebrafish model for the identification of previously unknown virulence factors, large-
scale signature-tagged mutagenesis screens were conducted in adult zebrafish for S. 
iniae and S. pyogenes (Kizy and Neely 2009; Miller and Neely 2005). 
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By testing the ability of S. agalactiae and S. pneumoniae mutants lacking known 
virulence factors to cause an infection in zebrafish, we noticed that the main bacterial 
factors affecting the severity of sepsis and meningitis are conserved from zebrafish 
to humans. In both a S. agalactiae and a S. pneumoniae infection, the virulence was 
impaired in mutants lacking the antiphagocytic polysaccharide capsule (I, II, III), 
recapitulating the results obtained from rodents (Hyams et al., 2010a; Morona et al., 
2004; Marques et al., 1992). Similarly, the cytolytic enzymes of both streptococci, as 
well as the CovS/CovR regulatory system of S. agalactiae and the autolysin A of S. 
pneumoniae were recognized as important mediators of pathogenesis in zebrafish, 
again supporting the previous studies in rodents (Lamy et al., 2004; Doran et al., 
2003; Berry et al., 1989a; Berry et al., 1989b). Later, similar observations by Kim et 
al. (2015) and Jim et al. (2016) gave more evidence for the conserved mechanisms of 
pathogenesis in the onset of meningitis in S. pneumoniae and S. agalactiae infections. 
Our results, supported by those of others, indicate the existence of specific, and 
importantly, conserved interactions between the host and the studied streptococci 
in zebrafish. These interactions promote the survival of bacteria in the bloodstream 
and their transmission into the central nervous system, providing us with a useful 
model for the study of these important actions during a streptococcal infection in 
humans.  
6.1.3 Using the zebrafish model in the development of S. pneumoniae 
vaccines 
 
As was discussed in section 2.4 “The remaining challenges in the eradication of S. 
pneumoniae and S. agalactiae” of this thesis, global concerns regarding the efficacy of 
the current S. pneumoniae vaccines, as well as the absence of a S. agalactiae vaccine in 
clinics are constantly driving the search for novel vaccine candidates forward. As in 
most vaccine research, the development of a streptococcal vaccine for humans is 
dependent on mammalian models, and thus cannot be carried out using efficient and 
large-scale vaccine antigen screens. Zebrafish, on the other hand, have been proven 
to be suited for this task, as is exemplified by the successful screen conducted for 
Mycobacterium marinum, a model bacterium for Mycobacterium tuberculosis, antigens 
(Myllymäki et al., 2017; Oksanen et al., 2013). Having a potential model organism in 
our hands, we wanted to test the ability of the zebrafish to contribute to the 
development of a vaccine against S. pneumoniae.  
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As in humans, the zebrafish adaptive immune system comprises of T and B 
lymphocytes that serve the same immune functions as their human counterparts (see 
section 2.5.1 “The zebrafish immune system and its relation to the human immune 
system”). Although their capacity to produce antibodies with varying specificity is 
limited compared to humans, zebrafish are able to mount a protective antibody 
response against several bacteria and viruses upon immunization (Tandberg et al., 
2017; Cui et al., 2010; Novoa et al., 2006). However, in original communication III, 
the infection of zebrafish devoid of active lymphocytes, due to a defect in Rag-
dependent VDJ recombination, resulted in similar survival rates compared to the 
wild type fish. Moreover, the immunization of zebrafish with live or killed S. 
pneumoniae did not confer protection against a following infection. From these results, 
we concluded, that the S. pneumoniae infection model described in this thesis is not 
suitable for vaccine development. This is also consistent with an earlier study with 
the zebrafish model for S. iniae infection (Neely et al., 2002) and was also seen with 
S. agalactiae in our unpublished study.  
The limited role of the adaptive immunity in our model of S. pneumoniae infection 
might be explained by the acute nature of the infection which is cleared rabidly 
through the innate immune system. In contrast, M. marinum, for example, causes a 
chronic disease in zebrafish and is slow enough to engage the adaptive immunity and 
is therefore amenable also for vaccine development. In order to thoroughly address 
the role of adaptive immune response to S. pneumoniae infection, other experimental 
settings should be tested. For example, instead of the intraperitoneal and 
intramuscular administration of the bacteria, another, milder infection strategy might 
be adequate for mounting an adaptive immune response. Supporting this, a recent 
research by Membrebe et al. reported that immunization with killed S. iniae protected 
zebrafish from a following subcutaneous infection (Membrebe et al., 2016). In 
addition, trying a different immunization and infection schedule or using a 
noninvasive pneumococcal strain could be necessary to detect the interaction 
between the S. pneumoniae and the adaptive immune system of the zebrafish.  
6.1.4 Using the zebrafish model to study the innate immune response to 
S. pneumoniae 
 
As was described in section 2.5.1 “The zebrafish immune system and its relation to 
the human immune system” of this thesis, the innate immune system of the zebrafish 
is very similar to the human immune system and has counterparts for most of the 
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human innate immune cells, receptors, and soluble effectors, such as cytokines, 
chemokines, and complement components (Zhang and Cui 2014; Kanther and 
Rawls 2010; Stein et al., 2007; Meijer et al., 2004). Despite the high level of 
conservation in the immune response between zebrafish and humans, relatively few 
studies have concentrated on the host response to a streptococcal infection in 
zebrafish. So far, the role of phagocytosing leukocytes in the eradication of 
streptococci has been the main target of interest in zebrafish studies. The innate 
immune system of zebrafish, including the innate leukocytes, arises by 2 days post 
fertilization, allowing the study of these host responses to a bacterial infection at the 
very early stages of development (Kanther and Rawls 2010; Le Guyader et al., 2008; 
Herbomel et al., 1999). In addition, since the adaptive immune response is active 
only after 4 weeks of development, the innate immune mechanisms can be studied 
without the influence of these factors. As another unique characteristic for a 
vertebrate, transgenic zebrafish lines can be used to study the function of immune 
cells in vivo in real-time during the bacterial invasion. Nowadays, a fluorescent 
reporter line for almost any immune cell type exists and has been used to analyze 
their function during a bacterial invasion (Ellett et al., 2011; Renshaw et al., 2006; 
Langenau et al., 2004; Ward et al., 2003). In original communication I, the transgenic 
reporter line for myeloid cells was used to visualize the localization and function of 
these cells in a S. pneumoniae infection. At 3 hpi, myeloid cells were seen to migrate 
to the site of infection, form protrusions towards, and ingest the injected bacteria. 
Similarly, the important role of the myeloid cells in the host response to a 
streptococcal infection has also been demonstrated by others (Vincent et al., 2017; 
Kim et al., 2015; Harvie et al., 2013). As yet another beneficial characteristic, there 
are multiple opportunities for reverse genetics in zebrafish embryos, for studying 
specific immune functions in the defense against bacteria. In this thesis the transient 
silencing of genes with the antisense oligonucleotide method was utilized to further 
verify the importance of myeloid cells in the host defense against S. pneumoniae in 
zebrafish embryos (I).  
Along with the functional studies on the myeloid cells in a S. pneumoniae infection 
in zebrafish, we characterized the zebrafish innate immune response to S. pneumoniae 
in a larger scale through a whole genome level transcriptome analysis (IV). 
Importantly, the analysis revealed that many of the activated protein coding genes 
were associated with a common innate immune response, including genes coding for 
complement components, acute phase proteins, innate immune signaling molecules, 
and mediators of leukocyte migration and function. Since phagocytosis is the primary 
clearance mechanism for S. pneumoniae also in zebrafish (as shown in original 
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communication I), it was not surprising that the genes postulated to be associated 
with enhanced phagocytosis were enriched among the upregulated genes. For 
example, the most enriched functional group of proteins was formed by the 
complement components. The phagocytosis and the clearance of S. pneumoniae in 
mammals is highly dependent on the complement system which functions as 
opsonin to aid the recognition and intake of bacteria by the host’s phagocytosing 
cells (Ali et al., 2012; Hyams et al., 2011; Kerr et al., 2005; Brown et al., 2002; Xu et 
al., 2001). Moreover, complement also serves other important immunomodulatory 
functions during a S. pneumoniae infection, including the recruitment of leukocytes 
and the activation of adaptive immune responses (Andre et al., 2017; Dunkelberger 
and Song 2010). In a S. pneumoniae infection, the complement system can be activated 
by any of the three activation pathways, the classical, the alternative, or the lectin 
pathway, the first of which seems to be the dominating pathway in a S. pneumoniae 
infection (Ali et al., 2012; Brown et al., 2002).  
The importance of complement in the defense against S. pneumoniae is also 
emphasized by the number of pathogenic strategies developed to disturb its function 
(Andre et al., 2017). Again, the most important of these factors is the capsule, and 
the ability to resists the complement mediated immunity is in part linked to the 
capsular serotype (Hyams et al., 2010a; Hyams et al., 2010b; Melin et al., 2010). In 
addition, several protein virulence factors of S. pneumoniae, including PspC, PspA, 
pneumolysin, and Autolysin A also interact with the complement components and 
contribute to the resistance (Ramos-Sevillano et al., 2015; Mukerji et al., 2012; Dave 
et al., 2004; Alcantara et al., 2001; Tu et al., 1999). The mechanisms of complement 
resistance are numerous and include, for example, the direct binding to C3 or the 
derivative opsonins (e.g. PspC and PspA), the recruitment of inhibitors of the 
complement system (e.g. PspC, PspA, Autolysin A), depletion of the complement 
components (pneumolysin), or the inhibition of the binding of opsonin to its 
corresponding receptor (capsule) (Ramos-Sevillano et al., 2015; Mukerji et al., 2012; 
Dave et al., 2004; Alcantara et al., 2001; Tu et al., 1999). In fact, the pathogenic 
mechanism of each of these factors in mice has been strongly linked to their ability 
to inhibit complement. Similarly, the highly induced complement-related genes upon 
a S. pneumoniae infection and the attenuated nature of the capsule, the pneumolysin 
and the autolysin A deficient mutants in zebrafish embryos, suggests the presence of 
an analogous mechanisms for pathogenesis in our model as well.   
The transcriptome data in original communication IV indicated the increased 
expression of genes specifically associated with the classical and alternative pathways, 
including the genes for Crp, known to activate the classical pathway of complement, 
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as well as the C1 complex subcomponent C1r and the complement factor B required 
for the activation of the C3 convertase in the classical and the alternative pathway, 
respectively (Dunkelberger and Song 2010). Importantly, the central complement 
component in every pathway, C3, was also highly upregulated upon infection. As 
was described earlier in this thesis, the zebrafish innate immune system is highly 
diversified compared to mammals, and this was also seen in our transcriptome data. 
For example, the most induced genes included four of the eight zebrafish C3 variants 
and a set of zebrafish genes with no putative homolog in mammals. With the still 
limited gene annotation and the lack of functional studies, the biological significance 
of the variants and the zebrafish specific genes remains unknown. However, the 
mechanisms of the innate immune response are in general well conserved across 
species, as is exemplified by the existence of complement in organisms as low as 
lancelets and sea urchins (Dunkelberger and Song 2010; Al-Sharif et al., 1998). 
Therefore, the complement system in zebrafish is likely to have retained its basic 
functions in the innate host response and, as has been proposed for other 
components of the innate immune system, the diversification might allow broader 
target specificity and the recognition of micro-organisms compared to mammals. 
Moreover, analogous gene synteny and sequence as well as the evidence obtained 
from other fish species (Zhang and Cui 2014; Boshra et al., 2006), strongly suggests 
also the functional conservation of the complement system in zebrafish.  
6.2 The genetic screen for host factors affecting S. pneumoniae 
susceptibility in zebrafish 
 
In addition to bacterial factors, differences in the clinical outcome may also be a 
result of the genetic variation within the human population. The host factors 
affecting the outcome of a S. pneumoniae infection have been searched for through 
numerous genetic association studies in humans and mice. While polymorphisms in 
the genes coding for common innate immune components, such as the 
inflammasome (Geldhoff et al., 2013), NF-kB signaling (Chapman et al., 2010; 
Chapman et al., 2007; Ku et al., 2007), and the complement system (Jönsson et al., 
2005; Roy et al., 2002) have been associated with a susceptibility to pneumococcal 
infections in humans, the predisposing host factors are still poorly known. The 
evaluation of these factors has frequently been carried out in mice, through knock-
out studies or by comparing the host response in various inbred strains (Alper et al., 
2016; Jonczyk et al., 2014; Endo et al., 2012; Sun et al., 2011; Kerr et al., 2002).     
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To add our own contribution to the effort, we carried out a medium-scale 
forward genetic screen for host factors affecting the susceptibility to S. pneumoniae in 
zebrafish (original communication IV). Zebrafish are ideal models for such a screen 
since they develop fast and can be kept in big numbers in a relatively small space. 
From the large pool of different methods for forward genetics in zebrafish, we chose 
to use gene-breaking transposon-based insertional mutagenesis (Clark et al., 2011). 
As an advantage over more traditional chemical mutagenesis strategies, the disrupted 
genomic locus can be more easily identified. In addition, using a fluorescent marker 
in the mutagenesis construct, the mutated individuals can be specifically chosen for 
the crosses and the phenotypic analyses. Finally, the role of novel genes obtained 
from the screen can be studied using the practical reverse genetic tools that are 
available for zebrafish, including antisense morpholino knockdown or 
CRISPR/Cas9 targeted mutagenesis.  
The practicality of this model complemented with the high level of conservation 
between the human and zebrafish innate immune systems provides an intriguing 
opportunity for studying the genetic susceptibility associated with a S. pneumoniae 
infection in humans. Overall, while zebrafish have frequently been utilized in screens 
for genes associated with development and human disorders (Golling et al., 2002; 
Haffter et al., 1996), relatively few screens have concentrated on the function and 
development of the immune system. The successful screens for T cell development 
(Iwanami et al., 2016; Seiler et al., 2015) and the innate susceptibility to a M. marinum 
infection (Tobin et al., 2010), however, will certainly pave the way for other screens 
uncovering unknown immune functions.  
The screen carried out in our group was the first to study the innate susceptibility 
to a S. pneumoniae infection in zebrafish. Through the screen we found several mutant 
zebrafish lines with an increased susceptibility to a S. pneumoniae infection. One of 
the most susceptible lines showed hampered defense mechanisms against S. 
pneumoniae and thus the uncontrolled systemic growth of bacteria (IV). By analyzing 
the differentially expressed genes at the whole genome level in a S. pneumoniae 
infection in wild type and mutant embryos, the associating factor for a more severe 
S. pneumoniae infection was found to be the decreased expression of the gene 
homologous for human CRP. CRP is an acute phase protein whose production is 
rapidly induced by the pro-inflammatory cytokines IL1B, IL6 and TNF as a response 
to infection, injury or trauma (Slaats et al., 2016; Gruys et al., 2005; Zhang et al., 
1995; Castell et al., 1989; Gauldie et al., 1987). Human CRP can specifically recognize 
and bind the C-polysaccharide on the surface of S. pneumoniae and promote the 
complement-mediated phagocytosis of S. pneumoniae (Holzer et al., 1984; Kaplan and 
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Volanakis 1974). Due to its rapid production upon infection, CRP may provide an 
immediate way of recognizing bacteria and promoting phagocytic clearance, as 
opposed to antibodies, which are produced in a more delayed manner. In addition 
to its ability to activate the classical pathway of complement (Kaplan and Volanakis 
1974) CRP binding can also directly stimulate the uptake of bacteria by phagocytes 
and lead to the production of inflammatory mediators (Thomas-Rudolph et al., 2007; 
Mold and Du Clos 2006). 
Much evidence for the importance of CRP for the innate immune response to S. 
pneumoniae has been gained from in vitro studies. The lack of a proper animal model 
for the biological role of CRP is mainly due to functional differences (e.g. between 
humans and mice) and the lack of cross-reactivity between the human CRP and 
complement components in other species (Torzewski et al., 2014; Black et al., 2003; 
Whitehead et al., 1990; Volanakis and Kaplan 1974). However, although CRP is not 
an acute phase protein in mice, human CRP is able to protect mice from severe 
bacteremia and mortality in a complement mediated way after an infection with S. 
pneumoniae (Suresh et al., 2006; Szalai et al., 1996; Yother et al., 1982; Mold et al., 
1981). Quite recently, the importance of the CRP for the innate defense against S. 
pneumoniae was also shown in a knock-out mice model (Simons et al., 2014). As in 
humans, the endogenous CRP has been shown to activate complement in rats and 
trout indicating the conservation of this important biological function across species 
(Padilla et al., 2003; Nakanishi et al., 1991). According to the current knowledge, 
zebrafish has seven Crp isoforms (Bello-Perez et al., 2017a; Bello-Perez et al., 2017b; 
Chen et al., 2015). However, due to the missing comprehensive functional analysis 
of the isoforms, the exact biological role of these proteins in a S. pneumoniae infection 
remains unknown. The induction of zebrafish Crp genes in S. pneumoniae (IV) and 
other bacterial infections (Bello-Perez et al., 2017b; Benard et al., 2014) as well as the 
postulated association between Crp deficiency and an increased susceptibility to S. 
pneumoniae infections in zebrafish, clearly indicate the retained function of Crp as an 
important part of the innate immune response in this species.     
To verify the role of CRP and the mechanisms of action in the host response to 
a S. pneumoniae infection in zebrafish, further evaluation through reverse genetics is 
required. However, the finding of such a component, with a previously shown strong 
association with a S. pneumoniae infection, as a potential predisposing factor to an 
infection in zebrafish, proves the value of our model and the screen in the study of 
the host factors associated with this pathogen. Noteworthy, besides the mutant line 
described in this thesis, several other mutant lines with impaired survival in a S. 
pneumoniae infection were discovered in the screen. Future studies will show, whether 
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these mutants and the corresponding candidate genes will help us reveal novel host 
factors associated with the innate susceptibility to a S. pneumoniae infection.  
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7 SUMMARY AND CONCLUSIONS 
The zebrafish has a long history as a model organism for studying embryonic 
development, and more recently it has gained popularity also in the study of cancer, 
cardiovascular disease, neurological disease, and immune function. In many cases, 
the results obtained from zebrafish studies complement discoveries made in higher 
model organisms, such as rodents, surprisingly well. In the field of immunology, the 
mechanisms of pathogenesis of a continuously increasing number of infectious 
agents, including bacteria, viruses and parasites, have been successfully studied in 
zebrafish. These micro-organisms include both human-specific and fish-adapted 
species, thus indicating the conservation of the basic mechanisms of pathogenesis in 
fish and humans.  
This study focused on the evaluation of the potential of the zebrafish to act as an 
infection model for the zoonotic pathogen Streptococcus agalactiae and the human-
specific Streptococcus pneumoniae. Although they were recognized as major human 
pathogens already about a century ago, the complex mechanisms of the pathogenesis 
as well as the relevant host susceptibility factors of S. pneumoniae and S. agalactiae 
remain largely unclear. In the early stages of this study both pathogens were shown 
to cause a fulminant, dose-dependent infection when introduced systemically to 
zebrafish embryos (S. pneumoniae) or adult zebrafish (S. pneumoniae and S. agalactiae). 
The infections progressed rapidly and were associated with an inflammatory 
response (production of IL1B and TNF, IL6) and dissemination of the bacteria into 
the brain. The importance of known virulence factors of S. pneumoniae (the capsule, 
pneumolysin, and autolysin A) and S. agalactiae (the capsule, β-hemolysin, and the 
CovS/CovR system) for the pathogenesis of these streptococci was shown in 
zebrafish by testing the virulence capacity of the corresponding mutant bacteria. 
Besides the bacterial factors promoting the infection, the conservation of the host’s 
response to a S. pneumoniae infection was evaluated in zebrafish. First, the importance 
of the phagocytic clearance of S. pneumoniae in zebrafish was discovered by analyzing 
the effect of depleting myeloid cells on the survival of the zebrafish and by imaging 
the behavior of myeloid cells during the infection. Second, a genome level 
transcriptome analysis of the infected zebrafish embryos revealed the overall 
similarity of the innate immune response to a S. pneumoniae infection in zebrafish and 
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in humans. Finally, further support for the conserved host responses to a S. 
pneumoniae infection in zebrafish came from the forward genetic screen in which the 
lack of crp expression was identified as a potential susceptibility factor for severe 
bacteremia. In contrast to the conservation of the innate immune response to S. 
pneumoniae in zebrafish, the adaptive immunity did not seem to play a significant role 
in combating the infection in our model. For this reason, this model is not a propriate 
model for the development of pneumococcal vaccines.    
In conclusion, our studies indicate that both the infection models represented in 
this thesis are capable of reproducing the pathology of human streptococcal sepsis 
and meningitis. The zebrafish provides a practical model in which the important 
pathological features of human infections, including the bacterial counts and the 
inflammatory response, can be easily analyzed. In addition, the studies conducted in 
zebrafish embryos highlight the benefits of the unique methodologies available for 
this model, including the tracking of immune cell migration and function in real-time 
and the ease of reverse and forward genetics. Due to the conserved host-pathogen 
interactions in zebrafish and humans, this model shows great potential in revealing 
novel host factors associated with the clearance of bacteria from the bloodstream as 
well as the bacterial factors promoting immune evasion during S. pneumoniae and S. 
agalactiae infections. Importantly, zebrafish also provide a valuable model for the 
elucidation of the specific interactions promoting the penetration of the BBB and 
the onset of meningitis associated with both pathogens. Although there is no doubt 
that the traditional mammalian models will still provide important knowledge of the 
pathophysiology of human streptococcal infections, the zebrafish will serve as a 
beneficial alternative and also a superior model for large-scale experiments, such as 
genetic and drug screens.  
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a b s t r a c t
Severe community acquired pneumonia caused by Streptococcus pneumoniae is the most common cause
of death from infection in developing countries. Serotype speciﬁc conjugate vaccines have decreased the
incidence of invasive infections, but at the same time, disease due to non-vaccine serotypes have
increased. New insights into host immune mechanisms against pneumococcus may provide better treat-
ment and prevention strategies. Zebraﬁsh is an attractive vertebrate model for studying host immune
responses and infection biology. Here we show that an intravenous challenge with pneumococcus infects
zebraﬁsh embryos leading to death in a dose dependent manner. Survival rates correlate with the bacte-
rial burden in the embryos. The production of proinﬂammatory cytokines is induced in zebraﬁsh after
pneumococcal exposure. Importantly, morpholino treated embryos lacking either myeloid cells or the
ability to phagocytose bacteria have lowered survival rates compared to wild type embryos after pneu-
mococcal challenge. These data suggest that the survival of zebraﬁsh embryos upon intravenous infection
with S. pneumoniae is dependent on the clearance of the bacteria by phagocytosing cells. Additionally, we
demonstrate that mutant pneumococci lacking known virulence factors are attenuated in the zebraﬁsh
model. Our data demonstrate that zebraﬁsh embryos can be used for study innate immune responses
as well as virulence determinants in pneumococcal infections.
 2011 Elsevier Ltd. All rights reserved.
1. Introduction
Streptococcus pneumoniae (pneumococcus) is a major cause of
respiratory tract infections such as otitis media, sinusitis, and
pneumonia as well as invasive diseases (septicemia and meningi-
tis). Children, the elderly and immuno-compromised patients suf-
fer from severe pneumococcal diseases (van der Poll and Opal,
2009). It is estimated that half a million children under ﬁve years
of age die of pneumococcal pneumonia every year (Yu et al.,
2003). For decades, penicillin was the drug of choice for treating
pneumococcal infections, but increasing levels of penicillin resis-
tance has resulted in the use of alternative antibiotics (Yu et al.,
2003). It is known that the ability of S. pneumoniae to cause inva-
sive disease depends on its ability to colonize the nasopharynx,
traverse the respiratory epithelium, and eventually enter the
bloodstream across the vascular endothelium (Tuomanen et al.,
1995). During this process pneumococci will launch an inﬂamma-
tory response, mediated by the host’s innate immune system. The
inﬂammatory response is triggered by the recognition of microbial
molecular patterns in the bacterial cell wall or in the cytosol of
lysed bacteria (Ishii et al., 2008). Toll-like receptors (TLR) have
been shown to play a central role in the initiation of cellular innate
immune responses against pneumococci. Mice deﬁcient in the
common TLR-adaptor protein MyD88 are more susceptible than
wild type mice to pneumococcal disease (Albiger et al., 2005). Also
children with a genetic MyD88 deﬁciency have been shown to
have an increased susceptibility to invasive pneumococcal disease
(von Bernuth et al., 2008). Moreover, the clearance of pneumococci
from the blood has been shown to be dependent on complement
components, another important part of the innate immune system
(Brown et al., 2002). The recognition of pneumococci by innate im-
mune receptors leads to the induction of inﬂammatory cytokines
and chemokines, which recruit other inﬂammatory cells to the site
of the infection eventually leading to the activation of the adaptive
immunity (Tuomanen et al., 1995).
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Pneumococci express a variety of virulence factors, which en-
able the colonization and invasion of the host (Jedrzejas, 2001).
The bacterial capsule is the most important virulence factor
(Nelson et al., 2007b). It is strongly antiphagocytic and unencapsu-
lated pneumococci are considered avirulent (Hyams et al., 2010;
Morona et al., 2006). Recently, it was discovered that pneumococci
may express pilus-like structures on their surface, promoting
adhesion and bacterial spread (Barocchi et al., 2006; Nelson
et al., 2007a). Also, several other bacterial factors have been shown
to affect pathogenicity in experimental animal models (Hirst et al.,
2004; Iannelli et al., 2004; Paterson and Mitchell, 2006).
The zebraﬁsh (Danio rerio) has been used to study embryogen-
esis and organ development for decades. The use of zebraﬁsh in
studies of host–pathogen interactions during infection is more re-
cent (van der Sar et al., 2004). As a teleost, zebraﬁsh possesses both
an innate and adaptive immunity (Yoder et al., 2002). Many as-
pects of its immune responses correspond to those of mammals.
In zebraﬁsh, TLRs have been characterized and as many as 24 puta-
tive variants have been described (Jault et al., 2004). Sequencing of
the zebraﬁsh genome has led to the identiﬁcation of homologs of
mammalian genes encoding cytokines, and interferons (Levraud
et al., 2007; Roca et al., 2008). Also, studies indicate that T and B
cells, antigen-presenting cells, and phagocytic cells are present in
zebraﬁsh (Yoder et al., 2002). Several bacterial infection models
have been established in zebraﬁsh (Clay et al., 2007; Miller and
Neely, 2004; Stockhammer et al., 2009; van der Sar et al., 2006).
Even pathogens that do not naturally infect ﬁsh (Staphylococcus
aureus and Pseudomonas aureginosa) have been successfully used
to trigger immune responses in zebraﬁsh (Clatworthy et al.,
2009; Prajsnar et al., 2008).
In this study, we show for the ﬁrst time that zebraﬁsh embryos
may be used as a model for host immune responses in systemic
pneumococcal infections. We demonstrate that the inoculation of
pneumococci into the circulation of zebraﬁsh embryos causes a
fatal infection, which is dependent on the host’s immune cells
and their ability to clear the bacteria from the blood. We found that
pneumococci may evade clearance in the host by interfering with
phagocytic functions. Moreover, isogenic pneumococcal mutants
harboring defects in important virulence factors were attenuated
in this in vivo model system.
2. Materials and methods
2.1. Bacterial strains
S. pneumoniae TIGR4 belongs to a clone (ST205) with a high
invasive disease potential. It is an encapsulated serotype 4 (ATCC
BAA-334) originally isolated from a patient in Norway (Aaberge
et al., 1995). The insertion–deletion mutagenesis used for most
strains is described elsewhere (Barocchi et al., 2006). Brieﬂy,
approximately 1 kB of the upstream and downstream fragments
of the relevant ORF were ampliﬁed by PCR and ligated to the ends
of an erythromycin-resistance cassette (ErmR, Genbank accession
AB057644). The resulting construct was transformed into the
appropriate wt pneumococcal strain and plated on blood agar
plates with erythromycin (1 lg/ml). Mutants were conﬁrmed by
PCR, sequencing, and immunogenicity.
Unless stated elsewhere, T4 and the isogenic mutants were
grown overnight on blood agar plates (at 37 C and CO2). Cells were
suspended in 10 ml Todd Hewitt broth (Becton, Dickinson and
Company, BD) supplemented with (0.5%) yeast extract (THY) and
incubated at 37 C until they reached an OD620 of 0.4. Bacteria
were harvested by centrifugation (4000 rpm, 10 min) and the cell
pellet was washed and re-suspended in 0.2 M KCl-buffer to obtain
the desired dilutions.
2.2. Zebraﬁsh embryos
Wild type AB zebraﬁsh embryos were maintained according to
standard protocols. During the experiments embryos were kept in
E3 medium at 28.5 C. The Tg(spi1:EGFP) mutant strain was ob-
tained from ZIRC (http://zﬁn.org/zirc).
2.3. Preparation and microinjection of zebraﬁsh embryos
Zebraﬁsh embryos were dechorionated at 48–50 hpf and anaes-
thetized with buffered 0.02% tricaine (Sigma–Aldrich). A 70 kDa
rhodamine dextran (Invitrogen/Molecular Probes) tracer was
added to the bacterial suspension before injections. Injections of
1 nl each, were directed into the blood circulation valley so that
a group of 24–30 embryos were injected with the same glass
microcapillary needle ﬁlled with bacterial suspension. The output
of each needle was controlled by plating the injection dose before
and after the injections.
2.4. Following the mortality of infected embryos
After infection, embryos were kept in 24-well plates at 28.5 C,
a single embryo in each well. Embryos were followed frequently
and dead embryos in every group were counted at each time point
to obtain survival rates. Lack of movement and heartbeat was
interpreted as a sign of death.
2.5. Determination of bacterial growth in infected embryos
Five embryos from each group were randomly collected at reg-
ular time points (2 h, 7 h, 20 h, and 48 h) and anaesthetized with
tricaine. Individual embryos were then homogenized in 1.5 ml cen-
trifuge tubes with 200 ll PSB and 1% triton-X by pipetting up and
down. Thereafter, the homogenates were serially diluted in PBS
and plated onto selective blood agar plates. After incubating over-
night at (37 C and CO2), bacteria were counted on each plate.
2.6. Generation of morphants
The morpholinos used in the study were designed to block
translation (TB) or pre-mRNA spilicing (SB). The gene silencing
morpholinos targeting zebraﬁsh WASP1 50-CCCTTTGCTTTTGC
CTTTGCTCATC30 (ZDB-GENE-030131-7098) and WASP2 50-
CCTCATGGCCTCATACGCCGTCTAA-30 (ZDB-GENE-081104-419),
Pu.1 (ZDB-GENE-980526-164) 50-CCTCCATTCTGTACGGATGCAG
CAT30 (TB) and 50-GGTCCTTCTCCTTACCATGCTCTCC-30 (SB), were
obtained from Gene Tools (Philomath, OR). For Pu.1 and WASP a
mix of both morpholinos was used. The morpholino concentration
for Pu.1 was 130 lM + 130 lM (TB + SB) and for WASP
100 lM + 100 lM (WASP1 + WASP2). A total of 1 nl morpholinos
in 0.2 M KCl was injected into the yolk sacs of fertilized eggs at
the 1–2 cell stage. A standard control mismatch morpholino from
Genetools was used in each experiment.
2.7. Real time qRT-PCR analysis
A total of 10–15 embryos from each group were pooled and to-
tal RNA extraction was done using standard procedures. qRT-PCR
for mRNA expression levels of selected genes were obtained using
the QuantiTect SYBR green RT-PCR kit (Qiagen) and ABI7000
instrument (Applied Biosystems). Primers were: TNF-a upstream
50-GGG CAA TCA ACA AGA TGG AAG-30 and downstream 50-GCA
GCT GAT GTG CAA AGA CAC-30, IL-1ß upstream 50-TGG ACT TCG
CAG CAC AAA ATG-30 and downstream 50-GTT CAC TTC ACG CTC
TTG GAT G-30, ß-Actin upstream 50-ATC GAT GAG GAA ATC GCT
G-30 and downstream 50-ATG CCA ACC ATC CCC TG-30. The primers
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for IL-1ß and ß-Actin were obtained from a study carried out by
Pressley et al. (2005).
2.8. Live ﬂuorescent microscopy
For live imaging, Tg(spi1:EGFP) embryos were injected with
Baclight™ (Invitrogen) labelled T4. Brieﬂy, the bacteria were grown
in THY medium to log-phase and washed with KCL. Washed bacte-
ria were incubated according to the manufacturers instructions
with Baclight red stain at room temperature. Thereafter, the infec-
tion procedure was carried out as described earlier. One hour after
injection, living embryos were anesthetized and mounted onto 1%
low-melting-point agarose. The interaction between red ﬂuores-
cent bacteria and GFP expressing myeloied cells was captured from
the circulation valley area. Microscopy was carried out using 40
or 100 (Olympus BX51) water immersion objectives. Stacks of ob-
tained ﬁgures were assembled using ImageJ (National Institutes of
Health) and the ﬁnal editing was done with Photoshop CS2 (Adobe
systems Inc.).
2.9. Statistical analysis
Survival rates were analyzed using the Mantel-Cox Log Rank
test. The data for colony forming units and cytokine expression lev-
els were analyzed using one-way ANOVA with Bonferroni’s post
test or the T-test. A p-value of <0.05 was considered statistically
signiﬁcant. All data was analyzed using the Graph Pad Prism 5.0
software.
3. Results
3.1. S. pneumoniae infection in zebraﬁsh embryos
The completely sequenced, pathogenic pneumococcal strain
TIGR4 (T4), previously used in mice model infections, was chosen
to be intravenously infected into zebraﬁsh embryos (Aaberge
et al., 1995; Sandgren et al., 2005). To study the possible virulence
capacity of pneumococci, various doses of the T4 strain were in-
jected into the blood stream of zebraﬁsh embryos, whose survival
was then monitored. Regardless of the dose, mortality was highest
during the ﬁrst 48 h post injection. Fig. 1A shows the dose depen-
dent mortality post infection. The combined mean survival propor-
tion with a 100 cfu/e inoculum was 49%, with 1000/e it was 15%
and with 10,000 cfu/e 3% (p < 0.0001). The highest dose
(10,000 cfu/e) was associated with the most rapid disease progres-
sion. No deaths occurred in the control group. These results dem-
onstrate that pneumococci may cause a fatal infection in
zebraﬁsh embryos after injection into the blood stream.
In addition to intravenous injections, a set of yolk sac injections
was also carried out. In this setting, all the embryos tended to die
regardless of the number of bacteria injected (data not shown).
This is likely due to a lack of circulating immune cells inside the
yolk, which leads to unlimited growth of the bacteria.
To monitor the expansion of bacteria in the host after intrave-
nous injection, embryos were pooled (24 per group) and lyzed at
various time points for bacterial counts. As shown in the Fig. 1B
and C, pneumococcal growth in zebraﬁsh embryos was logarithmic
with inputs of both 100 cfu (Fig. 1B) and 1000 cfu (Fig. 1C) per em-
bryo. These data show that pneumococci are able to expand in zeb-
raﬁsh embryos following an intravenous injection.
To investigate whether zebraﬁsh embryos are able to combat
and kill pneumococci, single embryos were collected and lysed to
obtain bacterial counts. Both surviving and dying embryos were
analyzed. As shown in the Fig. 2A, the survival of the embryos is
associated with clearance of the bacteria. After 48 h, embryos
had either cleared the infection or died. Importantly, the number
of bacteria following the intravenous injection increased in dying
embryos, while in the surviving individuals the bacterial load de-
creased (P < 0.001). Noteworthy, this clearance mechanism was
not seen after a yolk sac injection of pneumococci as the bacterial
counts increased gradually over time (Fig. 2B). In summary, these
results show that zebraﬁsh embryos may combat pneumococcal
infections although this is not the case in the yolk sac.
3.2. Pneumococcal virulence factors contribute to pathogenicity in
zebraﬁsh embryos
The host environment such as the temperature (+28 C) in zebra-
ﬁsh is not optimal for the human adapted pathogen S. pneumoniae.
However, when growing the bacteria in THY medium at +28 C we
did not see a signiﬁcant difference in the growth curves compared
to growth at +37 C (data not shown). Importantly, our data indicate
that pneumococci are able to grow and replicate when injected into
the blood streamof zebraﬁsh. Thus, we sought to determine if pneu-
mococcal virulence factors contributed to the pathogenicity in this
model. The pneumococcal capsule is essential during all steps of dis-
ease progression, adherence, invasion and dissemination (Nelson
et al., 2007b) and it helps the bacteria to evade phagocytosis (Hyams
et al., 2010). To test if the capsule is required for virulence, the non-
encapsulatedmutant derivative T4Rwas used in the zebraﬁshmod-
el. In agreement with ﬁndings in mouse models, T4R appeared
avirulent in zebraﬁsh embryos following an intravenous injection
(Fig. 3). Pneumolysin, a cytotoxin expressed by pneumococci, has
been shown to be lytic to host cells, to impair respiratory burst of
phagocytic cells and to induce the production of cytokines and che-
mokines (Gilbert et al., 1999; Hirst et al., 2004). A pneumolysinmu-
tant of T4, T4Dply, showed higher survival rates (46%) compared to
the wild type bacterium (70%) (P = 0.01), indicating that pneumoly-
sin inﬂuences pneumococcal pathogenicity in zebraﬁsh embryos
(Fig. 3). Autolysin is another virulence factor, shown to hamper a
range of host immune responses in pneumococcal infections (Berry
et al., 1989a; Martner et al., 2009). An autolysin mutant, T4DlytA,
showed signiﬁcantly higher survival rates (72%) compared to wild
type pneumococci (P = 0.001). Finally, the T4DrlrA mutant, lacking
the genetic locus encoding pneumococcal pili showed lowered
pathogenicity compared to the wild type strain (P = 0.001) in this
model for systemic infection. Pili have been shown to be important
for adhesion and for the dissemination of pneumococci from local
sites into the blood stream (Barocchi et al., 2006; Nelson et al.,
2007a). These results show that zebraﬁsh embryos can be used as
amodel to identify and study the virulence factors of S. pneumoniae.
3.3. Clearance of pneumococci is dependent on myeloid cell
recognition and phagocytosis
At the developmental stage of 2 dpf, immune defenses of zebra-
ﬁsh are dependent on innate immune responses, and especially on
phagocytosing cells. When encountering bacteria, leukocytes rec-
ognize pathogen-associated patterns or molecules by pattern rec-
ognition receptors. This leads to signaling events that induce
inﬂammatory mediators like cytokines. To examine innate im-
mune responses of zebraﬁsh embryos in pneumococcal infections,
we used qRT-PCR to measure the expression levels of two impor-
tant pro-inﬂammatory mediators, tumor necrosis factor (TNF)-a
and interleukin (IL)-1ß, after pneumococcal challenge. For cytokine
expression analyses, we used a time point when the embryos
started to show the ﬁrst signs of severe infection (lack of move-
ment, lowered heart rate). Fig. 4A shows that both TNF-a and IL-
1ß expression is highly induced after a pneumococcal infection
(P < 0.001). The data show that the zebraﬁsh immune system is
able to respond to pneumococci. In addition, the avirulent strain
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T4R failed to induce cytokine response (Fig. 4B) correlating to
severity of infection at chosen time point.
Next, making use of the optical transparency of zebraﬁsh
embryos we visualized host–pathogen interactions using live
ﬂuorescence microscopy. Red ﬂuorescent labeled T4 pneumococci
were injected into the bloodstream of Tg(Spi:EGFP) embryos, in
which the myeloid cells express GFP. Also wild type embryos were
used. Images were taken during the early steps (1–3 h post injec-
tion) of infection. At this time point, most of the bacteria were still
present in the blood stream. Importantly, some red ﬂuorescent-la-
beled pneumococci co-localized with green ﬂuorescent myeloid
cells (Fig. 4B–D). As shown, phagocytosing cells reaching out for
pneumococci (Fig. 4B) as well as leukocytes with ingested bacteria
(Fig. 4C and D), were detected. This is indicative of direct recogni-
tion and phagocytosis of pneumococci by myeloid cells.
To further evaluate the roles of different phagocytic cells and
other components of the innate immunity for defending against
pneumococci we used a morpholino gene silencing technique
(Fig. 5). First we knocked down the transcription factor Pu.1, which
has been shown to cause myeloid cell depletion (Hsu et al., 2004).
The lack of myeloid cells was conﬁrmed using Tg(Spi1:EGFP)
embryos, where no GFP expressing cells could be found after
morpholino treatment (data not shown). When using morpholino
Fig. 1. Streptococcus pneumoniae infection in zebraﬁsh embryos. (A) Survival rates of 2 dpf embryos after injection of S. pneumoniae (wild type, TIGR4, T4) with the indicated
doses. The data comprise three separate experiments with 24 embryos in each group. P < 0.0001 (B and C). The amount of live S. pneumoniae increases in zebraﬁsh embryos
during the ﬁrst 48 h after injection with 100 (B) or 1000 (C) bacteria per embryo. CTR = Control treated with KCl buffer. Hpi = hours post injection. Cfu = colony forming units.
Fig. 2. Bacterial burden in zebraﬁsh embryos during pneumococcal infection.
Bacteria in embryos were enumerated at indicated time points post-injection (S.
pneumoniae T4 strain). Each circle represents an individual embryo. (A) Expansion
of pneumococcus (inj.100 cfu/e) in the blood. Open circles indicate the amount of
live bacteria recovered from dead embryos, whereas solid circles represent bacterial
loads in live embryos P < 0.001 (B). Expansion of pneumococcus (100 cfu/e) in the
yolk. Only live embryos (solid circles) were analyzed. The ﬁgures are representative
of three or more individual experiments. Hpi = hours post injection, cfu = colony
forming units.
Fig. 3. The pathogenicity of pneumococcus is attenuated in avirulent mutant
strains. Survival curves of 2 dpf embryos challenged with wild type pneumococcus
(T4), and with its isogenic mutant derivates lacking pneumolysin (T4Dply), capsule
(T4R), pilus structure (T4DrlrA), and autolysin (T4DlytA). In each group, 100 cfu/e.
were injected into the circulation. The data represent three individual experiments.
⁄P = 0.01, ⁄⁄P = 0.001, ⁄⁄⁄P = 0.0001. CTR = Control treated with KCl buffer.
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injections to knock downPu.1, embryos becamemore susceptible to
infectionswith T4 pneumococci as compared to controls (mean sur-
vivals 15% and 50%, respectively, P < 0.01). The mortality rates were
very high despite the size of the inoculum, suggesting a failure in the
mechanisms needed to overcome pneumococcal infection rather
thandefectivewoundhealing. To further investigate the importance
of leukocyte phagocytosis for resistance against pneumococci, a
morpholino targeting the Wiskott–Aldrich syndrome protein
(WASP)was designed.WASP is a key regulator of the actin cytoskel-
eton and thus needed for immune cell migration and phagocytosis
(Badour et al., 2003). The survival of embryos treated with a
WASP-morpholino was signiﬁcantly weaker compared to control
morpholino treated (30%, and 50%, respectively, P < 0.05) embryos
(Fig. 5), further arguing for the importance of phagocytic immune
cells for defending against S. pneumoniae in this model.
4. Discussion
In recent years the zebraﬁsh embryo has been established as a
new model host for human pathogens. The gram-positive
Fig. 4. S. pneumoniae induces an in innate immune response in zebraﬁsh embryos. (A) Proinﬂammatory cytokine expression 18 h post-inoculation of pneumococcus T4
(100 cfu/e). Relative mRNA levels of TNF-a and IL-1bwere measured using quantitative RT-PCR. The results were normalized to embryos injected with buffer (KCl 0.2 M, CTR).
10–15 Embryos were pooled for each experiment. Data are the mean ± standard error of the mean of three individual experiments. The asterix (⁄) depicts a statistically
signiﬁcant difference compared to the control, P < 0.001. (B) TNF-a espression induced by pneumococcal mutants. The values are correlated to wild type T4 expression level
(=1.0). P < 0.0001. (C) Live microscopy with a zebraﬁsh embryo showing a myeloid cell (expressing green ﬂuorescent protein, GFP) reaching for red ﬂuorescent bacteria (T4).
(D) A live microscopy image showing a zebraﬁsh phagocyte (expressing GFP), which has ingested live pneumococci (orange). (E) Image montage showing co-localization of
ﬂuorescent bacteria (ﬁrst images on the left) inside a phacytosing cell (arrowhead). Dashed line represents endothelial lining of a blood vessel. Images were obtained from
anesthetized zebraﬁsh embryos 1–3 h post-inoculation.
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streptococci S. pyogenes and Streptococcus iniae have previously
been studied in adult zebraﬁsh (Miller and Neely, 2004). The
most signiﬁcant human streptococcus S. pneumoniae, however,
has not been studied in this model until now. In the present
study, we demonstrate for the ﬁrst time that zebraﬁsh embryos
can be used to study both innate immune responses against
pneumococci and pneumococcal virulence factors.
In this study, we show dose dependent mortality after injection
of S. pneumoniae into to the blood stream of zebraﬁsh embryos. A
dose of 100 cfu/e caused approximately 50% mortality, whereas
10,000 cfu/e caused 100% mortality in 48 h. Importantly, there
was a drastic difference between the two different sites of injection
used in this study, the yolk sac and the blood circulation. There
were no surviving individuals in the yolk-injected group when
yolks were infected with 100 cfu/e (data not shown). This is anal-
ogous to earlier studies with other non-host pathogens such as S.
aureus (Prajsnar et al., 2008) and suggests that there are no potent
immune mechanisms in the yolk sac. Notably the doses used in
these experiments are relatively high compared to, for example,
mouse studies (Albiger et al., 2005). On the other hand, the doses
are comparable to other studies with human pathogens in zebra-
ﬁsh embryos (Prajsnar et al., 2008; Wiles et al., 2009).
The immune system in zebraﬁsh is remarkably similar to that of
mammals although at the developmental stage of 50 hpf defense
mechanisms are restricted to innate immune responses (Traver
et al., 2003). At this point, both granulocytes and macrophages
are present and functional (Lieschke et al., 2001). This stage is ideal
for investigating the role of leukocytes for microbial resistance and
was thus used in this study.
Previously it has been reported, that the survival of zebraﬁsh
after systemic bacterial inoculation is strongly dependent on
phagocytosing cells (Brannon et al., 2009; Prajsnar et al., 2008).
In the present study, we demonstrate analogous data for a pneu-
mococcal infection. Importantly, bacterial counts increased in dy-
ing individuals over time, while in surviving embryos the
bacterial burden decreased. This suggests that surviving individu-
als are able to clear the bacteria from the circulation. Although
the embryos were monitored up to 96 hpi, there was no signiﬁcant
mortality after 48 h, indicating the importance of immune re-
sponses during the ﬁrst two days after bacterial inoculation. We
used live imaging of transparent zebraﬁsh embryos to study the
nature of the host–pathogen interaction during the ﬁrst hours of
infection. Notably, this method revealed clear co-localization and
phagocytosis of pneumococci by myeloid cells. The increased
production of pro-inﬂammatory cytokines also indicated that
pneumococci were recognized by immune cells.
An important advantage of the zebraﬁsh model is its easy ge-
netic manipulation with Morpholino injections. Here we used this
technique to transiently knockdown some of the essential genes
regulating innate immune functions. The ablation of myeloid cells
by knocking down the transcription factor Pu.1 led to a severely
compromised zebraﬁsh immune response against pneumococci.
This indicates that the immune defense at this developmental
stage is strongly dependent on myeloid cells i.e. macrophages
and neutrophils. To test the role of phagocytosis more directly,
morpholinos targeting an essential gene for phagocytosis, WASP,
were used. In the zebraﬁsh genome, the gene encoding WASP is
duplicated, and thus both WASP genes (WASP1, WASP2) were
blocked. The WASP morphants showed decreased survival after
pneumococcal challenge suggesting a central role for myeloid cells
and their phagocytic activity in resistance against pneumococci.
This ﬁnding is in line with the results that WASP/mice are more
susceptible to S. pneumoniae infection (Andreansky et al., 2005).
Furthermore, WAS patients often suffer from pneumococcal dis-
eases (Sullivan et al., 1994).
Earlier studies have shown that the zebraﬁsh model can be used
to elucidate the virulence factors of Escherichia coli (Wiles et al.,
2009) and Pseudomonas aeruginosa (Brannon et al., 2009). Impor-
tantly, our data demonstrated signiﬁcant differences in the sur-
vival of attenuated mutant derivatives compared to wild type
pneumococci. Furthermore, unencapsulated pneumococci were
avirulent in this model, which highlights the antiphagocytic prop-
erties of the capsule. Also injections of other mutant strains lacking
pneumolysin secretion, autolysin and pneumococcal pili showed
higher survival rates compared to wild type pneumococci. All of
these virulence factors have been shown to hamper innate immune
responses, and a resulting reduction in pathogenicity has been re-
ported in mammalian models (Barocchi et al., 2006; Berry et al.,
1989a,b; Nelson et al., 2007b). Although, the ecological niche for
zebraﬁsh is very different from the human host, our ﬁndings show
that zebraﬁsh embryos may be used to study pneumococcal viru-
lence factors. Moreover, the model could be ideal for the functional
analyses of pneumococcal virulence factors and for large-scale
mutagenesis screens for new virulence factors in invasive diseases.
This approach has been used for screening new virulence genes of
S. iniae in adult zebraﬁshes (Miller and Neely, 2005).
5. Conclusion
In conclusion, we report the use of zebraﬁsh embryos for study-
ing the pathogenesis of pneumococcal infections in a new verte-
brate host. We have evaluated some of the key factors involved
in the host’s innate immune response against S. pneumoniae. Fur-
thermore, we have shown the importance of selected pneumococ-
cal virulence determinants in this system. This model appears to be
a powerful tool for studying this important human pathogen.
Available genetic manipulation techniques and easy live imaging
make zebraﬁsh very suitable for large-scale screening and for the
delicate modeling of pathogen–host interactions.
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a b s t r a c t
Streptococcus agalactiae (Group B Streptococcus, GBS) is the major cause of severe bacterial disease and
meningitis in newborns. The zebraﬁsh (Danio rerio) has recently emerged as a valuable and powerful ver-
tebrate model for the study of human streptococcal infections. In the present study we demonstrate that
adult zebraﬁsh are susceptible to GBS infection through the intraperitoneal and intramuscular routes of
infection. Following intraperitoneal challenge with GBS, zebraﬁsh developed a fulminant infection 24–
48 h post-injection, with signs of pathogenesis including severe inﬂammation at the injection site and
meningoencephalitis. Quantiﬁcation of blood and brain bacterial load conﬁrmed that GBS is capable of
replicating in the zebraﬁsh bloodstream and penetrating the blood–brain barrier, resulting in the induc-
tion of host inﬂammatory immune responses in the brain. Additionally, we show that GBS mutants pre-
viously described as avirulent in the mice model, have an impaired ability to cause meningitis in this new
in vivomodel. Taken together, our data demonstrates that adult zebraﬁsh may be used as a bacterial men-
ingitis model as a means for deciphering the pathogenesis and development of invasive GBS disease.
 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Streptococcus agalactiae, or Group B Streptococcus (GBS), is the
predominant cause of bacterial meningitis and sepsis in newborn
infants. This gram positive encapsulated bacterium is also respon-
sible for invasive disease in adults; particularly in the elderly and
in individuals with underlying disease (Skoff et al., 2009). GBS is
an opportunistic pathogen which asymptomatically colonizes the
lower gastro-intestinal and genito-urinary tracts of approximately
10–30% of the healthy adult population (Johri et al., 2006; Melin,
2011). Neonatal GBS disease occurs in approximately 0.2–4 cases
per 1000 live births, and is considered a global health burden in fe-
tal medicine (Edmond et al., 2012). Newborns become infected
intrapartum or during delivery from colonized mothers, and de-
spite the use of intrapartum antimicrobial prophylaxis (IAP) to pre-
vent its transmission, GBS remains the leading cause of neonatal
bacterial meningitis in Europe, Asia and the United States (Chang
et al., 2011; Edmond et al., 2012). Surviving newborns frequently
develop life-long neurological sequelae as a consequence of GBS
meningitis, and can suffer from seizures, hearing impairments
and cognitive defects (Chang et al., 2011; Senn et al., 2011). In
these instances, it is likely that brain damage is a result of blood-
borne GBS disrupting and penetrating the blood–brain barrier
(BBB). This barrier is responsible for the protection of the central
nervous system (CNS) from invading microbial pathogens, and is
formed by a single layer of specialized brain microvascular endo-
thelial cells (BMECs) (for a review, see Kim, 2008). All ten known
GBS serotypes can inﬁltrate the CNS and cause meningitis; how-
ever serotype III, in particular, is responsible for more than 80%
of all neonatal meningitis cases (Doran et al., 2005; Ippolito
et al., 2010; Melin, 2011; Tazi et al., 2010).
In order to cause meningitis, GBS must infect BMECs as a means
of inducing a host inﬂammatory response and disrupting the BBB,
thus permitting its entry into the CNS. In vitro and in vivo studies
have previously conﬁrmed that both GBS virulence factors and host
immune responses contribute signiﬁcantly to the development of
bacterial meningitis. Several animal studies have demonstrated
that high-levels of bacteria in the blood correlate with the ability
of GBS to breach the BBB and invade the CNS (Doran et al., 2005;
Ferrieri et al., 1980). In vitro investigations have also established
that GBS virulence factors contribute to the adherence and inva-
sion of human BMECs (HBMECs), resulting in the activation of
acute inﬂammatory responses which inevitably compromise the
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integrity of the BBB (Nizet et al., 1997; Tenenbaum et al., 2007).
Murine models further support these ﬁndings and have been used
to identify speciﬁc GBS virulence factors. The GBS polysaccharide
capsule and b-hemolysin/cytolysin are the best characterized viru-
lence factors (for a review, see Maisey et al., 2008; Nizet, 2002).
The capsule protects the bacterium from killing by complement-
dependent phagocytosis, whereas the b-hemolysin/cytolysin (b-
h/c) activates speciﬁc signaling pathways in HBMECs resulting in
IL-8 release, neutrophil recruitment and better access to the cen-
tral nervous system (CNS) (Doran et al., 2003). The development
of new in vitro and in vivo models are imperative for better under-
standing of the molecular mechanisms involved in CNS invasion by
GBS.
No commercial vaccine is currently available for GBS disease,
although conjugate vaccine preparations have demonstrated
promising results following Phase I and II clinical trials in the
USA (Baker et al., 2003; Bottomley et al., 2012). Of note, major con-
cerns and ethical issues associated with maternal vaccination may
impede Phase III evaluations of candidate GBS vaccines. On the
other hand, the increased use of IAP is associated with the risk of
emerging antibiotic-resistant strains, and rare GBS isolates with
decreased susceptibility to penicillin have recently been reported
in the USA and Japan (Dahesh et al., 2008). Therefore new prophy-
lactic and therapeutic strategies are strongly needed.
Over the last decade, the zebraﬁsh (Danio rerio) has emerged as
a valuable vertebrate model for the study of infectious diseases
(van der Sar et al., 2004). The zebraﬁsh, a teleost, shares advanta-
geous qualities with both invertebrate and mammalian model
organisms. Like invertebrate models, zebraﬁsh have a short gener-
ation time, give rise to large numbers of progeny and are amenable
to large-scale genetic screens (Meeker and Trede, 2008; Sullivan
and Kim, 2008). Adult zebraﬁsh possess both innate and adaptive
immune systems, surpassing classic invertebrate models such as
Drosophila melanogaster and Caenorhabditis elegans who lack func-
tional components of adaptive immunity (van der Sar et al., 2004).
Compared to these invertebrate model systems, zebraﬁsh are evo-
lutionary closer to mammals and share many orthologous genes
with higher vertebrates including mice and humans (Yoder et al.,
2002). Nearly all components of the human immune system have
been identiﬁed in zebraﬁsh, including myeloid and lymphoid cell
lineages (Rombout et al., 2011; Sullivan and Kim, 2008; Yoder
et al., 2002), pathogen recognition receptors (Jault et al., 2004),
and cytokines and chemokines (Peatman and Liu, 2007; Roca
et al., 2008). Sequencing of the zebraﬁsh genome has identiﬁed
the conservation and homology between human and zebraﬁsh,
thus allowing effective modeling of human diseases (Allen and
Neely, 2010).
Multiple streptococcal infection models have already been
established in zebraﬁsh, including Streptococcus pyogenes and
Streptococcus pneumoniae (Neely et al., 2002; Rounioja et al.,
2012), and also more recently Streptococcus agalactiae (GBS)
(Hanson et al., 2012; Hsieh et al., 2010; Pan et al., 2011). In the
present study, we show for the ﬁrst time that zebraﬁshmay be used
as a bacterial meningitis model in GBS infection. We demonstrate
that zebraﬁsh are susceptible to GBS infection following intraperi-
toneal (IP) and intramuscular (IM) challenge. We found that IP
infection causes a fulminant infection, with signs of pathogenesis
including severe inﬂammation at the injection site andmeningoen-
cephalitis. Furthermore, we show that GBS can successfully
replicate within the bloodstream of the zebraﬁsh and disseminate
across the BBB, resulting in the inﬁltration of the CNS and induction
of host inﬂammatory immune responses in the brain. We also
found that infection with mutant GBS strains resulted in
decreased mortality and bacterial BBB dissemination in our
in vivomeningitis model. These results constitute a proof of concept
study for the use of Danio rerio in understanding GBS pathogenesis.
2. Materials and methods
2.1. Bacterial strains and culture conditions
Streptococcus agalactiae (GBS) FIM314 used throughout the
majority of this study was isolated from a septic neonatal patient,
and it belongs to capsular serotype III, ST-17. Other GBS strains in-
cluded the hypervirulent COH1 (serotype III, ST-17), wild-type
NEM316 (serotype III, ST-23), and the isogenic NEM316 mutants
deﬁcient in b-hemolysin (DcylE) (Forquin et al., 2007), the polysac-
charide capsule (DcpsD) (Poyart et al., 2001), and the major two-
component signal transduction system CovS/CovR (DcovSR) (Lamy
et al., 2004).
All GBS strains were grown overnight on 5% lamb blood agar
plates (37 C and 5% CO2). Cells were suspended in 5 ml Todd-
Hewitt broth (Becton, Dickinson and Company, BD) supplemented
with 0.5% Todd-Hewitt yeast extract (THY), and incubated at 37 C
to allow cells to reach mid-log phase of growth. Bacteria were then
harvested when they reached an OD620 of 0.4 (corresponding to
108 colony forming units cfu/ml) by centrifugation (7000 rpm,
10 min). Cell pellets were washed and re-suspended in 0.2 M KCl
to obtain the desired concentrations for the infection doses. The
ﬁnal bacterial concentrations were conﬁrmed by preparing eight
ten-fold serial dilutions and plating them onto 5% lamb blood agar
plates (overnight, 37 C, 5% CO2).
2.2. Zebraﬁsh
Wild-type AB adult zebraﬁsh (6–9 months old) were used
throughout this study. Infected zebraﬁsh were transferred to an
isolated PP module stand-alone unit with a separate ﬂow-through
system. Care and maintenance of zebraﬁsh used in this study fol-
lowed established protocols (Nusslein-Volhard and Dahm, 2002),
and experiments were approved by the Animal Experiment Board
in Finland. All animal studies were conducted in accordance with
the European Union regulations for animal experimentation.
2.3. Infection of adult zebraﬁsh
Groups of 15 ﬁsh were used for survival assays. Adult zebraﬁsh
were ﬁrst anesthetized with buffered 0.02% tricaine (Sigma–
Aldrich). For IP injection, an anesthetized ﬁsh was placed supine
(i.e. abdomen facing upwards) and supported by a moistened foam
bed to ensure it remained in an upright position. A U-100 insulin
syringe with a 12 mm needle was used to administer 5 ll of bacte-
rial suspension into the ﬁsh (Supplementary Fig. 1). The needle was
inserted into the midline of the abdomen posterior to the pectoral
ﬁns, as described by Phelps et al. (2009). No more than the tip of
the needle was inserted into the abdomen of each ﬁsh, as a means
of preventing damage of internal organs. For the IM injection, an
anesthetized ﬁsh was placed inside a moistened foam bed, as
above, and positioned prostrate (i.e. abdomen facing downwards).
A micromanipulator was used to position the microcapillary nee-
dle anterior to the dorsal ﬁn, at a 45 angle relative to the spine
(Neely et al., 2002; Phelps et al., 2009) (Supplementary Fig. 1). Five
microliters of the bacterial suspension was delivered into the dor-
sal muscle of the ﬁsh using a PV830 Pneumatic PicoPump microin-
jector (World Precision Instruments). To visualize the possible
leakage of solution during injections, sterile-ﬁltered phenol red
(3 mg/ml) was added to bacterial suspensions before injections
(1:10 ratio).
In the survival assays, strictly deﬁned non-terminal humane
endpoint criteria were followed and approved by the National Ani-
mal Experiment Board. Fish seen as displaying aberrant swimming
behaviors (i.e. spiral-like swimming movements) or observed to be
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suffering were euthanized, and time of death was recorded. Fish
were monitored and mortalities recorded three times a day, over
a seven-day period, in order to obtain survival rates.
2.4. Collection of blood samples
Following IP infection, 5 ﬁsh were randomly sampled and anes-
thetized at the speciﬁed time points. The ﬁsh’s neckline was cut
using a sterile scalpel blade and a 5 ll blood sample collected.
Blood samples were transferred to an eppendorf tube containing
45 ll KCl buffer on ice to prevent the blood from coagulating. Eight
ten-fold serial dilutions of each recovered blood sample were pre-
pared using 0.2 M KCl and plated onto selective 5% lamb blood agar
plates (erythromycin, 1 lg/ml) and incubated overnight (37 C and
5% CO2) for enumeration of bacterial colonies.
2.5. Isolation of the brain
Fish were collected at the speciﬁed time points and euthanized
with tricaine. Fish were sprayed with 95% EtOH before being
placed on a sterile dissecting board and pinned dorsal side up. A
sterilized scalpel blade was used to remove the skull plate and ex-
pose the brain cavity (Phelps et al., 2009). Whole brain tissue was
removed using sterile forceps and transferred to an eppendorf tube
containing 200 ll sterile phosphate buffered saline (PBS) solution.
Eight ten-fold serial dilutions of brain samples were prepared
using 0.2 M KCl and plated onto selective 5% lamb blood agar
plates, as before. After overnight incubation, the bacterial colonies
were counted and the brain bacterial loads were determined.
2.6. Real-time qRT-PCR analysis
Fish were ﬁrst injected IP with either 105 cfu FIM314 or 0.2 M
KCl, and ﬁve ﬁsh were randomly sampled from each group at 2,
6, 12, 24 and 48 h post-infection. Fish were euthanized with tri-
caine and their brains recovered, as described previously, for
qRT-PCR analysis. Total RNA extraction was performed using the
TRIsure RNA Puriﬁcation Kit (Bioline) according to the manufac-
turer’s instructions. Real-time qRT-PCR for mRNA expression levels
of IL-1b, IL-6 and b-actin were performed using the iScript™ One
Step RT-PCR Kit with SYBR Green (Bio-Rad) and the ABI7000
instrument (Applied Biosystems) according to the manufacturer’s
instructions. Reactions were carried out in triplicate, and relative
expression levels were calculated using the standard curve method
(Larionov et al., 2005). Expression levels of IL-1b and IL-6 were nor-
malized to the corresponding b-actin values and non-treated con-
trols. Results were analyzed with the ABI 7000 System SDS
software, version 1.2.3. The primers used in this assay are listed
in Table 1. IL-6 primers were obtained from a study carried out
by Varela et al. (2012), and IL-1b and b-actin primers from Pressley
et al. (2005).
2.7. Statistical analyses
Each experiment was repeated three times. The 50% lethal
doses (LD50) for IP and IM infection routes were determined by
performing three separate survival experiments and infecting
groups of 15 ﬁsh with concentrations of GBS, ranging between
102 and 106 cfu. For each infection route, the survival data was col-
lated and the dose that killed 50% of a test population was consid-
ered as the LD50. Survival data were tested using the Kaplan–Meier
survival analysis, and qRT-PCR data analyzed using one-way ANO-
VA. Statistical analysis of blood and brain cfu was performed using
an unpaired two-tailed Student’s t-test, and Pearson’s correlation
coefﬁcients were calculated to evaluate the relationship between
blood and brain bacterial loads. All data were analyzed using the
GraphPad Prism 5.0 software. Values of P 6 0.05 were accepted
as statistically signiﬁcant.
3. Results
3.1. GBS infection in adult zebraﬁsh
We ﬁrst sought to determine whether the FIM314 GBS strain
causes signiﬁcant disease through the intraperitoneal (IP) and
intramuscular (IM) routes of infection. In order to investigate the
virulence capacity of FIM314, groups of 15 adult ﬁsh were chal-
lenged with various doses of FIM314 ranging from 102 to 106 cfu.
Survival rates were recorded daily and followed over a period of
7 days following infection. Regardless of the injection route, mor-
tality was dose-dependent following infection with FIM314
(Fig. 1A and B). Importantly, the LD50 for the IP infection route
(102 cfu) was relatively lower than that of the IM route (104 cfu).
Time of death also differed between these two routes, with IP
injections causing mortalities from 24 to 96 h post-injection (hpi)
and IM injections from 48 to 120 hpi. Infection with 106 cfu re-
sulted in the death of all zebraﬁsh (n = 15) for both IP and IM
routes, and was associated with the most rapid progression of dis-
ease. Control ﬁsh, which were injected IP or IMwith sterile KCl buf-
fer, exhibited no abnormal behaviors and survived throughout
these experiments.
These survival assays revealed that the zebraﬁsh immune sys-
tem is capable of resolving GBS infection at lower doses. To vali-
date these ﬁndings and examine the expansion of bacteria in the
bloodstream, ﬁsh were injected IP with 102 cfu FIM314 and blood
samples were recovered from ﬁsh at the speciﬁed time points fol-
lowing infection (Fig. 1C). Both healthy and sick ﬁsh were included
in this assay to quantify the level of bacteremia. Fig. 1C shows that
FIM314 is capable of replicating within the zebraﬁsh bloodstream
post-infection, and that survival is associated with the activation of
bacterial clearance mechanisms. Some ﬁsh were capable of resolv-
ing the infection better than others, and dying ﬁsh had higher lev-
els of bacteremia compared to those evidently coping with the
infection. However, no ﬁsh appeared sick or dying 96 h following
infection, and almost all ﬁsh had completely cleared FIM314 from
the bloodstream 120 hpi. Taken together, these results demon-
strate that GBS can successfully replicate and establish infection
in zebraﬁsh, and that the zebraﬁsh immune system is capable of
resolving GBS infection following injection of low bacterial doses.
3.2. Hematogenous dissemination of GBS into the brain
As IP injection results in an immediate spread of GBS to the
bloodstream (Supplementary Fig. 2) and causes an overwhelming
systemic infection similar to what is observed during human neo-
natal GBS sepsis, we used this injection route for the rest of the
study. Fish infected with 105 and 106 cfu via the IP route were
examined 48 hpi for signs of systemic infection. All ﬁsh suffered
from severe trauma at the injection site (Fig. 2F). Interestingly, ﬁsh
exhibited visible swollen brain cavities and cerebral edema
(Fig. 2C–E), suggesting high bacterial loads in the brain. These ﬁsh
Table 1
Primer sequences used for real-time qRT-PCR.
Target
gene
Forward primer sequence (50–
30)
Reverse primer sequence (50–
30)
b-actin ATG GAT GAG GAA ATC GCT G ATG CCA ACC ATC CCC TG
IL-1b TGG ACT TCG CAG CAC AAA
ATG
GTT CAC TTC ACG CTC TTG GAT
G
IL-6 TCA ACT TCT CCA GCG TGA TG TCT TTC CCT CTT TTC CTC CTG
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also displayed abnormal, spiral-like swimming patterns at the time
of death. Control ﬁsh injected IP with sterile KCl buffer displayed
no such behaviors and showed no signs of disease (Fig. 2A and
B). These observations led us to hypothesize that GBS could pene-
trate the BBB and cause meningitis in adult zebraﬁsh.
To investigate whether GBS are capable of inﬁltrating the brain
and thus causing the observed cerebral edema, we next quantiﬁed
the bacterial loads in blood and whole brain tissue samples. Fish
were collected at the speciﬁed time points following IP challenge
with 105 cfu FIM314. Fig. 3A shows a direct correlation between
Fig. 1. Kaplan–Meier survival curves of adult zebraﬁsh following intraperitoneal (IP) (A) and intramuscular (IM) (B) injection with the indicated doses of FIM314. Data
comprise of three replicate experiments (n = 15 per group, per experiment). Control ﬁsh were injected either IP or IM 0.2 M sterile KCl buffer. The asterix (⁄) depicts a
statistically signiﬁcant difference compared to the control group, where ⁄⁄P 6 0.005, ⁄⁄⁄P 6 0.0005. (C) Immune clearance of GBS infection following IP challenge with 102 cfu
FIM314. Each circle represents one blood sample taken from an individual zebraﬁsh at each indicated time point. Both surviving and dying ﬁsh were analyzed in this
clearance assay. Graph represents collated data from three replicate experiments (n = 5 per time point, per experiment).
Fig. 2. Gross pathology of adult zebraﬁsh infected IP with GBS. Following IP injection with 105 cfu (C and D) and 106 cfu (E and F) FIM314, ﬁsh were examined 48 hpi for signs
of visible GBS disease. Black arrowheads indicate visible cerebral edema and the white arrowhead indicates severe inﬂammation at the injection site. Control ﬁsh were
injected IP with sterile 0.2 M KCl (A and B).
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the level of bacteremia and the bacterial load in the brain after
infection. GBS was present in the bloodstream almost immediately
after injection; however bacteria were not present in the brain un-
til 6 hpi. GBS colonies were detected in all brain samples recovered
12 hpi, and mean bacterial cfu increased from 12 to 48 hpi. No GBS
colonies were present in blood and brain samples collected from
KCl-injected ﬁsh (data not shown).
To evaluate the host inﬂammatory response to GBS infection in
the brain, we used quantitative RT-PCR to measure the production
of pro-inﬂammatory cytokines IL-1b and IL-6 following IP injection
with 105 cfu FIM314. Fig. 3B and C show an increase in both cyto-
kines 24 hpi, suggesting that the zebraﬁsh brain promotes the pro-
duction of pro-inﬂammatory cytokines in response to CNS
invasion. These results indicate that GBS induces an innate inﬂam-
matory response following CNS invasion, in agreement with previ-
ous work using mouse models of GBS meningitis (Banerjee et al.,
2011; Doran et al., 2005).
3.3. GBS virulence factors contribute to the pathogenesis of meningitis
in zebraﬁsh
The zebraﬁsh temperature (28.5 C) is not considered optimal
for human-adapted pathogens such as GBS; however all GBS strains
used in this study grow at a comparable rate in THYmedium at 28.5
and 37 C (Supplementary Fig. 3). Earlier rodent studies have iden-
tiﬁed speciﬁc virulence factors important for GBS meningitis (for a
review, see Maisey et al., 2008; Tazi et al., 2012). Thus, we next em-
ployed our GBS-meningitis model to determine whether mutant
GBS strains lacking particular virulence factors were attenuated in
this in vivo model system. Fish were infected IP with 106 cfu of
the non-hemolytic mutant NEM316DcylE, the non-capsulated
mutant NEM316DcpsD and the NEM316DcovSR mutant lacking
the CovS/CovR regulatory system (Fig. 4). Survival rates were fol-
lowed over a period of 7 days, as before, following infection with
mutant GBS strains. It has been previously reported that GBS mu-
tants lacking the cylE gene encoding for b-hemolysin show de-
creased virulence in mice and have an impaired ability to
penetrate the BBB (Doran et al., 2003; Liu et al., 2004). Following
infection with 106 cfu of NEM316DcylE, zebraﬁsh showed signiﬁ-
cant higher rates of survival (82%) compared to those infected with
WT NEM316 (65%) (P 6 0.05). Moreover, NEM316DcpsD appeared
avirulent in adult zebraﬁsh, exhibiting higher survival rates (84%)
compared to WT NEM316 (P 6 0.05). The polysaccharide capsule
is another virulence factor which has been implicated in the path-
ogenesis of GBS, as it prevents the binding of opsonizing antibodies
thus promoting GBS survival in the bloodstream (Rubens et al.,
1987). Correspondingly, ﬁsh infected IP with the highly encapsu-
lated COH1 strain showed enhanced virulence, resulting in the
Fig. 3. Hematogenous dissemination of GBS into the CNS induces an inﬂammatory response in adult zebraﬁsh brain. (A) GBS dissemination from the bloodstream into the
brain following IP challenge with 105 cfu FIM314. Each symbol represents one blood and brain sample taken from individual zebraﬁsh at each indicated time point. Graph
shows collated data from three replicate experiments (n = 5 per time point, per experiment). Bars represent mean bacterial cfu. Real time qRT-PCR analysis of IL-1b (B) and IL-
6 (C) in zebraﬁsh brain following IP injection with 105 cfu FIM314. RNA was extracted from adult zebraﬁsh brains sampled at the speciﬁed time points. Data shown are the
mean ± standard error of the mean of three replicate experiments. ⁄P 6 0.05, ⁄⁄P 6 0.005; NS = not signiﬁcant compared to FIM314.
Fig. 4. Kaplan–Meier survival curve of adult zebraﬁsh following IP infection with
106 cfu wild-type NEM316, mutant NEM316 strains and hypervirulent GBS strain
COH1. Graph represents data from three replicate experiments (n = 15 per group,
per experiment). ⁄P 6 0.05, ⁄⁄P 6 0.005, ⁄⁄⁄P 6 0.0005 compared to wild-type
NEM316.
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death of 85% of ﬁsh (P 6 0.0005). The CovS/CovR system (also
known as the CsrRS system) has been proven to regulate the expres-
sion of important GBS virulence factors, including b-hemolysin and
the polysaccharide capsule (Jiang et al., 2005; Lamy et al., 2004),
and NEM316DcovSR also showed signiﬁcantly higher survival rates
(89%) in zebraﬁsh than WT NEM316 (P 6 0.005).
Fig. 5. Attenuation of mutant GBS strains in zebraﬁsh meningitis model. (A) Bacterial load in blood and brain 24 h post IP injection with 106 cfu wild-type NEM316, NEM316-
derived mutant strains and hypervirulent GBS strain COH1. Each symbol represents one blood and brain sample recovered from individual zebraﬁsh 24 hpi. Bars represent
mean bacterial cfu. Graph shows collated data from three individual experiments (n = 5 per time point, per experiment). ⁄P 6 0.05, ⁄⁄P 6 0.005 compared to wild-type
NEM316. (B) Data from ﬁgure 5A represented as scatter plots, illustrating the direct correlation between the level of bacteremia and brain bacterial load following IP infection
with 106 cfu of each strain. Pearson’s correlation coefﬁcients (r) were calculated to evaluate the relationship between blood and brain bacterial loads.
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To investigate whether b-hemolysin, the polysaccharide capsule
and the CovS/CovR regulatory system were essential for GBS to
cause meningitis in zebraﬁsh, blood and brain samples were recov-
ered from ﬁsh 24 h following IP challenge with 106 cfu (Fig. 5A).
The majority of brain samples recovered from ﬁsh infected with
mutant GBS strains were clear of bacteria (80%), indicating that
these virulence factors are important for BBB penetration. These
ﬁsh also had signiﬁcantly lower mean levels of bacteremia
(68  103 cfu/5 ll) compared to those infected with WT NEM316
(4.2  104 cfu/5 ll) (P 6 0.05). Conversely, COH1-infected ﬁsh
exhibited signiﬁcantly higher mean bacterial loads in the blood
(3.5  105 cfu/5 ll) and brain (4.2  103 cfu/5 ll) compared with
WT NEM316-infected ﬁsh (P 6 0.05). As shown in Fig. 5B, a direct
correlation exists between the level of bacteremia and the bacterial
load in the brain after infection with WT and mutant NEM316
strains. In summary, our results prove that adult zebraﬁsh may
be used as an in vivomodel to identify and further evaluate the role
of GBS virulence factors in the pathogenesis of meningitis.
4. Discussion
The zebraﬁsh has recently emerged as a valuable infection mod-
el for human streptococcal diseases. Zoonotic streptococcal patho-
gens such as Streptococcus iniae and Streptococcus suis have been
studied previously in adult zebraﬁsh (Neely et al., 2002; Wu
et al., 2008), as well as important human pathogens Streptococcus
pyogenes and Streptococcus pneumoniae (Miller and Neely, 2004;
Rounioja et al., 2012). In the present study, we have established
an adult zebraﬁsh model of GBS meningitis, proving that GBS suc-
cessfully causes systemic disease and inﬁltrates the CNS by dis-
seminating from the bloodstream and penetrating the BBB.
Adult zebraﬁsh are susceptible to infection by FIM314 through
the IP and IM injection routes. The low LD50 of 102 cfu following IP
injection highlights the lethality of GBS and its ability to induce a
fulminant infection in zebraﬁsh, resembling infection in human
neonates. Notably, the visible cerebral edema was observed more
frequently, and earlier (48 hpi), in those ﬁsh which were injected
IP with FIM314 than by the IM route. As IP injections give bacteria
direct access to the vasculature, GBS can establish an almost imme-
diate systemic infection and invade the CNS. IM injections resulted
in localized infections, allowing for the activation of the zebraﬁsh’s
innate immune defense mechanisms involved in the resolution of
the infection. As our results revealed that injection into the perito-
neal cavity resulted in rapid GBS disease, the IP injection route was
used throughout our study to determine whether GBS dissemi-
nates to the CNS hematogenously in zebraﬁsh, thus causing men-
ingitis. We note that the IP delivery route is not physiologic for
zebraﬁsh; however it is a well-established infection route for this
model organism and has been successfully implemented in several
previous zebraﬁsh infection studies (Miller and Neely, 2004; Neely
et al., 2002; Phelan et al., 2005; Pressley et al., 2005; Prouty et al.,
2003).
In vivo models have previously reported that the ability of GBS
to invade the CNS is associated with the level and duration of bac-
teremia (Doran et al., 2005; Ferrieri et al., 1980). In the present
study, we demonstrate that a direct correlation exists between
the level of bacteremia and brain bacterial load following GBS
infection in zebraﬁsh. Recent murine studies have also conﬁrmed
that GBS infection promotes pro-inﬂammatory cytokine expres-
sion in the brain endothelium; in particular IL-1b and IL-6 have
been shown to be produced early in CNS infection (Banerjee
et al., 2011; Barichello et al., 2011). Quantiﬁcation of bacterial
loads in the brain conﬁrmed high levels of GBS present 24 h
post-infection, coinciding with the qRT-PCR results that revealed
an upregulation of IL-1b and IL-6 production in the brain 24 h
post-injection. IL-1b is of particular importance in the pathogene-
sis of bacterial meningitis as it promotes the production of other
pro-inﬂammatory cytokines (including IL-6) and promotes trafﬁck-
ing of peripheral leukocytes to the brain, resulting in increased
inﬂammation at the BBB and thus compromising its integrity (Leib
and Täuber, 1999). Overall our ﬁndings provide evidence that an
innate inﬂammatory response is initiated in the brain in response
to bacterial inﬁltration of the CNS 24 h post-infection with GBS; in
agreement with previously reported results from meningitis
mouse models.
We report that b-hemolysin and the polysaccharide capsule
have important roles in the development of meningitis in zebra-
ﬁsh. Infection with mutant GBS strains deﬁcient in these
virulence factors are attenuated in our zebraﬁsh meningitis
model, resulting in signiﬁcantly higher survival rates and reduced
CNS inﬁltration compared to the wild-type NEM316 strain. b-
hemolysin and the polysaccharide capsule (also known as the
CPS) have been recognized as important virulence factors which
impact the pathogenesis of GBS meningitis. b-hemolysin is a
pore-forming cytolysin proven to cause damage to a wide array
of host cell types, including BMECs which protect the CNS from
bacterial invasion (Doran et al., 2003, 2005; Nizet et al., 1997).
The sialylation of the polysaccharide capsule allows GBS to mimic
host cell surfaces and evade immune recognition, thus prolonging
GBS survival in the bloodstream (Chafﬁn et al., 2005; Doran and
Nizet, 2004). Hanson et al. (2012) demonstrated that infection
with a mutant GBS strain lacking the CpsA protein (responsible
for capsule synthesis) is attenuated in zebraﬁsh, highlighting
the importance of the polysaccharide capsule in the pathogenesis
of GBS disease.
The two-component CovS/CovR system has been shown to di-
rectly regulate the expression of over one hundred of GBS genes
(Lamy et al., 2004; Jiang et al., 2005). We report that the CovS/
CovR-deﬁcient strain is also attenuated in our zebraﬁsh meningitis
model, showing higher survival rates and poor CNS inﬁltration
compared with the wild-type GBS strain. Our results are in agree-
ment with Lamy et al. (2004), who showed that the CovS/CovR sys-
tem is critical for GBS virulence in the neonate rat model, and
reported a 3 log increase of the LD50 of the DcovSR strain compared
to the wild-type strain. Conversely, Lembo et al. (2010) demon-
strated that infection with a CovR-deﬁcient GBS strain promoted
inﬂammatory cytokine production and increased BBB penetration
in a murine model of GBS meningitis. Thus, our results suggest that
both the CovS and CovR components are important for BBB pene-
tration and CNS invasion. Overall our results with these mutant
GBS strains are in line with murine models of GBS meningitis
and what is known in human GBS disease; validating our research
model despite the fact that GBS is not natural pathogen of zebra-
ﬁsh. As such, this zebraﬁsh meningitis model may be employed
in the future as a means of providing further mechanistic insight
into the role of GBS virulence factors in the pathogenesis of
meningitis.
5. Conclusion
In this study, we report the use of the adult zebraﬁsh as a model
for GBS-induced meningitis. Our results coincide with those previ-
ously reported in murine studies of GBS meningitis, highlighting
that the zebraﬁsh is another valuable in vivo model for studying
the pathogenesis of GBS meningitis. This zebraﬁsh model is highly
suitable for large-scale genetic screens which could identify and
evaluate novel GBS virulence factors and vaccine candidates. We
hope that this new model will provide tools to decipher the molec-
ular mechanisms exploited by GBS to invade the CNS, hence inﬂu-
encing the progression and outcome of GBS disease.
H. Patterson et al. / Developmental and Comparative Immunology 38 (2012) 447–455 453
Acknowledgements
We would like to thank Hannaleena Piippo for technical help.
This work has been supported by the Finnish Academy (M.R.),
the Emil Aaltonen Foundation (S.R.), Competitive Research Funding
of the Pirkanmaa Hospital District (S.R., M.P., and M.R.), the Sigrid
Juselius Foundation (M.R.) and Tampere Tuberculosis Foundation
(M.R. and M.P.). The zebraﬁsh work was carried out at the Tampere
Zebraﬁsh Core Facility funded by Biocenter Finland, Tampere
Tuberculosis Foundation and the Emil Aaltonen Foundation.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.dci.2012.07.007.
References
Allen, J.P., Neely, M.N., 2010. Trolling for the ideal model host: zebraﬁsh take the
bait. Future Microbiol. 5 (4), 563–569.
Baker, C.J., Rench, M.A., McInnes, P., 2003. Immunization of pregnant women with
group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate
vaccine. Vaccine 21 (24), 3468–3472.
Banerjee, A., Kim, B.J., Carmona, E.M., Cutting, A.S., Gurney, M.A., Carlos, C., Feuer, R.,
Prasadarao, N.V., Doran, K.S., 2011. Bacterial pili exploit integrin machinery to
promote immune activation and efﬁcient blood–brain barrier penetration. Nat.
Commun. 2, 462.
Barichello, T., Lemos, J.C., Generoso, J.S., Cipriano, A.L., Milioli, G.L., Marcelino, D.M.,
Vuolo, F., Petronilho, F., Dal-Pizzol, F., Vilela, M.C., Teixeira, A.L., 2011. Oxidative
stress, cytokine/chemokine and disruption of blood–brain barrier in neonate
rats after meningitis by Streptococcus agalactiae. Neurochem. Res. 36 (10),
1922–1930.
Bottomley, M.J., Serruto, D., Sáfadi, M.A., Klugman, K.P., 2012. Future challenges in
the elimination of bacterial meningitis. Vaccine 30, B78–B86.
Chafﬁn, D.O., Mentele, L.M., Rubens, C.E., 2005. Sialylation of group B streptococcal
capsular polysaccharide is mediated by cpsK and is required for optimal capsule
polymerization and expression. J. Bacteriol. 187 (13), 4615–4626.
Chang, Y.C., Wang, Z., Flax, L.A., Xu, D., Esko, J.D., Nizet, V., Baron, M.J., 2011.
Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central
nervous systems. PLoS Pathog. 7 (6), e1002082.
Dahesh, S., Hensler, M.E., Van Sorge, N.M., Gertz Jr., R.E., Schrag, S., Nizet, V., Beall,
B.W., 2008. Point mutation in the group B streptococcal pbp2x gene conferring
decreased susceptibility to beta-lactam antibiotics. Antimicrob. Agents
Chemother. 52 (8), 2915–2918.
Doran, K.S., Liu, G.Y., Nizet, V., 2003. Group B streptococcal beta-hemolysin/
cytolysin activates neutrophil signaling pathways in brain endothelium and
contributes to development of meningitis. J. Clin. Invest. 112 (5), 736–744.
Doran, K.S., Nizet, V., 2004. Molecular pathogenesis of neonatal group B
streptococcal infection: no longer in its infancy. Mol. Microbiol. 54 (1), 23–31.
Doran, K.S., Engelson, E.J., Khosravi, A., Maisey, H.C., Fedtke, I., Equils, O., Michelsen,
K.S., Arditi, M., Peschel, A., Niset, V., 2005. Blood–brain barrier invasion by group
B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid.
J. Clin. Invest. 115 (9), 2499–2507.
Edmond, K.M., Kortsalioudaki, C., Scott, S., Schrag, S.J., Zaidi, A.K., Cousens, S., Heath,
P.T., 2012. Group B streptococcal disease in infants aged younger than
3 months: systematic review and meta-analysis. Lancet 379 (9815), 547–556.
Ferrieri, P., Burke, B., Nelson, J., 1980. Production of bacteremia and meningitis in
infant rats with group B streptococcal serotypes. Infect. Immun. 27 (3), 1023–
1032.
Forquin, M.P., Tazi, A., Rosa-Fraile, M., Poyart, C., Trieu-Cuot, P., Dramsi, S., 2007. The
putative glycosyltransferase-encoding gene cylJ and the group B Streptococcus
(GBS)-speciﬁc gene cylK modulate hemolysin production and virulence of GBS.
Infect. Immun. 75 (4), 2063–2066.
Hanson, B.R., Runft, D.L., Streeter, C., Kumar, A., Carion, T.W., Neely, M.N., 2012.
Functional analysis of the CpsA protein of Streptococcus agalactiae. J. Bacteriol.
194 (7), 1668–1678.
Hsieh, J.C., Pan, C.Y., Chen, J.Y., 2010. Tilapia hepcidin (TH)2–3 as a transgene in
transgenic ﬁsh enhances resistance to Vibrio vulniﬁcus infection and causes
variations in immune-related genes after infection by different bacterial
species. Fish Shellﬁsh Immunol. 29 (3), 430–439.
Ippolito, D.L., James, W.A., Tinnemore, D., Huang, R.R., Dehart, M.J., Williams, J.,
Wingerd, M.A., Demons, S.T., 2010. Group B Streptococcus serotype prevalence
in reproductive-age women at a tertiary care military medical center relative to
global serotype distribution. BMC Infect. Dis. 10, 336.
Jault, C., Pichon, L., Chluba, J., 2004. Toll-like receptor gene family and TIR-domain
adapters in Danio rerio. Mol. Immunol. 40 (11), 759–771.
Jiang, S.M., Cieslewicz, M.J., Kasper, D.L., Wessels, M.R., 2005. Regulation of
virulence by a two-component system in group B Streptococcus. J. Bacteriol.
187 (3), 1105–1113.
Johri, A.K., Paoletti, L.C., Glaser, P., Dua, M., Sharma, P.K., Grandi, G., Rappuoli, R.,
2006. Group B Streptococcus: global incidence and vaccine development. Nat.
Rev. Microbiol. 4 (12), 932–942.
Kim, K.S., 2008. Mechanisms of microbial traversal of the blood–brain barrier. Nat.
Rev. Microbiol. 6 (8), 625–634.
Lamy, M.C., Zouine, M., Fert, J., Vergassola, M., Couve, E., Pellegrini, E., Glaser, P.,
Kunst, F., Msadek, T., Trieu-Cuot, P., Poyart, C., 2004. CovS/CovR of group B
streptococcus: a two-component global regulatory system involved in virulence.
Mol. Microbiol. 54 (5), 1250–1268.
Larionov, A., Krause, A., Miller, W., 2005. A standard curve based method for relative
real-time PCR data processing. BMC Bioinformatics 21 (6), 62.
Leib, S.L., Täuber, M.G., 1999. Pathogenesis of bacterial meningitis. Infect. Dis. Clin.
North Am. 13 (3), 527–548.
Lembo, A., Gurney, M.A., Burnside, K., Banerjee, A., de los Reyes, M., Connelly, J.E.,
Lin, W.J., Jewell, K.A., Vo, A., Renken, C.W., Doran, K.S., Rajagopal, L., 2010.
Regulation of CovR expression in Group B streptococcus impacts blood–brain
barrier penetration. Mol. Microbiol. 77 (2), 431–443.
Liu, G.Y., Doran, K.S., Lawrence, T., Turkson, N., Puliti, M., Tissi, L., Nizet, V., 2004.
Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and
carotenoid pigment function to subvert host phagocyte defense. Proc. Natl.
Acad. Sci. USA 101 (40), 14491–14496.
Maisey, H.C., Doran, K.S., Nizet, V., 2008. Recent advances in understanding the
molecular basis of group B Streptococcus virulence. Expert Rev. Mol. Med. 10,
e27.
Meeker, N.D., Trede, N.S., 2008. Immunology and zebraﬁsh: spawning new models
of human disease. Dev. Comp. Immunol. 32 (7), 745–757.
Melin, P., 2011. Neonatal group B streptococcal disease: from pathogenesis to
preventive strategies. Clin. Microbiol. Infect. 17 (9), 1294–1303.
Miller, J.D., Neely, M.N., 2004. Zebraﬁsh as a model host for streptococcal
pathogenesis. Acta Trop 91 (1), 53–68.
Neely, M.N., Pfeifer, J.D., Caparon, M., 2002. Streptococcus-zebraﬁsh model of
bacterial pathogenesis. Infect. Immun. 70 (7), 3904–3914.
Nizet, V., Kim, K.S., Stins, M., Jonas, M., Chi, E.Y., Nguyen, D., Rubens, C.E., 1997.
Invasion of brain microvascular endothelial cells by group B streptococci. Infect.
Immun. 65 (12), 5074–5081.
Nizet, V., 2002. Streptococcal b-hemolysins: genetics and role in disease
pathogenesis. Trends Microbiol. 10 (12), 575–580.
Nusslein-Volhard, C., Dahmn, R., 2002. Zebraﬁsh. A practical approach. Oxford
University Press, Oxford.
Pan, C.Y., Peng, K.C., Lin, C.H., Chen, J.Y., 2011. Transgenic expression of tilapia
hepcidin 1–5 and shrimp chelonianin in zebraﬁsh and their resistance to
bacterial pathogens. Fish Shellﬁsh Immunol. 31 (2), 275–285.
Peatman, E., Liu, Z., 2007. Evolution of CC chemokines in teleost ﬁsh: a case study in
gene duplication and implications for immune diversity. Immunogenetics 59
(8), 613–623.
Phelan, P.E., Pressley, M.E., Witten, P.E., Mellon, M.T., Blake, S., Kim, C.H., 2005.
Characterization of snakehead rhabdovirus infection in zebraﬁsh (Danio rerio). J.
Virol. 79 (3), 1842–1852.
Phelps, H.A., Runft, D.L., Neely, M.N. 2009. Adult zebraﬁsh model of streptococcal
infection. Curr. Protoc. Microbiol. 9, Unit-9D.1.
Poyart, C., Pellegrini, E., Gaillot, O., Boumaila, C., Baptista, M., Trieu-Cuot, P., 2001.
Contribution of Mn-cofactored superoxide dismutase (SodA) to the virulence of
Streptococcus agalactiae. Infect. Immun. 69 (8), 5098–5106.
Pressley, M.E., Phelan 3rd, P.E., Witten, P.E., Mellon, M.T., Kim, C.H., 2005.
Pathogenesis and inﬂammatory response to Edwardsiella tarda infection in
the zebraﬁsh. Dev. Comp. Immunol. 29 (6), 501–513.
Prouty, M.G., Correa, N.E., Barker, L.P., Jagadeeswaran, P., Klose, K.E., 2003.
Zebraﬁsh-Mycobacterium marinum model for mycobacterial pathogenesis.
FEMS Microbiol. Lett. 225 (2), 177–182.
Roca, F.J., Mulero, I., López-Muñoz, A., Sepulcre, M.P., Renshaw, S.A., Meseguer, J.,
Mulero, V., 2008. Evolution of the inﬂammatory response in vertebrates: ﬁsh
TNF-alpha is a powerful activator of endothelial cells but hardly activates
phagocytes. J. Immunol. 181 (7), 5071–5081.
Rombout, J.H., Abelli, L., Picchietti, S., Scapigliati, G., Kiron, V., 2011. Teleost
intestinal immunology. Fish Shellﬁsh Immunol. 31 (5), 616–626.
Rounioja, S., Saralahti, A., Rantala, L., Parikka, M., Henriques-Normark, B.,
Silvennoinen, O., Rämet, M., 2012. Defense of zebraﬁsh embryos against
Streptococcus pneumoniae infection is dependent on the phagocytic activity of
leukocytes. Dev. Comp. Immunol. 36 (2), 342–348.
Rubens, C.E., Wessels, M.R., Heggen, L.M., Kasper, D.L., 1987. Transposon
mutagenesis of type III group B Streptococcus: correlation of capsule
expression with virulence. Proc. Natl. Acad. Sci. USA 84 (20), 7208–7212.
Senn, B.M., Visram, Z., Meinke, A.L., Neubauer, C., Gelbmann, D., Sinzinger, J.,
Hanner, M., Lundberg, U., Boisvert, H., Reinscheid, D., von Gabain, A., Nagy, E.,
2011. Monoclonal antibodies targeting different cell wall antigens of group B
streptococcus mediate protection in both Fc-dependent and independent
manner. Vaccine 29 (24), 4116–4124.
Skoff, T.H., Farley, M.M., Petit, S., Craig, A.S., Schaffner, W., Gershman, K., Harrison,
L.H., Lynﬁeld, R., Mohle-Boetani, J., Zansky, S., Albanese, B.A., Stefonek, K., Zell,
E.R., Jackson, D., Thompson, T., Schrag, S.J., 2009. Increasing burden of invasive
group B streptococcal disease in nonpregnant adults, 1990–2007. Clin. Infect.
Dis. 49 (1), 85–92.
Sullivan, C., Kim, C.H., 2008. Zebraﬁsh as a model for infectious disease and human
function. Fish Shellﬁsh Immunol. 25 (4), 341–350.
Tazi, A., Disson, O., Bellais, S., Bouaboud, A., Dmytruk, N., Dramsi, S., Mistou, M.Y.,
Khun, H., Mechler, C., Tardieux, I., Trieu-Cuot, P., Lecuit, M., Poyart, C., 2010. The
454 H. Patterson et al. / Developmental and Comparative Immunology 38 (2012) 447–455
surface protein HvgA mediates group B streptococcus hypervirulence and
meningeal tropism in neonates. J. Exp. Med. 207 (11), 2313–2322.
Tazi, A., Bellais, S., Tardieux, I., Dramsi, S., Trieu-Cuot, P., Poyart, C., 2012. Group B
Streptococcus surface proteins as major determinants for meningeal tropism.
Curr. Opin. Microbiol. 15 (1), 44–49.
Tenenbaum, T., Spellerberg, B., Adam, R., Vogel, M., Kim, K.S., Schroten, H., 2007.
Streptococcus agalactiae invasion of human brain microvascular endothelial cells
is promoted by the laminin-binding protein Lmb.Microbes Infect. 9 (6), 714–720.
van der Sar, A.M., Appelmelk, B.J., Vandenbroucke-Grauls, C.M., Bitter,W., 2004. A star
with stripes: zebraﬁsh as an infectionmodel. TrendsMicrobiol. 12 (10), 451–457.
Varela, M., Dios, S., Novoa, B., Figueras, A., 2012. Characterisation, expression and
ontogeny of interleukin-6 and its receptors in zebraﬁsh (Danio rerio). Dev.
Comp. Immunol. 37 (1), 97–106.
Wu, Z., Zhang, W., Lu, C., 2008. Comparative proteome analysis of secreted proteins
of Streptococcus suis serotype 9 isolates from diseased and healthy pigs. Microb.
Pathog. 45 (3), 159–166.
Yoder, J.A., Nielsen, M.E., Amemiya, C.T., Litman, G.W., 2002. Zebraﬁsh as an
immunological model system. Microbes Infect. 4 (14), 1469–1478.
H. Patterson et al. / Developmental and Comparative Immunology 38 (2012) 447–455 455

 PUBLICATION 
III 
Adult Zebrafish Model for Pneumococcal Pathogenesis 
 
Saralahti A, Piippo H, Parikka M, Henriques-Normark B, Rämet M, Rounioja S. 
 
Developmental and Comparative Immunology. 2014. 42(2):345-53.  
doi: 10.1016/j.dci.2013.09.009. 
 
 
Publication reprinted with the permission of the copyright holders. 
 
  
  
 
 
 
 
 
 
Adult zebraﬁsh model for pneumococcal pathogenesis
Anni Saralahti a, Hannaleena Piippo a, Mataleena Parikka a, Birgitta Henriques-Normark d,e,
Mika Rämet a,b,f,g, Samuli Rounioja c,⇑
a Institute of Biomedical Technology, BioMediTech, University of Tampere, FI-33014 Tampere, Finland
bDepartment of Pediatrics, Tampere University Hospital, P.O. Box 2000, FI-33521 Tampere, Finland
c Fimlab Laboratories, P.O. Box 66, FI-33101 Tampere, Finland
dDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-17177 Stockholm, Sweden
eDepartment of Laboratory Medicine, Division of Clinical Microbiology, Karolinska University Hospital, Solna, Sweden
fDepartment of Children and Adolescents, Oulu University Hospital, Finland
gDepartment of Pediatrics, Medical Research Center Oulu, University of Oulu, Finland
a r t i c l e i n f o
Article history:
Received 2 August 2013
Revised 16 September 2013
Accepted 17 September 2013
Available online 25 September 2013
Keywords:
Zebraﬁsh
Streptococcus pneumoniae
Host-pathogen interactions
Bacterial meningitis
a b s t r a c t
Streptococcus pneumoniae (pneumococcus) is a leading cause of community acquired pneumonia, septi-
cemia, and meningitis. Due to incomplete understanding of the host and bacterial factors contributing
to these diseases optimal treatment and prevention methods are lacking. In the present study we exam-
ined whether the adult zebraﬁsh (Danio rerio) can be used to investigate the pathophysiology of pneumo-
coccal diseases. Here we show that both intraperitoneal and intramuscular injections of the
pneumococcal strain TIGR4 cause a fulminant, dose-dependent infection in adult zebraﬁsh, while iso-
genic mutant bacteria lacking the polysaccharide capsule, autolysin, or pneumolysin are attenuated in
the model. Infection through the intraperitoneal route is characterized by rapid expansion of pneumococ-
ci in the bloodstream, followed by penetration of the blood–brain barrier and progression to meningitis.
Using Rag1 mutant zebraﬁsh, which are devoid of somatic recombination and thus lack adaptive immune
responses, we show that clearance of pneumococci in adult zebraﬁsh depends mainly on innate immune
responses. In conclusion, this study provides evidence that the adult zebraﬁsh can be used as a model for
a pneumococcal infection, and that it can be used to study both host and bacterial factors involved in the
pathogenesis. However, our results do not support the use of the zebraﬁsh in studies on the role of adap-
tive immunity in pneumococcal disease or in the development of new pneumococcal vaccines.
 2013 Elsevier Ltd. All rights reserved.
1. Introduction
Despite signiﬁcant advances in the development of vaccination
strategies against Streptococcus pneumoniae (pneumococcus), the
bacterium is still a major human pathogen causing over one mil-
lion deaths every year, a majority among children (Lynch and Zha-
nel, 2010). Pneumococci are common colonizers of the human
upper respiratory tract and can persist there as asymptomatic,
harmless inhabitants (van der Poll and Opal, 2009). In many cases,
however, pneumococci spread to the lower respiratory tract or fur-
ther into the bloodstream, and cause a variety of diseases (van der
Poll and Opal, 2009). These diseases range from relatively mild but
very common infections, such as sinusitis or otitis media to life-
threatening diseases such as pneumonia, sepsis, and meningitis
(Gladstone et al., 2011).
S. pneumoniae is the leading cause of community acquired
pneumonia worldwide (Chiavolini et al., 2008; Said et al., 2013).
It has been estimated to be responsible for up to 5 million cases
of pneumonia annually, with around 10% of all cases leading to
death (Feldman and Anderson, 2011). Pneumococci are also one
of the most important causative agents of bacterial meningitis
(Brouwer et al., 2010; Randle et al., 2011). Pneumococcal meningi-
tis is associated with a lethality of as high as 37% (Lynch and Zha-
nel, 2010; Mook-Kanamori et al., 2011). In addition, up to 52% of
surviving patients suffer from neurological sequelae such as hear-
ing loss, cognitive impairment, and seizures (Mook-Kanamori et al.,
2011; Randle et al., 2011). Furthermore, recurrent ear infections
caused by pneumococci are also the most common reason for doc-
tors’ consultations and the use of antibiotics (Boonacker et al.,
2011).
Pneumococci express a range of virulence factors, such as a
polysaccharide capsule, pneumolysin, autolysin, and a pilus struc-
ture, which contribute to the pathogenesis and the progression of
the infection (Jedrzejas, 2001; Kadioglu et al., 2008; Orrskog
et al., 2012). The polysaccharide capsule is commonly accepted
as the most important virulence factor of the bacterium (Mitchell
and Mitchell, 2010; Vernatter and Pirofski, 2013). The capsule is
highly antiphagocytic, and un-encapsulated pneumococcal mu-
tants are avirulent in several animal models (Nelson et al., 2007;
0145-305X/$ - see front matter  2013 Elsevier Ltd. All rights reserved.
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Watson and Musher, 1990). The polysaccharide composition of the
pneumococcal capsule is also the basis for the division of pneumo-
cocci into the so far recognized 93 serotypes (Gladstone et al.,
2011). Several epidemiological studies have shown that pneumo-
coccal capsular serotypes differ in their frequency and geographi-
cal occurrence, as well as in their tendency to cause infections in
humans (Brueggemann et al., 2003; Sandgren et al., 2004; Sjöstrom
et al., 2006). These studies have also shown that some pneumococ-
cal serotypes, more often than are others, are associated with se-
vere invasive diseases in humans. Serotypes with a high potential
to cause invasive disease are for example types 1, 4 and 7F (Sand-
gren et al., 2005; Sjöström et al., 2006). Types 6B and 14 have a
medium invasive potential, and serotype 19F a low invasive poten-
tial (Sandgren et al., 2005; Sjöström et al., 2006). However, when
the different strains caused an invasive disease, serotypes belong-
ing to the group with a high invasive potential (i.e., types 1, 4 and
7F) had a lower mortality rate than did serotypes with a lower
invasive potential such as type 19F (Sjöström et al., 2006). Pneu-
mococci of the same serotype can also vary in their pathogenicity,
indicating that clonal properties other than the capsular structure
also affect the ability of the bacterium to cause an invasive disease
(Brueggemann et al., 2003; Sandgren et al., 2005). Although the
serotype and clone speciﬁc properties are evident, the factors con-
tributing to these differences are still poorly understood.
Two vaccine formulations against pneumococcal diseases have
been developed and are in use globally: a 23-valent polysaccharide
vaccine and a conjugated vaccine (Gladstone et al., 2011). These
vaccines are serotype speciﬁc polysaccharide-based formulations
directed against the most prevalent pneumococcal serotypes found
to cause an invasive disease (Gladstone et al., 2011). However, the
complex nature and structural variability of pneumococci pose
challenges for the prevention and treatment of the diseases associ-
ated with this pathogen, and despite the positive impact of current
vaccines pneumococci remain to be eradicated. In addition,
increasing antibiotic resistance among clinical strains further com-
plicates the control of pneumococcal spread (Lynch and Zhanel,
2010; Song et al., 2012). In order to overcome these challenges,
the best possible understanding of the interactions occurring be-
tween the host and the pneumococci during the infection is re-
quired. These details are best revealed by studying animal
models where both pathogenic and host speciﬁc determinants of
infection can be investigated. Several rodent models have proved
their feasibility and reliability in infection studies, but methodical
difﬁculties in addition to ethical issues concerning these models
complicate their use in this ﬁeld (van der Sar et al., 2004). The zeb-
raﬁsh, Danio rerio, provides an attractive alternative non-mamma-
lian vertebrate model for the study of infection biology and
immunology (Lohi et al., 2013). In addition to being more ethical,
zebraﬁsh are cost-effective and easy to manipulate genetically.
Importantly, the adult ﬁsh has fully developed innate and adaptive
immune systems. These factors make the zebraﬁsh an ideal infec-
tion model suitable also for large scale genetic screens (Phelps and
Neely, 2005; van der Sar et al., 2004). So far, the zebraﬁsh has been
successfully used to model host-pathogen interaction in infectious
diseases caused by various pathogens, including both zoonotic
(e.g., Mycobacterium marinum) and human speciﬁc pathogens
(e.g., Salmonella typhimurium, Staphylococcus aureus) (Parikka
et al., 2012; Prajsnar et al., 2008; Prouty et al., 2003; van der Sar
et al., 2003). These pathogens also include several streptococcal
species, such as Streptococcus iniae and Streptococcus agalactiae
(Neely et al., 2002; Patterson et al., 2012).
Here we introduce a new non-mammalian model to be used in
the study of pathophysiological mechanisms of pneumococcal
infection. We have previously shown that pneumococci can cause
a fulminant infection in zebraﬁsh embryos and that surviving em-
bryos can combat the infection using innate immunity
mechanisms (Rounioja et al., 2012). Here we show that a pneumo-
coccal infection can also be established in adult zebraﬁsh, which
provides a more diverse model for the study of pneumococcal
infection.
2. Materials and methods
2.1. Bacterial strains
The wild type pneumococcal strain TIGR4 (T4) used throughout
these studies was originally isolated from a Norwegian patient suf-
fering from a systemic pneumococcal infection (Aaberge et al.,
1995). It belongs to capsular serotype 4 and a highly invasive clone
ST205 and has previously been used in a zebraﬁsh embryo model
(Rounioja et al., 2012). The other pneumococcal strains used were
four clinical isolates belonging to serotypes with different invasive
disease potentials (serotype 1 (ST306), serotype 14 (ST124), sero-
type 6B (ST138) and serotype 19F (ST162)) as well as four T4 iso-
genic mutants deﬁcient in either the polysaccharide capsule
(T4R), autolysin (T4DlytA), pneumolysin (T4Dply), or the pilus-like
structure (T4Drlr).
All the pneumococcal strains used were grown overnight on
blood agar plates at 37 C and 5.0% CO2. Bacterial cells were sus-
pended in 5 ml of Todd Hewitt broth (Becton, Dickinson and Com-
pany, New Jersey, USA) supplemented with 0.5% Todd-Hewitt
yeast extract (Becton, Dickinson and Company) until they reached
an OD620 of 0.1. Bacteria were grown in the media until they
reached an OD620 of 0.4, after which the bacterial cells were har-
vested by centrifugation (4000 rpm, 10 min) and re-suspended in
sterile 0.2 M KCl to obtain the desired concentrations. To be able
to visualize the injection, 10% ﬁltered phenol red (3 mg/ml; Sig-
ma–Aldrich, St. Louis, Missouri, USA) was added to the injection
solution. The exact bacterial numbers in inoculates were conﬁrmed
by quantitative plating before and after the experiment.
2.2. Zebraﬁsh and maintenance
Wild type AB zebraﬁsh of 5–8 months of age were used in the
majority of the experiments. In addition, the mutant ﬁsh line
(Rag1hu1999) (from ZIRC), which lack active lymphocytes was used
to assess the role of the adaptive immunity. All the animal studies
were conducted in accordance with the regulations of the Animal
Experiment Board in Finland and the ﬁsh were maintained accord-
ing to standard protocols (Nusslein-Volhard and Dahm, 2002). Fol-
lowing infection ﬁsh were kept in an isolated stand-alone unit with
a separate ﬂow-through system.
2.3. Infection of adult zebraﬁsh by intraperitoneal and intramuscular
injection
Generally, ﬁsh were randomly divided into groups of 15–20
ﬁsh, each group receiving a different concentration of bacterial
inoculation. Prior to injection the ﬁsh were anesthetized in water
containing 0.02% 3-aminobenzoic acid ethyl ester (pH 7.0) (Sig-
ma–Aldrich) and gently laid on a moistened foam bed ventral side
up. An Omnican 100 30G insulin needle (Braun, Melsungen, Ger-
many) containing 5 ll of the desired injection suspension was held
parallel to the ﬁsh and inserted into the midline of the abdomen,
between the pectoral ﬁns and the entire content of the needle
was carefully injected into the ﬁsh peritoneum. Similarly, the ﬁsh
in the control group received 5 ll 0.2 M KCl. If any leakage of the
injection solution was observed at the injection site, the ﬁsh was
euthanized. Successfully infected ﬁsh were transferred to a fresh
water tank and their recovery was veriﬁed before moving them
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into the water unit. Any ﬁsh observed to be bleeding or otherwise
suffering was immediately euthanized.
For the intramuscular (i.m.) injection, anesthetized ﬁsh were
placed on a moistened foam bed dorsal side up. The i.m. injection
was carried out using a micromanipulator and the PV830 Pneu-
matic PicoPump microinjector (World Precision instruments, Sara-
sota, Florida, USA). A microcapillary needle ﬁlled with 5 ll of
bacterial suspension was positioned anterior to the dorsal ﬁn at a
45 angle in relation to the back of the ﬁsh and the suspension
was delivered into the dorsal muscle. As above, successfully in-
fected ﬁsh were transferred to the fresh water tank to recover.
To obtain survival rates, the mortality of the infected ﬁsh was
followed twice a day during a 7-day period. Dead ﬁsh were re-
moved and the ﬁsh likely to be suffering were euthanized and
the time of death was recorded. Strict humane endpoint criteria
were followed during the survival assays. Aberrant swimming
and behavior, increased rate of respiration, and lack of movement,
for example, were considered as criteria for euthanasia.
2.4. Collection of blood samples
Blood samples were taken from ﬁve randomly chosen infected
ﬁsh at given time points (0, 2, 6, 12, 24, 48, 72 and 96 h post infec-
tion, hpi). The ﬁsh were brieﬂy anesthetized as described above
(Section 2.3) and laid on a sterile plastic surface. Blood samples
were taken by cutting the ﬁsh neckline with a scalpel blade and
collecting 5 ll of blood which we estimate to represent on average
one fourth of the total volume of adult zebraﬁsh blood. Blood sam-
ples were transferred to Eppendorf tubes containing 45 ll 0.2 M
KCl and mixed carefully to prevent coagulation. Each blood sample
was serially diluted and the dilutions were plated onto selective
lamb blood agar plates containing 1 lg/ml erythromycin. After
an overnight incubation at 37 C and 5.0% CO2 the bacterial colo-
nies were counted to determine the bacterial numbers in each
blood sample.
2.5. Isolation of the brain
Five infected ﬁsh from each group were randomly collected and
prepared for the isolation of the brain. The ﬁsh were euthanized as
above and placed on a dissecting board dorsal side up. Fish were
tacked to the board by pinning and the surface of the ﬁsh was ster-
ilized with 70% ethanol in order to prevent the contamination of
the brain. A sterile scalpel blade and forceps were used to remove
the skull plate and expose the brain. The exposed brain tissue was
then completely removed using sterile equipment and transferred
to an Eppendorf tube containing 200 ll of phosphate buffered sal-
ine (PBS) solution. Special care was taken to prevent contamination
of the brain tissue. The brain tissue in PBS was then homogenized
using a sterile pestle, after which the homogenate was serially di-
luted in PBS. The dilutions were plated onto selective blood agar
plates and incubated overnight (37 C and 5.0% CO2). After incuba-
tion, the colony forming units were counted and the bacterial load
in each brain homogenate was determined.
2.6. Immunization
20–30 randomly chosen ﬁsh were immunized with a heat-
killed T4, a non-lethal dose of live T4, or a live un-encapsulated
mutant of T4 (T4R). To prepare the killed bacteria for immuniza-
tion, bacteria were ﬁrst grown in suspension as described in Sec-
tion 2.1. Thereafter, the bacterial cells were harvested by
centrifugation (4000 rpm, 10 min) and resuspended in 500 ll
0.2 M KCl. The bacterial suspension was then autoclaved to heat-
kill the bacteria. These autoclaved immunization stocks were then
either used for immunization or stored at 20 C to be used later.
Both i.p. and i.m. injection routes (described in Section 2.3) were
tested for immunization. After immunization the humoral immune
response was allowed to develop for 2 or 3 weeks after which the
immunized individuals were infected with a semilethal dose
(2.5  106 cfu) of pneumococcus either through the i.p. or the
i.m. route. The infection dose was veriﬁed as above. Two negative
control groups received either a KCl immunization followed by
infection or infection without immunization. The mortality of the
infected ﬁsh was monitored for approximately 14 days.
2.7. Statistical analyses
Survival rates in the experiments were analyzed with the Graph
Pad Prism 5.02 software. The statistical signiﬁcance in these assays
was measured using the Mantel-Cox log-rank test. p values of
<0.05 were considered signiﬁcant.
3. Results
3.1. The adult zebraﬁsh can be used as a disease model for a systemic
pneumococcal infection
We ﬁrst determined if pneumococci can cause a systemic infec-
tion in adult zebraﬁsh using the pneumococcal strain T4. Since
pneumococci are not natural ﬁsh pathogens, and their optimal
growth temperature (+37 C) differs from the optimal temperature
for zebraﬁsh (+28 C), the ability of the bacteria to grow and repli-
cate in this environment was veriﬁed. To this end, the growth of T4,
T4 mutants and the four clinical strains used in this study was
tested in conditions resembling the host environment (at 28 C in
poor medium). All the strains were able to replicate under these
conditions. Most importantly, there were no signiﬁcant differences
between the growth rates of the different pneumococcal strains
(data not shown).
To investigate pneumococcal virulence in adult zebraﬁsh, we
infected ﬁsh (n = 15/group) with wild type T4 via either intraperi-
toneal (i.p.) or intramuscular (i.m.) injection using three bacterial
doses ranging from 1  106 to 5  106 cfu. The survival and symp-
toms of the infected ﬁsh were then recorded twice a day for 7 days.
The infected ﬁsh showed signs of severe infection including edema
at the site of injection, abnormal spiral-like swimming, increased
respiration, and ultimately, death. As is shown in Fig. 1 both the
i.p. and i.m. injections lead to a dose-dependent mortality. For
the i.p. infection the combined mean survival rate with
1  106 cfu was 87%, with 2.5  106 cfu it was 44% and with
5  106 cfu the survival was 7% (p < 0.0001) (Fig. 1A). The mortality
rate during the infection was also dependent on the bacterial dose
and the majority of the ﬁsh infected with the highest dose died
during the ﬁrst 24 h, while in the other groups the highest mortal-
ity rate was reached during the ﬁrst 48 and 72 hpi (Fig. 1A).
Noteworthy, infecting the zebraﬁsh i.m. resulted in a slower
disease progression and a higher survival than did the i.p. infection
route (Fig. 1B). The highest mortality rates were reached by 48 h
for an inoculation dose of 5  106 cfu, by 72 h for 2.5  106 cfu
and by 96 h for 1  106 cfu and the mean survival percentages
were 12%, 66% and 93%, respectively. Visible signs of local infection
could also be detected after the i.m. infection; most of the infected
ﬁsh had a hypopigmented lesion and notable tissue necrosis at the
dorsal muscle. The lesions were visible in both dead and surviving
individuals. With both injection routes, the control ﬁsh injected
with KCl had no visible signs of the disease and showed 100% sur-
vival. In conclusion, both infection routes can cause a lethal, dose-
dependent infection in adult ﬁsh. With moderate doses, some indi-
viduals are able to resist the infection and survive.
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Next we examined bacteremia levels and the ability of the ﬁsh
to clear injected bacteria. The level of bacteremia was measured at
different time points after an i.p. injection of 2.5  106 cfu of T4.
Some individuals died during the 96 h period in which the samples
were taken and the bacteremia levels were only measured from
live ﬁsh. As is shown in Fig. 1C, pneumococci are present in the
blood immediately after injection (0 h time point), as expected,
since the ﬁsh peritoneal cavity is directly connected to the vascu-
lature (Neely et al., 2002). During the ﬁrst hours the bacterial bur-
den in the blood increases and reaches its highest level 6 h pi. The
observed increase in the bacteremia level is likely due to the bac-
terial replication occurring in the blood but it may also be, in part,
due to the transfer of injected bacteria from the peritoneal cavity.
During the early time points the mortality rate is the highest and
most of the ﬁsh unable to resolve the infection die. Thereafter,
the bacterial burden starts to decrease in the surviving individuals,
and 48 h pi most of the surviving ﬁsh are free of pneumococci.
However, in some individuals the bacterial burden remains high
up to 96 h pi (data not shown). These ﬁndings indicate that a pneu-
mococcal infection in adult zebraﬁsh is associated with rapid bac-
terial growth in the blood, and if unrestricted, the bacterial growth
leads to the death of the ﬁsh. However, some individuals are able
to resolve the pneumococcal infection leading to the clearance of
the bacteria in the blood and survival.
3.2. Mutants in important pneumococcal virulence factors are
attenuated in the adult zebraﬁsh model
We next assessed the role of important pneumococcal virulence
factors in the adult zebraﬁsh model using pneumococcal mutants
lacking known virulence factors that have been shown to be atten-
uated in murine models as well as in the zebraﬁsh embryo model
(Berry et al., 1989a,b; Nelson et al., 2007; Rounioja et al., 2012;
Watson and Musher, 1990). We challenged a group of 15–20 ﬁsh
with 2.5  106 cfu of the following four isogenic mutants in the
T4 background: non-encapsulated (T4R), pneumolysin-deﬁcient
(T4Dply), autolysin-deﬁcient (T4Dlyt) and pilus-deﬁcient (T4Drlr)
mutant.
The pneumococcal polysaccharide capsule is essential for every
step of the pneumococcal disease progression, playing a role in col-
onization, adherence and in invasion and it enables the evasion of
bacteria from the host immune response (Mook-Kanamori et al.,
2011; Zancolli et al., 2011). Using the un-encapsulated T4R strain
we show that the capsular knockout is attenuated in our adult zeb-
raﬁsh model with signiﬁcantly higher survival rates (87%) com-
pared to the wild type T4 (38%) (p < 0.05) (Fig. 2). Pneumolysin is
a pore-forming toxin that is expressed by virtually all clinical
strains of pneumococci (Kadioglu et al., 2008; Mitchell and Mitch-
ell, 2010). This cytosolic protein is released when the bacteria un-
dergo autolysis and when released, its two main functions are to
cause host cell lysis and activate the complement system (Mitchell
Fig. 1. Streptococcus pneumoniae infection in adult zebraﬁsh. The survival of adult zebraﬁsh after intraperitoneal (A) and intramuscular (B) injection of wild type (T4)
pneumococcus is dose-dependent. The ﬁgures depict the survival of adult zebraﬁsh infected either i.p. or i.m. with the three indicated doses. Control ﬁsh received sterile
0.2 M KCl. The asterisk (⁄) depicts the statistically signiﬁcant difference compared to the control group, where ⁄⁄ p < 0.001 and ⁄⁄⁄ p < 0.0001. (C) Bacterial burden in adult
zebraﬁsh during pneumococcal infection. The bacterial burden was measured at the indicated time points in adult zebraﬁsh infected i.p. with 2.5  106 cfu of T4. The ﬁgure
represents the mean (+SD) bacterial burden in 10 individuals measured from blood samples taken at speciﬁc time points. Cfu = colony forming units. Hpi = hours post
infection.
Fig. 2. Survival of adult zebraﬁsh after i.p. infection with T4 mutants. The Non-
encapsulated mutant (T4R), the pneumolysin deﬁcient mutant (T4Dply) and the
autolysin deﬁcient mutant (T4Dlyt) of T4 have an attenuated virulence in adult
zebraﬁsh compared to the wild type T4. The data comprise the combined results
from three individual experiments (n = 15) where the ﬁsh were infected with
2.5  106 cfu of the desired pneumococcal strain. The asterix (⁄) depicts the
statistically signiﬁcant difference compared to the wild type T4, where ⁄ p < 0.05.
Control ﬁsh were injected with 0.2 M KCl. Hpi = hours post infection. T4Drlr = T4
pilus mutant.
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and Mitchell, 2010). The pneumolysin-deﬁcient mutant of T4
(T4Dply) also showed an attenuated virulence resulting in a mean
survival rate of 71% (Fig. 2). Yet another virulence factor is the
pneumococcal autolysin LytA (Jedrzejas, 2001; Kadioglu et al.,
2008). Its contribution to bacterial virulence is thought to be med-
iated, at least in part, by pneumolysin, as it functions by causing
the autolysis of pneumococcal cells, which leads to the release of
pneumolysin (Kadioglu et al., 2008). In the i.p. infection of adult
zebraﬁsh, the virulence of the autolysin-deﬁcient mutant (T4Dly-
tA) was clearly low as the survival rate of the inoculated ﬁsh was
signiﬁcantly higher (87%) compared to the ﬁsh inoculated with
wild type bacteria (p < 0.05) (Fig. 2). Finally, we investigated the
role of the pneumococcal pilus-like structure in the virulence of
pneumococcus in adult zebraﬁsh. The pilus structure is a relatively
recently discovered virulence factor which mediates the adhesion
of pneumococci to epithelial cells, and therefore, it has been sug-
gested to contribute to early stages of the infection (Barocchi
et al., 2006; Orrskog et al., 2012). In our model, the pilus structure
seems to have no role in the pneumococcal disease as the infection
of zebraﬁsh with a pilus-deﬁcient mutant of pneumococcus
(T4Drlr) resulted in a survival rate similar to an infection with wild
type bacteria (42%).
3.3. Invasive disease potentials of pneumococcal clinical isolates
Serotype- and clone-speciﬁc properties have been shown to
contribute to the ability of pneumococci to cause an invasive dis-
ease in humans. To study the potential impact of serotypes and clo-
nal types we challenged adult zebraﬁsh i.p. with 2.5  106 cfu of
clinical isolates belonging to serotypes with different invasive dis-
ease potential in man and in mice, serotypes 1, 6B, 14 and 19F
(Sandgren et al., 2004, 2005; Sjöström et al., 2006). As is shown
in Fig. 3, these isolates have varying virulence capacities in adult
zebraﬁsh; the mean survival percentages associated with the
strains differed from 4% for type 19F to 93% for type 6B. The strains
of serotypes 1, 4 and 14 caused an infection with moderate lethal-
ity, with mean survival percentages of 19%, 49% and 33%, respec-
tively. These results indicate that the zebraﬁsh model can
distinguish between the virulence differences of pneumococcal
isolates and can potentially be used in the characterization of the
virulence potentials of pneumococcal strains.
3.4. The adult zebraﬁsh model can be used to study pneumococcal
meningitis
Adult zebraﬁsh infected with pneumococci show swollen brain
cavities and visible cerebral edema, apparent signs of inﬂammation
of the brain (Fig. 4). Therefore, we next examined whether pneu-
mococci can cross the blood–brain barrier and consequently cause
meningitis in adult zebraﬁsh. We quantiﬁed the bacterial loads in
the whole brain tissue of adult zebraﬁsh during a pneumococcal
infection after an i.p. challenge with 2.5  106 cfu of T4. Blood sam-
ples were collected and the brain tissue removed at speciﬁc time
points. As is shown in Fig. 5, substantial amounts of bacteria are
present in the zebraﬁsh blood and brain already 2 h pi. Thereafter,
the bacterial load keeps increasing until 12–24 h pi. Noteworthy,
bacterial loads in the brain correlated with the bacterial loads in
the bloodstream (Fig. 5). These results indicate that pneumococci
are able to cross the blood–brain barrier and cause meningitis in
adult zebraﬁsh.
Furthermore, we examined whether the pneumococcal viru-
lence factors tested above contribute to meningitis in this model
and determined the bacterial burden 6 h pi in the blood and brain
of adult zebraﬁsh infected with the four T4 mutant strains. Infec-
tion with the capsular mutant T4R and the autolysin mutant
T4DlytA resulted in the lowest number of bacteria in the blood
and brain compared to the wild type T4, but only the difference be-
tween T4R and wild type bacteria was statistically signiﬁcant
(p < 0.05) (Fig. 6A and B). Also, we challenged the ﬁsh with the four
clinical isolates to study meningitis. The bacterial numbers in the
blood and brain of the infected ﬁsh were measured as above 6 h
pi. Although these isolates had different levels of virulence in adult
zebraﬁsh (Fig. 3), they cause equivalent levels of bacteremia and
meningitis (Fig. 6A and B).
Fig. 3. The virulence potential of invasive pneumococcal isolates in zebraﬁsh.
Survival of adult zebraﬁsh after an i.p. infection with serotypes 4 (T4), 14, 6B, 1 and
19F. The ﬁgure combines the results of three independent experiments (n = 20)
where zebraﬁsh were infected with 2.5  106 cfu of certain serotype. The asterisk
(⁄) depicts the statistically signiﬁcant difference compared to the T4 strain
(⁄⁄⁄p < 0.0001). Control ﬁsh were injected with 0.2 M KCl. Hpi = hours post infection.
Fig. 4. Gross pathology of adult zebraﬁsh after i.p. infection with T4. (A) Control ﬁsh
injected with 0.2 M sterile KCl. (B) Zebraﬁsh injected i.p. with 2.5  106 cfu of T4.
The black arrow indicates visible cerebral edema.
Fig. 5. Bacterial loads in the blood and brain of adult zebraﬁsh after an i.p. infection
with pneumococcus. The bacterial loads were measured at speciﬁc time points from
ﬁsh infected with 2.5  106 cfu of T4. The ﬁgure represents the mean (+SD) bacterial
burden in 5 ll of blood and 5 ll of a brain homogenate measured from 10
individuals. Hpi = hours post infection. Cfu = colony forming units.
A. Saralahti et al. / Developmental and Comparative Immunology 42 (2014) 345–353 349
3.5. The adult zebraﬁsh model is not an appropriate model for vaccine
studies
The survival assays indicated a rapid disease progression in
adult zebraﬁsh after an i.p. infection with wild type T4. This sug-
gests that the acute infection might be mainly resolved by compo-
nents of the innate immunity. In order to test the role of the
adaptive immunity in the acute infection, we used the transgenic
ﬁsh line, Rag1hu1999, which lacks the ability to undergo somatic
rearrangements, and therefore, active lymphocytes. The Rag1 mu-
tants were infected i.p. with 2.5  106 cfu of T4 and assayed for
survival. When compared to wild type ﬁsh, no signiﬁcant differ-
ence in the survival was observed (Fig. 7A). This result veriﬁes
our previous suggestion, that the infection kinetics of acute pneu-
mococcal infection is too fast to activate the adaptive arm of
immunity and that the adult zebraﬁsh resist the acute pneumococ-
cal infection primarily through mechanisms of their innate
immunity.
To test whether immunization can confer protection against a
pneumococcal infection in zebraﬁsh, groups of 20–30 ﬁsh were in-
fected with non-lethal doses of live T4, heat-killed T4, or live T4R
pneumococci prior to infection. Similarly, we also tested the pro-
tective effect of two commercially available pneumococcal vac-
cines, the 13-valent conjugate vaccine Prevenar 13 (Pﬁzer) and
the 23-valent polysaccharide vaccine Pneumovax 23 (Merck).
Both the i.p. and i.m. injection routes were tested for immunization
and the following infection was introduced through the same route
2 or 3 weeks later. Previously, it was shown that a teleost ﬁsh can
develop a protective antibody response in 3 weeks after sub-lethal
infection (Castro et al., 2013). As is shown in Fig. 7B, the pre-infec-
tion with T4, killed T4 or T4R did not signiﬁcantly reduce the mor-
tality of T4 infected adult ﬁsh compared to the mock immunized or
unimmunized ﬁsh. Similarly, the human pneumococcal vaccines
were not able to confer protection against a pneumococcal infec-
tion in the zebraﬁsh model (data not shown). In light of these re-
sults, we conclude that immunization does not confer protection
against pneumococci in this model.
Fig. 6. Levels of bacteremia and meningitis in the adult zebraﬁsh infected with T4 mutants and clinical strains of different serotypes. The bacterial loads were measured at
6 hpi from 5 ll of blood and 5 ll of a brain homogenate from adult ﬁsh infected i.p. with 2.5  106 cfu of the given strain. (A+B) Bacterial loads 6 hpi in the blood (A) and the
brain (B) of adult ﬁsh infected with T4, the un-encapsulated mutant (T4R), the autolysin deﬁcient mutant (T4Dlyt), the pneumolysin deﬁcient mutant (T4Dply), or the pilus
mutant (T4Drlr). (C+D) Bacterial loads at 6 hpi in the blood (C) and the brain (D) of adult ﬁsh infected with serotypes 4 (T4), 14, 6B, 1 and 19F. Control ﬁsh were injected with
0.2 M KCl. Hpi = hours post infection. Cfu = colony forming units.
Fig. 7. The role of the adaptive immunity in a pneumococcal infection in adult
zebraﬁsh. (A) Pneumococcal infection in zebraﬁsh Rag1 mutants. The Rag1 and wild
type ﬁsh were infected with 2.5  106 cfu of pneumococcus, after which the
mortality was recorded. No difference in the survival of these two groups can be
seen (p = 0.700). WT+KCl = wild type zebraﬁsh injected with KCl; WT+T4 = wild
type zebraﬁsh infected with T4; Rag+T4 = Rag1 mutant ﬁsh infected with T4. (B)
Immunization assays in adult zebraﬁsh. Groups of 20–30 adult ﬁsh were immu-
nized with live T4, live T4R, or killed T4 by an i.m. injection. Control ﬁsh received
either KCl immunization or no immunization. Immunized and control ﬁsh were
infected i.m. 2–3 weeks after immunization with 2.5  106 cfu of T4. Immunization
assays were repeated at least 3 times in each case, and the ﬁgure combines the
results of three separate experiments (n = 20–30). Hpi = hours post infection.
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4. Discussion
Zebraﬁsh are cost effective, easy to handle, and genetically
manipulate. These features make them, a very feasible tool for clar-
ifying the mechanisms of disease pathogenesis, for testing novel
drugs, and for investigating the role of host speciﬁc and pathogenic
factors in a variety of infections. Zebraﬁsh have been previously
used to model infections caused by important b-hemolytic strepto-
coccal pathogens such as zoonotic S. iniae (Neely et al., 2002) and
Streptococcus suis (Wu et al., 2008) as well as the human speciﬁc
strains S. agalactiae (Patterson et al., 2012) and Streptococcus pyog-
enes (Neely et al., 2002). Furthermore, we have previously estab-
lished a zebraﬁsh embryo model for pneumococcal pathogenesis
(Rounioja et al., 2012). In the present study we introduce an adult
zebraﬁsh model for a systemic pneumococcal infection and for
pneumococcal meningitis.
Our results show that the wild type pneumococcus strain T4
causes a fulminant infection in adult zebraﬁsh when introduced
through either an i.p. or an i.m infection route. Regardless of the
injection site, the infection is dose-dependent and leads to death
within 2–3 days after injection. With both injection routes the
lethal dose of pneumococcus that kills 50% of infected ﬁsh (OD50)
is approximately 2.5  106 cfu. When compared to other strepto-
cocci-zebraﬁsh models, for example S. iniae (LD50 of 5  103 cfu
for i.p. and i.m.), S. pyogenes (LD50 of 1  103 cfu for i.p. and
5  104 cfu for i.m.) and S. agalactiae (LD50 of 1  102 cfu for i.p.
and 1  104 cfu for i.m.) pneumococcus seems to be less virulent
in adult zebraﬁsh and a bigger dose of bacterial inoculate is needed
to cause a notable infection (Neely et al., 2002; Patterson et al.,
2012). The i.p. infection of adult zebraﬁsh leads to a systemic pneu-
mococcal infection associated with high levels of bacteremia and
therefore, this infection route was used throughout the study. Ra-
pid bacterial expansion in the blood demonstrates the ability of
pneumococcus to replicate in zebraﬁsh and cause an acute infec-
tion. If unrestricted, pneumococcal expansion leads to the death
of the ﬁsh. Simultaneously, we noticed that some zebraﬁsh were
able to resist the bacterial expansion leading to the complete clear-
ance of the bacteria within 4 days. Because of such a short time
period, we hypothesize that in lethal and sublethal infections in
adult zebraﬁsh the pneumococcus is primarily confronted by com-
ponents of the innate immunity and that the clearance of the pneu-
mococcus is mainly dependent on these factors. In our previous
study the innate immunity mechanisms associated with the clear-
ance of pneumococcus were investigated using the zebraﬁsh em-
bryo model for pneumococcal pathogenesis (Rounioja et al.,
2012). In that study we reported that pneumococcus activates
the common actors of the innate immunity, including phagocytosis
and the production of pro-inﬂammatory cytokines as a response to
infection in zebraﬁsh embryos. Although the clearance mecha-
nisms were not investigated more closely in the present study,
we suggest that the above listed innate responses are also impor-
tant for resisting pneumococcus in the adult zebraﬁsh model.
In addition to their innate immunity, adult zebraﬁsh possess a
fully developed adaptive immunity including both cellular and hu-
moral responses. An important role of the adaptive immunity in
the protection of zebraﬁsh from a M. marinum infection has been
reported (Meijer et al., 2005; Swaim et al., 2006). Importantly, a
M. marinum infection in adult zebraﬁsh can last months, long en-
ough for the activation of the adaptive immunity. In contrast, a
pneumococcal infection leads to death within a few days, a time
period probably too short for engaging the adaptive arm of immu-
nity. In order to verify this suggestion, we tested whether adult ﬁsh
from the transgenic line Rag1hu1999, which lack active lympho-
cytes, are hypersusceptible to pneumococcal infection. No differ-
ences between the survival of Rag1 mutants and wild type ﬁsh
were seen, indicating that the adaptive immunity has a limited role
in an acute pneumococcal infection in adult zebraﬁsh.
Although there is limited information on the zebraﬁsh in vacci-
nation studies, its ability to induce an immunological memory
upon immunization has been veriﬁed (Lam et al., 2004). Experi-
mental evidence for the effectiveness of immunization in zebraﬁsh
also exists, since pre-infections of adult zebraﬁsh with an attenu-
ated M. marinum mutant as well as an attenuated viral hemor-
rhagic septicemia virus have been shown to protect zebraﬁsh
from future infection (Cui et al., 2010; Novoa et al., 2006). How-
ever, we discovered that a pre-infection with inactivated T4, live
T4 or T4R does not seem to confer protection against future pneu-
mococcal infection indicating that pneumococcus does not induce
a protective immunological memory in our setting.
The adult zebraﬁsh provides an attractive model for the study of
speciﬁc host-pathogen interactions associated with a pneumococ-
cal infection. Previously, adult zebraﬁsh have been successfully
used in the search for novel virulence factors of S. iniae and S. pyog-
enes (Kizy and Neely, 2009; Miller and Neely, 2005). The model
proved to be particularly feasible and practical in large-scale
screens where previously unknown virulence determinants of
these streptococci were revealed. In the present study, we demon-
strate that the adult zebraﬁsh model for a pneumococcal infection
could also be reliably used in the search for novel virulence factors
of the pneumococcus; our result show a signiﬁcant attenuation in
virulence of T4 mutants lacking certain virulence factor compared
to the wild type T4. Most importantly, the un-encapsulated mutant
of T4, which has previously been shown to be avirulent (Nelson
et al., 2007; Watson and Musher, 1990), is almost completely
attenuated in adult zebraﬁsh. I.p. injections of the pneumolysin-
deﬁcient and the autolysin-deﬁcient mutants of T4 also resulted
in signiﬁcantly higher survival of the adult zebraﬁsh compared to
those infected with wild type T4. Previously, the important roles
of all these virulence factors in the pathogenesis of pneumococcus
as well as the attenuated virulence of the corresponding mutants
have been shown in rodent models of a pneumococcal infection
(Berry et al., 1989a,b). Therefore, our results demonstrate that also
pneumococcal virulence factors can be successfully studied in the
adult zebraﬁsh model.
An epidemiological study by Sjöström et al. (2006) reported a
correlation between disease severity and pneumococcal capsular
serotype. Serotypes 1, 4 and 7F have the highest invasive disease
potential in humans but rarely cause deaths, while other serotypes
such as 6B, 14 and 19F are more often associated with lethal infec-
tions. Previously, a mouse model for a pneumococcal infection was
used to investigate the varying virulence capacities of pneumococ-
cal serotypes and clonal types (Sandgren et al., 2005). In the pres-
ent study we used the adult zebraﬁsh model to compare the
virulence of ﬁve invasive pneumococcal serotypes 4, 14, 6B, 1
and 19F. Importantly, clear differences in the ability of these iso-
lates to cause a lethal infection were detected; serotypes 19F and
14 were the most virulent while an infection with 6B resulted in
almost 100% survival. Interestingly, the virulence of these strains
seems to differ from the virulence observed in mice, where i.p.
and intranasal injections of serotypes 4 and 6B caused the highest
lethality and level of bacteremia while 19F and 14 caused a more
moderate infection (Sandgren et al., 2005). The opposite ﬁndings
in mice and zebraﬁsh can in part be explained by the varying host
conditions (e.g., temperature) between these two model organ-
isms. Furthermore, pneumococcal strains are highly specialized
in infecting humans, where the speciﬁc host-pathogen interactions
required for the infection occur. Although no model is perfect for
the investigation of human isolates, we strongly suggest that the
zebraﬁsh model can be employed for assessing the disease poten-
tial of different pneumococcal serotypes and clonal types. Most
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importantly, this model could help to reveal the detailed host-
pathogen interactions associated with the different disease
capacities.
Pneumococcus is one of the most common causative agents of
bacterial meningitis and is associated with high mortality and se-
vere neurological sequelae in surviving patients (Chiavolini et al.,
2008). In humans the development of meningitis is usually pre-
ceded by pneumococcal bacteremia followed by the translocation
of the bacteria across the blood–brain barrier (Mook-Kanamori
et al., 2011). In the present study we demonstrate that a pneumo-
coccal bacteremia caused by an i.p. injection of T4 into adult zebra-
ﬁsh results in the invasion of the brain and develops into
meningitis. The development of meningitis in zebraﬁsh mimics
the common route of infection in humans and is associated with
visible signs of meningeal inﬂammation, including cerebral edema
and swollen brain cavities. Noteworthy, the severity of meningitis
in adult zebraﬁsh correlates with the level of the preceding bacter-
emia. We also evaluated the ability of pneumococcal mutants to
invade the brain and cause meningitis in this model. In particular,
the contribution of pneumolysin and autolysin in the onset and
progression of meningitis has been frequently studied in several
animal models (Friedland et al., 1995; Hirst et al., 2008; Wellmer
et al., 2002). However, results have been controversial, as Friedland
et al. reported no role for pneumolysin in the pathogenesis of men-
ingitis in rabbits, while Hirst et al. and Wellmer et al. showed that
the lack of pneumolysin and autolysin results in signiﬁcantly de-
creased signs of meningitis in mice and rats compared to the wild
type pneumococcus (Friedland et al., 1995; Hirst et al., 2008; Well-
mer et al., 2002). In agreement with Hirst et al. we found a slight,
although not signiﬁcant, decrease in the bacterial numbers in the
brain of autolysin-mutant infected ﬁsh compared to ﬁsh infected
with wild type bacteria (Hirst et al., 2008). In addition, an infection
with un-encapsulated mutants also resulted in a lower amount of
bacteria in the brain compared to wild type. Importantly, in each
case the lower levels of T4 mutants in the brain were accompanied
by a decreased bacterial load in the blood. This suggests that the
decreased ability of pneumococcal mutants to cause meningitis
in adult zebraﬁsh is mostly due to their more effective clearance
by innate immunity mechanisms in the blood, instead of an im-
paired ability to invade the brain tissue of the host.
5. Conclusions
The new vertebrate model introduced here shows potential for
use in future pneumococcal studies where both pathogenic and
host speciﬁc factors are investigated. We also report that pneumo-
coccal meningitis can be established in adult zebraﬁsh, which pro-
vides a valuable new tool for the forthcoming investigation of
pathophysiological mechanisms of bacterial meningitis and for
testing the efﬁcacy of novel drugs against the disease. Furthermore,
adult zebraﬁsh could provide a practical and more ethical model to
be used in large-scale mutagenesis screens where novel virulence
determinants of pneumococcus are investigated. Finally, we report
that the adaptive immunity has a limited role in an acute pneumo-
coccal infection in adult zebraﬁsh, and that the bacterium does not
induce a protective immunological memory in the ﬁsh, indicating
that this model cannot be used in the search for new vaccine can-
didates against pneumococcus.
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